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Abstract
One of the most common types of analysis in genome research
is the comparison of gene expression profiles (or transcriptomics)
to understand the relationship between genes (or genotype) and
the phenotype. Transcriptome analysis has been traditionally con-
ducted using microarrays and with increasing frequency since 2008
by RNA sequencing (RNA-seq). A fundamental goal in these
types of studies is to identify the genes whose expression changes
between different conditions, in other words, to select the most
relevant variables (genes) in terms of inter-condition variability.
The variable selection problem, usually known in transcriptomics
as “differential expression analysis”, can be addressed from the
univariate or multivariate point of view, but must always take
the complexity of the experimental design into account. One of
the challenges that biostatisticians face when tackling this prob-
lem is the so-called “curse of dimensionality”: hundreds or even
thousands of variables have to be analyzed with few observations
usually available. Therefore, it is essential to provide researchers
with efficient statistical tools to perform this task.
A typical approach to variable selection is to test the null hy-
pothesis of equality of average expression levels between two con-
ditions in a gene-wise fashion and to do this repeatedly for all
genes in the transcriptomics data set. However, transcriptomics
may also involve multifactorial experimental designs (eg multiple
treatments, several developmental states, time series...). The first
part of this thesis is dedicated to the variable selection problem
in multifactorial designs when multivariate methods are used to
model microarray gene expression profiles. In particular, we chose
the ASCA-genes multivariate technique as a starting point to pro-
pose some strategies to select differentially expressed genes in the
multivariate context, that were tested under different biological
scenarios.
RNA-seq technology emerged when work for this thesis was first
started and now it is widely applied in transcriptomics. RNA-seq
data is fundamentally different from microarray data and this has
motivated the development of new statistical methods to study
differential expression in this technology. Thus, the second part
of the thesis is entirely focused on RNA-seq experiments. First,
we develop a set of procedures to assess the quality of RNA-seq
measurements, to identify the potential biases of the technol-
ogy and to process the data to reduce the impact of technical
noise on statistical results. Secondly, we address the variable se-
lection problem for the two-class comparison case. Given that
some controversy exists on the theoretical distribution followed
by RNA-seq data, we opted to investigate non-parametric data-
driven techniques to overcome the limitations of parametric as-
sumptions and propose a strategy that is efficient in controlling
the false positive rate. Two methodologies, NOISeq for techni-
cal and NOISeqBIO for biological replicates, were developed and
compared to the state of the art methods.
Resumen
Uno de los ana´lisis ma´s comunes en investigacio´n geno´mica es la
comparacio´n de perfiles de expresio´n ge´nica (o transcripto´mica)
para entender la relacio´n entre los genes (o genotipo) y el fenotipo.
El ana´lisis del transcriptoma se ha llevado a cabo tradicional-
mente utilizando microarrays y cada vez con mayor frecuencia
desde 2008 mediante secuenciacio´n del ARN (RNA-seq). Un ob-
jetivo fundamental en este tipo de estudios es identificar aquellos
genes cuya expresio´n cambia entre condiciones, en otras palabras,
seleccionar las variables ma´s relevantes (genes) en te´rminos de
variabilidad entre-condiciones. El problema de seleccio´n de varia-
bles, normalmente conocido en transcripto´mica como “ana´lisis de
expresio´n diferencial”, se puede abordar desde el punto de vista
univariante o multivariante, siempre teniendo en cuenta la com-
plejidad del disen˜o experimental. Uno de los retos a los que los
bioestad´ısticos se enfrentan al tratar de resolver este problema es
la llamada “maldicio´n de la dimensio´n”: se tienen que analizar
cientos o incluso miles de variables con muy pocas observaciones
disponibles normalmente. Por tanto, es esencial proporcionar a
los investigadores herramientas estad´ısticas eficientes para llevar
a cabo esta tarea.
Un enfoque t´ıpico en seleccio´n de variables es contrastar la hipo´te-
sis nula de igualdad del nivel de expresio´n medio entre dos condi-
ciones para un gen particular y hacerlo repetidamente para todos
los genes del conjunto de datos transcripto´micos. Sin embargo, la
transcripto´mica puede conllevar tambie´n disen˜os experimentales
multifactoriales (mu´ltiples tratamientos, varios estados de desa-
rrollo, series temporales...). La primera parte de esta tesis se ha
dedicado al problema de seleccio´n de variables en disen˜os multi-
factoriales cuando se usan me´todos multivariantes para modelizar
los perfiles de expresio´n ge´nica en microarrays. En particular,
elegimos como punto de partida la te´cnica multivariante ASCA-
genes para proponer algunas estrategias de seleccio´n de genes
diferencialmente expresados en un contexto multivariante, que
fueron evaluadas bajo distintos escenarios biolo´gicos.
La tecnolog´ıa RNA-seq aparecio´ al comienzo de esta tesis y ahora
se aplica ampliamente en transcripto´mica. Los datos de RNA-seq
son en esencia diferentes a los datos de microarrays y esto ha mo-
tivado el desarrollo de nuevos me´todos estad´ısticos para estudiar
la expresio´n diferencial en esta tecnolog´ıa. Por tanto, la segunda
parte de la tesis se centra exclusivamente en experimentos de
RNA-seq. Primero, desarrollamos una coleccio´n de procedimientos
para determinar la calidad de las medidas de RNA-seq, identificar
los sesgos potenciales de la tecnolog´ıa y procesar los datos para
reducir el impacto del ruido te´cnico en los resultados estad´ısticos.
En segudo lugar, abordamos el problema de seleccio´n de variables
para el caso de comparacio´n de dos grupos. Dado que existe
cierta controversia en la distribucio´n teo´rica que siguen los datos
de RNA-seq, optamos por investigar te´cnicas no parame´tricas di-
rigidas por los datos para vencer las limitaciones de las hipo´tesis
parame´tricas y propusimos una estrategia que es eficiente a la
hora de controlar la tasa de falsos positivos. Se desarrollaron
dos metodolog´ıas, NOISeq para re´plicas te´cnicas y NOISeqBIO
para re´plicas biolo´gicas, y se compararon con los me´todos ma´s
punteros.
Resum
Una de les ana`lisis me´s comunes en investigacio´ geno`mica e´s
la comparacio´ de perfils d’expressio´ ge`nica (o transcripto`mica)
per entendre la relacio´ entre els gens (o genotip) i el fenotip.
L’ana`lisi del transcriptoma s’ha dut a terme tradicionalment uti-
litzant microarrays i cada vegada amb me´s frequ¨e`ncia des de
2008 mitjanc¸ant la sequ¨enciacio´ de l’ARN (RNA-seq). Un ob-
jectiu fonamental en aquest tipus d’estudis e´s identificar aquells
gens l’expressio´ dels quals canvia entre condicions, en altres pa-
raules, seleccionar les variables me´s rellevants (gens) en termes
de variabilitat entre-condicions. El problema de seleccio´ de vari-
ables, normalment conegut en transcripto`mica com a “ana`lisi
d’expressio´ diferencial”, es pot abordar des del punt de vista uni-
variant o multivariant, sempre tenint en compte la complexitat del
disseny experimental. Un dels reptes a que` s’enfronten els bioes-
tad´ıstics en tractar de resoldre aquest problema e´s l’anomenada
“maldicio´ de la dimensio´”: s’han d’analitzar centenars o milers de
variables amb molt poques observacions disponibles normalment.
Per tant, e´s essencial proporcionar als investigadors ferramentes
estad´ıstiques eficients per a dur a terme aquesta tasca.
Un enfocament t´ıpic en seleccio´ de variables e´s contrastar la
hipo`tesi nul·la d’igualtat de nivells d’expressio´ mitjans entre dues
condicions per a un gen particular i fer-ho repetidament per a tots
els gens del conjunt de dades transcripto`miques. No obstant aixo`,
la transcripto`mica pot comportar tambe´ dissenys experimentals
multifactorials (mu´ltiples tractaments, diversos estats de desen-
volupament, se`ries temporals...). La primera part d’aquesta tesi
s’ha dedicat al problema de seleccio´ de variables en dissenys mul-
tifactorials quan s’usen me`todes multivariants per a modelitzar els
perfils d’expressio´ ge`nica en microarrays. En particular, tria`rem
com a punt de partida la te`cnica multivariant ASCA-genes per a
proposar algunes estrate`gies de seleccio´ de gens diferencialment
expressats en un context multivariant, que van ser avaluades sota
diferents escenaris biolo`gics.
La tecnologia RNA-seq va apare`ixer al comenc¸ament d’aquesta
tesi i ara s’aplica a`mpliament en transcripto`mica. Les dades de
RNA-seq so´n en esse`ncia diferents a les dades de microarrays i
ac¸o` ha motivat el desenvolupament de nous me`todes estad´ıstics
per a estudiar l’expressio´ diferencial en aquesta tecnologia. Aix´ı
doncs, la segona part de la tesi se centra exclusivament en ex-
periments de RNA-seq. En primer lloc, vam desenvolupar una
col·leccio´ de procediments per a determinar la qualitat de les
mesures de RNA-seq, identificar biaixos potencials de la tecnolo-
gia i processar les dades per a reduir l’impacte del soroll te`cnic en
els resultats estad´ıstics. En segon lloc, es va abordar el problema
de seleccio´ de variables per al cas de comparacio´ de dos grups.
Donat que existeix certa controve`rsia en la distribucio´ teo`rica
que segueixen les dades de RNA-seq, vam optar per investigar
te`cniques no parame`triques dirigides per les dades per a ve´ncer
les limitacions de les hipo`tesis parame`triques i vam proposar una
estrate`gia que e´s eficient a l’hora de controlar la tasa de falsos
positius. Es desenvoluparen dues metodologies, NOISeq per a
re`pliques te`cniques i NOISeqBIO per a re`pliques biolo`giques, i es
compararen amb els me`todes me´s capdavanters.
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Introduction
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1.1 What is transcriptomics about?
The cell is the basic structural, functional and biological unit of a living
organism. There are two types of cells, eukaryotic cells, which contain a
nucleus, and prokaryotic cells, which do not. Prokaryotic cells are usually
single-celled organisms, while eukaryotic cells can be either single-celled or part
of multicellular organisms. Plants, animals, fungi, slime moulds, protozoa,
and algae are all eukaryotic.
The three main components of eukaryotic cells are the membrane, cy-
toplasm, and nucleus (Figure 1.1). The membrane is a lipid structure that
preserves the integrity of the cell and selectively regulates the flux of nutrients
and proteins. The nucleus contains the chromosomes, which are made up of
DNA (deoxyribonucleic acid). The genes, which are the hereditary units of
biological organisms, are localized along the DNA chains. In the cytoplasm,
there are many different molecules such as RNA (ribonucleic acid), proteins,
carbohydrates, etc. and also organelles that are responsible for various cellular
functions. RNA molecules are also known as transcripts and contain informa-
tion transcribed from DNA, which is translated into proteins by ribosomes.
Proteins are constituted by amino acid sequences and are the basic functional
elements of cellular physiology and metabolism.
Figure 1.1: Diagram of a eukaryotic cell
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DNA molecules (where genes are located) form a double helix: each DNA
chain is a linear sequence of nucleotides that are composed of one of the four
following bases: adenine (A), cytosine (C), guanine (G) and thymine (T). The
genetic information encoded by this sequence of bases determines the order of
amino acids in the protein and three DNA bases (a codon) encode one amino
acid. However, only a small part of the whole genome (3-8% in humans)
is considered “functional”, the part that encodes proteins or functional RNA
[32]. This means that most of the DNA is “non-functional” and may have
other structural or regulatory functions. For many years, it was believed
that each gene coded for a single protein because there are genetic diseases
in which a single gene mutation causes disease by disrupting the protein it
encodes. However, it is now known that a gene can encode more than one
protein through the process of “alternative splicing” and that a protein can
be encoded by more than one gene. Moreover, proteins may undergo post-
translational modifications and therefore, in higher eukaryots one single gene
serves as the basis for many possible versions of a particular protein.
The genetic code is the set of rules that defines how the information
contained in the sequence of bases in the genes is transfered to the amino
acids that form the proteins. But the fact that DNA is in the cell nucleus and
that proteins are synthesized by ribosomes located in the cytoplasm implies
the existence of a mechanism to transfer this information from the nucleus to
the cytoplasm. This process is called transcription (Figure 1.2), the synthesis
of DNA-derived intermediary molecules in the nucleus: RNA transcripts. RNA
has a similar structure to DNA, but is single chained rather than a double
helix and one of the four bases, thymine (T) is replaced by uracil (U). RNA
molecules are transported to the cytoplasm and the information they contain
(determined by the A, U, C and G base sequence) is translated to a specific
sequence of amino acids that constitutes a protein. Alternatively, RNAs may
not be translated into proteins and instead perform their cellular function as
“non-coding RNA” molecules which have different regulatory and processing
roles.
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Figure 1.2: Transcription and translation
Thus, the process of producing a biologically functional molecule of either
RNA or protein from DNA is called gene expression and this process consists
of two basic steps: transcription and translation. During transcription, a gene
(DNA) is copied into a transcript (RNA). In the case of protein-coding genes,
the translation allows for the RNA to generate a protein; non protein-coding
genes go through transcription but are not translated into a protein. The
number of transcripts synthesized from a certain gene in a given cellular con-
text is known as the expression level of that gene. Unlike the genome, which
is roughly fixed for a given cell line (excluding mutations), the transcriptome
varies through development and between different tissue types in response
to external environmental conditions. The composition of the transcriptome
reflects which genes are being actively expressed at any given time.
Therefore transcriptomic analyses essentially compare gene expression pro-
files between biological samples or experimental conditions to identify differ-
ences that could help to infer the function of the genes or understand the
ongoing biological processes. For instance, studying the genes that are dif-
ferentially activated between healthy and diseased people could help to find
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candidate genes that may be responsible for causing the disease, and which
could therefore become therapeutic targets.
There are many methods for measuring gene expression levels: transcrip-
tomics refers to the situation where all genes are observed simultaneously so
high-throughput techniques are needed to estimate the expression of thou-
sands of genes in order to obtain a global picture of cellular activity. The
most widely used techniques in this field are DNA microarray technology and
RNA-seq which are both described in detail in the next section.
1.2 Measuring gene expression
The cell transcriptome is dynamic: as opposed to the static genome, the
transcriptome continually changes. Expression profiling experiments often in-
volve measuring the relative amount of transcripts arising from each gene in
two or more experimental conditions. Altered gene expression levels suggest
a change in the level of the protein encoded by the gene and may indicate
the cause of a disease or the response to perturbations, clinical treatments, or
environmental conditions. Thus, gene expression changes may provide impor-
tant clues to understanding the biological mechanisms underlying differences
between phenotypes, i.e. the differences in the observable characteristics or
traits of an organism.
Some techniques for measuring gene expression include: microarrays, real-
time polymerase chain reaction (RT-PCR), serial analysis of gene expression
(SAGE), and RNA sequencing (RNA-seq). In this section, we describe the
most widely used high-throughput techniques for measuring gene expression:
microarrays and RNA-seq which were used to generate the data analyzed in
this work.
1.2.1 Microarrays
DNA microarrays (also called chips or arrays) are used to measure the ex-
pression level of a large number of genes simultaneously. The most common
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Figure 1.3: Example of a microarray.
types of microarrays for transcriptomics are cDNA arrays and oligonucleotide
arrays that are used in combination with one or two dye-labeling strategies.
A microarray is a solid surface which contains a collection of microscopic
DNA spots representing short sections of genes (Figure 1.3); these spots are
usually known as probes, and each one corresponds to a different gene. In
the case of one-color microarrays (one dye-labeling), the RNA of the bio-
logical sample being studied is labeled with a fluorescent dye and hybridized
to these target probes. Hybridization occurs between complementary nucleic
acid sequences because of their propensity to specifically pair with each other
by forming hydrogen bonds. Fluorescently labeled target sequences that bind
to a probe generate a signal. The intensity of that signal is measured with
a scanner and the intensity of each probe is registered. These intensity val-
ues are the expression level estimations of the target genes, once they have
been corrected for the background noise or other technical effects: the higher
the intensity of a given probe the higher the amount of RNA (transcripts) in
the biological sample and, therefore, the higher the expression level of that
particular gene.
Transcriptomic experiments usually consist of studying several biological
samples from different experimental conditions, which requires the processing
of several microarrays (one per sample). However, the measurements ob-
tained must be comparable for all samples: the procedure for transforming
the data to make meaningful biological comparisons is called normalization
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[115]. The gene expression values produced by microarray technologies are
continuous measurements and it is generally accepted that, albeit with ap-
propriate transformations on occasions, they follow a Gaussian distribution,
and many statistical methods have been adapted or developed to model this
kind of data based on this assumption [33, 133].
The advantage of DNA expression microarrays is that they can estimate
the relative activity of thousands of genes. However, the target genes must
have been previously characterized and it is not possible to identify or measure
genes that have not yet been discovered.
1.2.2 RNA-seq
Massive parallel DNA sequencing1 is termed as next generation sequencing
(NGS) or second-generation sequencing, and encompasses several technolo-
gies such as DNA-seq, RNA-seq, ChIP-seq, DNase-seq, Methyl-seq, among
others. Some of these technologies have been commercially available since
2005. Sequencing platforms can sequence millions of short reads (50-400
bases each) per instrument run and thus genome-wide studies are possible
using this technology. The advent of NGS technologies has created unprece-
dented possibilities for the characterization of genomes and has significantly
advanced our understanding of its organization. They can now be used to
tackle the de novo sequencing of large genomes [9, 87, 146], report individual
genome differences within the same species (DNA-seq or resequencing) [1],
characterize the interaction spectrum of DNA-binding proteins (ChIP-seq)
[110], map chromatin structure (DNase-seq, Hi-C), and to create genome-
wide epigenetic modification profiles (Methyl-seq) [84].
One of the most ground-breaking applications of NGS techniques is the
deciphering of the complexity of the transcriptome by means of RNA se-
quencing technology (RNA-seq). In the last few years the use of RNA-seq
has resulted in an incredible amount of new data that has dissected gene
1DNA sequencing is the process of determining the precise order of nucleotides within
a DNA molecule.
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isoforms1, allelic expression2, and extended 3’ UTR regions3, as well as re-
vealing novel splice junctions, modes of antisense regulation, and intragenic
expression [23, 52, 100, 144]. In addition, RNA-seq has made sequence-based
expression analysis an increasingly popular alternative to microarrays because
any active gene can be measured, as opposed to the pre-characterized set
of known genes which are recognized by microarrays. Other advantages of
RNA-seq have also been claimed, such as having a wider dynamic range of
expression measurements and a lower technical variability.
As previously described [107], in most RNA-seq experiments a sample of
purified RNA is taken, sheared, and converted to cDNA (as also done for
cDNA arrays). However, in contrast to microarrays, this cDNA is sequenced
on a high-throughput platform (e.g. Illumina, SOLiD or Roche 454). For
instance, the sequencing chemistry in the Illumina system occurs in the flow-
cell, which is a glass slide separated into lanes (usually 8) into which different
biological samples can be deposited (Figure 1.4).
The sequencing process generates millions of short reads (25 to 300 bp)
taken from one end of the cDNA fragments. When short reads from both
ends of each cDNA fragment are generated, they are called “paired-end”
reads. The platforms differ substantially in their chemistry and processing
steps, but the raw data they produce always consist of a long list of short
sequences with associated quality scores.
1Isoforms are transcripts produced from the same locus (specific spot on a chromo-
some), but their transcription start sites (TSSs), protein coding DNA sequences (CDSs), or
untranslated regions (UTRs) can differ, potentially altering gene function.
2Most multicellular organisms have two sets of homologous chromosomes. An allele is
the copy of a gene on each chromosome. The two alleles of a given gene are inherited, one
from each parent.
3DNA strands have directionality, since double helices are necessarily directional (a
strand running 5’-3’ pairs with a complementary strand running 3’-5’). DNA replication
occurs only in the 5’-3’ direction. The 3’-UTR is the section of messenger RNA that imme-
diately follows the translation termination codon, so this part of the gene is not translated
into a protein. However, the 3’-UTR often contains post-transcriptional gene expression
regulatory regions.
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Figure 1.4: Illumina flow-cell.
In contrast to microarrays, where the raw data generated requires little
pre-processing to obtain an expression level estimation, a more laborious pro-
cedure must be followed to obtain an expression estimation using the RNA-seq
strategy (an example of a process pipeline is shown in Figure 1.5). First, se-
quencing reads are mapped onto the reference genome, i.e. their genomic
location of origin must be identified. Some of the reads will not map to
the reference genome because of potential sequencing errors, or differences
in the sample and reference genome sequences, etc. Second, if the reference
genome has previously been studied and characterized (i.e. annotated) and
gene positions within each chromosome are known, the mapped reads from
each of the biological samples corresponding to each annotated gene can be
quantified. The number of sequencing reads mapped to a given gene is an
estimation of the expression level of that gene [92]. Finally, as occurs when
microarrays are used, these estimated expression levels have to be normalized
in order to remove unwanted technical effects and to calibrate the observa-
tions (samples).
Consequently, the nature of RNA-seq data is very different to microarrays.
Expression estimates from RNA-seq for a given gene are discrete measure-
ments since they are defined as the number of reads mapping to that gene
(read counts). Hence, statistical models developed for microarray analysis
have had to be revised for use for RNA-seq analysis. It is not easy to find a
good formula to transform these count data into a continuous distribution,
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Figure 1.5: Example of an RNA-seq analysis pipeline.
especially in the lower count range and for small samples. Initial analyses
using only technical replicates1 assumed that read counts followed a Poisson
distribution [18, 92]. However, soon it became clear that biological variability
was not well described by this distribution as over-dispersion was observed
among biological replicates. Thus, to take biological variability into account,
a negative binomial distribution (which would be equivalent to a Poisson dis-
tribution when the mean and variance are equal) is generally accepted as a
good option for modeling RNA-seq data [4, 122]. Even so, other specific
statistical methods for this new technology following different approaches are
still being developed.
1In RNA-seq, technical replicates are often considered to be the different sequencing
runs performed on the same biological sample. For instance, in Illumina technology, each
lane containing the same biological material might be taken as a technical replicate.
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1.3 The role of statistics in transcriptomics
Transcriptomics and other omics disciplines that study biological systems from
different perspectives all yield a huge amount of data to be stored, retrieved,
organized and analyzed. Bioinformatics is an interdisciplinary field that deals
with these topics. It covers tasks from the design or adaptation of statistical
models and algorithms for analyzing high-throughput data to the implementa-
tion of efficient software tools to generate useful biological knowledge. Hence
different areas such as computer science, mathematics, engineering and, of
course, statistics converge and interact in bioinformatics in order to success-
fully address these problems. There are several omics data analysis challenges
which are discussed in the following paragraphs:
First, the technical noise in the data is often high and thus an efficient
pre-processing step is required before starting the statistical analysis. The
process of removing technical effects to make samples and observations com-
parable is called “normalization”. These normalization methods aim to ensure
that technical biases minimally impact the results of the statistical analyses.
There are technical biases specific to each technology: two such technical
aspects which characterize microarrays are background noise and the differ-
ences between array platforms, although many methods have been suggested
to correct these unwanted sources of data variation [150]. The main biases
that can alter the expression levels of RNA-seq are the different number of
sequencing reads generated for each sample, the gene length, and the guanine
and cytosine nucleotide gene content (GC content). These aspects will be
looked at in more depth in Chapter 4. There are also other potential biases
that are more general, such as “batch effects”. These effects may appear
when biological samples have been processed at different moments, by dif-
ferent laboratories, on different devices, etc, although if the experiment has
been appropriately designed it is possible to remove or at least mitigate this
effect.
Another important challenge for statistics is the dimensionality of omics
data. Thousands of variables are typically generated in one experiment, while
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Figure 1.6: Total number of genes and transcripts for different species.
the sample size tends to be relatively small (most studies are not bigger than
twenty or thirty observations). In transcriptomics, and in particular in this
work, the variables analyzed are gene expression levels and the observations
are biological samples where the expression levels have been measured. Figure
1.6 shows the number of genes or transcripts for different species to illustrate
the high number of variables in the analysis of transcriptomic data.
When analyzing an experiment in which the expression levels were mea-
sured under different experimental conditions (over time, for different treat-
ments, or diseases, etc.), the first question that obviously arises is if an asso-
ciation between the expression of the gene and the experimental conditions
(i.e. the covariate) exists. In other words, the aim of the analysis is to identify
the genes with expression changes across conditions, a problem which is also
known as “differential expression analysis”. Many different approaches can
be envisaged to address differential expression (DE) studies and these can be
classified into two groups: univariate and multivariate methodologies.
Univariate statistical approaches are probably the most popular. In gen-
eral, they consist of testing a null hypothesis for each one of the variables
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(genes). The null hypothesis is equivalent to saying that gene expression is
not affected by the covariate that describes the experimental conditions com-
pared [108, 121, 133]. Due to the dimensionality problem mentioned above,
specifically the low number of available observations, it is common that meth-
ods in this category borrow information from all genes to better estimate the
parameters of the statistical model. In addition, the high number of tests
performed may lead to a pronounced increase in the false positive rate and so
multiple testing corrections must be used to adjust the p-values and reduce
the number of false positives [11, 39, 138]. A very well-known procedure to do
this is Bonferroni’s adjustment which aims to reduce the family-wise error rate
(FWER), i.e. the number of rejected true null hypotheses. However, Bonfer-
roni’s method is too restrictive and the reduction in false positives it would
produce comes at the expense of increasing the number of false negatives,
thus losing statistical power. Hence, other more permissive procedures have
been proposed with the goal of reducing the false discovery rate (FDR), rather
than the FWER. The FDR is defined as the proportion of true null hypotheses
with respect to the number of rejected null hypotheses. There are a number
of procedures that aim to reduce the FDR, among them the one proposed by
Benjamini and Hochberg [11], which is widely used in Bioinformatics.
An alternative to univariate methods is multivariate analysis which takes
into account the joint distribution of all variables in the study [20, 78, 103].
In transcriptomics, it is quite common to apply multivariate tools such as
clustering or principal component analysis (PCA) to explore the data prior to
statistical analysis to check if replicates within the same condition are properly
clustered or if there is a batch effect in the data. However, it is more unusual
to resort to these kinds of tools to analyze differential expression, maybe due
in part to the difficulty of identifying differentially expressed genes (DEG)
using these models. Even so, some examples can be found in the literature
that tackle the problem of differential expression from a multivariate approach
which succeed in selecting the most relevant genes [103, 114]. In addition,
these multivariate methodologies can be complemented by incorporating pre-
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viously known biological information, such as the biological pathways in which
genes are involved or their specific functional role. This class of methods is
classified as “pathway analysis” and focuses on analyzing sets of genes which
share, for instance, the same biological function [31, 36, 74, 104].
Both univariate and multivariate models can be constructed either un-
der parametric assumptions, i.e. based on data following a given probability
distribution, or without distributional assumptions. In transcriptomics (or
bioinformatics in general), it is not always straightforward to find a proba-
bility distribution that fits the data or even a suitable transformation that
fulfills the parametric assumptions. As previously mentioned, gene expression
is generally supposed to follow a Gaussian distribution when measured by mi-
croarrays and a Poisson or Negative Binomial distribution when RNA-seq is
used. Nevertheless, this may not always be a true and model validation (that
is required to check the distribution hypothesis), becomes tedious given the
huge number of models obtained in univariate analyses. On top of this, the
small number of replicates makes it difficult to estimate the model parame-
ters and information must often be borrowed from the rest of the variables
[122, 133]. Alternatively, non-parametric methods can instead be used to
tackle all these difficulties and resampling procedures are a very popular ap-
proach in this field [82, 109].
Once the differentially expressed genes (DEGs) have been identified, their
functional profile is usually interrogated to establish if they share biological
functions that are not characteristic of the rest of the genes. This type of
analysis is named “functional enrichment analysis” or “pathway analysis”.
There are many genes associated with a given biological function (e.g. “lipid
transport”), and a single gene may have many different biological functions.
Therefore, for each biological function and a given set of DEGs, a contingency
table can be generated to count the number of genes inside and outside this
set, and belonging to that functional category or not. To assess if the set
of DEGs is enriched in a particular function, a test of independence such as
18 1. INTRODUCTION
Fisher’s exact test can be performed. Again, many tests must be performed
(one per functional category) and multiple test correction is advisable.
In summary, transcriptomic studies do not only require a wide-ranging
knowledge of existing statistical methods to extract relevant biological infor-
mation from the data, but also a lot of inventiveness and flexibility in order to
find efficient and practical solutions for researchers. Moreover, biotechnology
is permanently evolving, and at high speed: in particular, technologies used
for measuring gene expression have undergone a major revolution over the last
few years. Microarrays became a very popular technique during the nineties,
but the more recent NGS technologies such as RNA-seq are replacing them.
Third generation, or single molecule long-read technologies (PacBio, Oxford
Nanopore), are also starting to take off which might create new sets of tran-
scriptome data in the future. As previously mentioned, the nature of the data
generated by each technology is very different, consequently, models used to
describe each type of transcriptomic data should be different and therefore
the development of new statistical procedures is constantly required [83].
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2.1 Motivation
One of the most common types of analysis in biological research is the com-
parison of gene expression profiles. A fundamental goal in these types of
genome-wide study is to identify genes whose expression profile changes be-
tween conditions, in other words, to select the most relevant variables (genes)
in terms of inter-condition variability. The variable selection problem, which is
usually known in transcriptomics as “differential expression analysis”, can be
addressed from the univariate or multivariate point of view, but the complexity
of the experimental design must always be taken into account.
When this PhD thesis started in 2009, DNA microarrays were a mature
technology used to measure gene expression levels and, due to their afford-
able cost, there were many experiments available that included many differ-
ent treatment types, developmental states, time series, etc. A wide variety
of statistical procedures had already been designed to identify differentially
expressed genes and their functional relationships [108, 115, 133, 139]. Specif-
ically, our group had been working on both univariate [3, 29] and multivariate
[3, 30, 103, 104] methodologies to solve these problems for complex exper-
imental designs such as single or multiple time course experiments, and we
detected a lack of proper tools to address differential gene expression analysis
in these scenarios. This motivated the first part of this thesis (Chapter 3),
which is dedicated to the variable selection problem when using multivari-
ate approaches to model microarray gene expression profiles. In particular,
we chose the ASCA-genes multivariate technique [103] as a starting point to
propose some strategies to select the genes responsible for phenotype changes
among different experimental conditions.
However NGS technologies quickly became common place in transcrip-
tome analysis and RNA-seq data were being generated in our projects, mak-
ing it necessary to develop new strategies to deal with this new kind of data.
Therefore, the second part of this work is entirely focused on RNA-seq exper-
iments. Being a novel technology, we first had to address the issue of data
quality monitoring to evaluate the accuracy of expression estimation. Chapter
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4 of this thesis deals with the quality assessment of expression measurements,
the potential sources of bias in the technology and how to process the data
to reduce the impact of technical noise on statistical results. In Chapter 5,
the variable selection problem for the two-class comparison case (differential
expression) is discussed. As stated in the previous chapter, the nature of
expression data for RNA-seq is different to microarrays, so specific DE meth-
ods were needed for this technology. We opted to develop non-parametric
data-driven procedures to overcome the limitations of parametric assump-
tions, and showed that these were efficient in controlling the false positive
rate: two methodologies (NOISeq and NOISeqBIO), for technical and biolog-
ical replicates respectively, were proposed and compared to the state of the
art methodologies.
This thesis has given me the opportunity to examine new and exciting
fields such as cell biology and bioinformatics, and specifically transcriptomics.
The principles of gene expression, the different ways of measuring it and the
statistical approaches for analyzing expression data obtained from different
technologies were studied in depth. It has been very challenging and enriching
to search for and develop suitable statistical tools to discover the biological
stories at the root of each transcriptomic project. Hopefully, these pages will
reflect the enthusiasm devoted to it.
2.2 Aims
1) To develop variable selection strategies for multivariate methods
applied to microarray data.
When using multivariate methods to model the association of gene
expression to covariates describing the experimental conditions under
study, a posteriori selection of the genes which meaningfully contributed
to the model construction is normally desired. These should be genes
with a significant change in expression levels between conditions. Vari-
able selection strategies will be studied, using our group’s previous work
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[103] as a starting point. In particular, the following tasks will be un-
dertaken:
• Proposal of new variable selection methods or variations of exist-
ing ones in the context of multivariate techniques for dimension
reduction.
• Simulation of multi-factorial expression data and assessment of
variable selection strategies on these synthetic data.
• Application of the best selection strategies to experimental data to
identify the genes responsible for human stem cell differentiation
under different oxygen concentration conditions.
• Application of these strategies to other analysis scenarios to assess
the general validity of the methods when using other multivariate
techniques.
2) To generate tools to control the quality of count data from se-
quencing experiments in order to discover potential biases and to
propose procedures to mitigate their effect.
Sequencing technologies such as RNA-seq produce count data that
might be biased due to technical noise. It is convenient to remove
or, at least, reduce these unwanted technical effects before performing
further statistical analyses. Regarding this issue, we will focus on the
following aspects:
• Design exploratory and diagnostic graphical tools to detect poten-
tial technical biases.
• Show the usefulness of these exploratory tools using different RNA-
seq experimental data sets.
• Review of the most popular normalization procedures to remove
these biases, and apply some of them to experimental data.
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• Propose methods to filter out low-count features, which are unre-
liable and can decrease the power of statistical methods to identify
true effects of the experimental factors.
3) To develop differential expression methodologies for RNA-seq
data.
There are many parametric methods available to study DE in pair-wise
comparisons. These kinds of methods might present some limitations
regarding the distributional assumptions but few non-parametric alter-
natives exist. In this work, we will propose two complementary non-
parametric approaches for application on data with technical replicates,
no replicates at all or with biological replicates. These are the main
issues we will address in this section:
• Development of the NOISeq method which can be applied to data
with technical replicates or without replicates. Comparison of
NOISeq to other DE methodologies on both simulated and ex-
perimental datasets.
• Adaptation of the NOISeq method for use on data with biolog-
ical replications (NOISeqBIO). Evaluation of several versions of
NOISeqBIO on simulated data to determine the best option.
• Comparison of NOISeqBIO to other DE methods in several simu-
lated scenarios to check the method’s performance and to assess
the influence of biological parameters such as noise, number of
features, percentage of differentially expressed genes, etc. on the
DE results.
2.3 Main contributions
I first arrived to Bioinformatics Department at the CIPF in 2008 to co-
supervise the final year project of one of my students at the Technical Univer-
sity of Valencia (“Functional prediction of novel citrus sequences from gene
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expression analysis”, awarded by Bancaja Prize 2008). About one year later,
I started to work on this thesis. Therefore, my first collaborations [104, 114]
taught me the basics of transcriptomics (specifically about microarray data
analysis) and allowed me to identify which lines of work in the group I would
follow. I became primarily interested in multivariate approaches and, in par-
ticular, in the variable selection problem. That is why the first part of this
document (Chapter 3) is focused on the study of variable selection strategies
in multivariate models, as published in [31, 113, 142]. Some of these strate-
gies were implemented in a web tool for analyzing serial gene expression data
named SEA [102].
By that time, NGS technologies emerged and there was a need for the
development of ad-hoc statistical methods to analyze this kind of data. RNA-
seq was rapidly gaining popularity in gene expression estimation but, due to
the still high cost of the technology, the experiments available at that time
had very simple designs, usually including only two experimental groups and
only a few replicates. Hence, the context for the variable selection problem
had slightly changed. First, we established pipelines for RNA-seq data qual-
ity assessment and pre-processing to obtain normalized and bias-free data
(Chapter 4) and then we focused on the variable selection problem for pair-
wise comparisons (Chapter 5). All these methodologies were gathered into
a Bioconductor R package named NOISeq and summarized in [141] and in
another paper (in preparation). The quality control tools were also imple-
mented in Qualimap software [49]. Our expertise in analyzing RNA-seq data
helped us to update the maSigPro tool [29] for dealing with RNA-seq time
series [105].
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3.1 Introduction
High-throughput genomic and transcriptomic experiments generate data for a
high amount of variables (e.g. genes) on a much lower number of individuals
(samples). Common approaches to explore this kind of data are clustering
methods such as hierarchical or KNN clustering [89, 135], and dimensional-
ity reduction techniques such as Principal Component Analysis (PCA). PCA
[63, 64, 68, 112] is frequently used in transcriptomic data to group samples,
identify associated genes or to spot those genes or samples behaving com-
pletely different from the rest [34, 117]. In simple case-control studies, the
methodology is able to provide biologically interpretable results. However,
more complex experimental designs can also be found in transcriptome re-
search, that include factors such as time effect, treatment, tissue, strain, etc.,
at different levels, giving rise to high-dimensional multifactorial datasets. For
these multifactorial experiments, other dimension reduction techniques exist
that tackle the analysis of the data in a more efficient way and achieve a better
interpretation of the results. Some examples are Tucker3 [145] or PARAFAC
[62], which have been successfully applied to the analysis of genomic data
[151]. Another interesting approach is ASCA (ANOVA-Simultaneous Com-
ponent Analysis) [132], adapted to genomic data in the ASCA-genes software
[103]. ASCA-genes is a powerful tool to extract targeted signals from noisy
data in complex experimental setups using a combination of ANOVA-like data
decomposition and PCA.
In many cases, though, descriptive analysis is not the only goal of the ex-
periment, but also the identification of responsive (or activated) genes, since
they give the clue to the molecular biology interpretation of transcriptional
regulation. When facing the issue of variable selection within the framework
of dimension reduction techniques, there exist some rules of thumb such as
considering that a variable is important if its loading absolute values are higher
than a certain threshold. However, this is a rather arbitrary way of select-
ing variables. More sophisticated variable selection methods can be found
in the literature, especially for PCA. Jolliffe [69, 70] used the absolute value
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of PCA loadings to measure the contribution of the original variables to the
model and selected as many of these variables as the number of selected la-
tent variables in order to retain the maximum variance of the data. McCabe
[95] recommended four different criteria to select what he called principal
variables and then evaluated all possible subsets of original variables to find
the one optimizing the pursued criterion. Krzanowski [76] combined PCA
with Procrustes analysis to select those variables preserving the multivariate
data structure, and used a Procrustes criterion to quantify the similarity of
compared structures. Since exploring all the subsets of q variables (q being
the number of variables to be selected) might be very computationally ex-
pensive, he included a backward procedure to discard variables. Guo et al.
[55] improved the search of the best subset in the latter method by applying
a genetic algorithm to avoid exhaustive searching. Westad et al. [149] used
Student’s t-tests based on loadings and their estimated standard uncertainties
to calculate the significance on each variable for each component. Principal
Feature Analysis [88] is based on taking PCA loadings and clustering them us-
ing the K-Means algorithm. The number of clusters must be equal or greater
than the number of PCs. In each cluster, the closest variable to the mean
of the cluster is selected (principal feature). Finally, variable selection can
be carried out by applying Sparse Principal Component Analysis [90]. Sparse
PCA generates linear combinations of the data variables explaining a maxi-
mum amount of variance in the data while having only a limited number of
nonzero coefficients.
The purpose of most of these methods is reducing the number of variables
to achieve a better interpretation of the principal components. Several of
them are unfeasible in the context of genomic data due to the large number
of variables (genes) or inappropriate due to the low signal to noise ratio that
characterizes these data. Another drawback is that the majority of these
approaches need to set the number of variables to be selected (or removed)
in advance, which is generally an unwanted constraint when trying to identify
responsive genes. In this chapter, several selection strategies are compiled
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that avoid this constraint and are compared by applying them to the analysis
of multifactorial genomic data following the work of adapting ASCA [132] to
genomic experiments in the ASCA-genes tool [103]. ASCA-genes was shown
to be an effective approach for the analysis of complex datasets and the gene
selection strategy presented in that work was proven to give good results with
signal rich transcriptomic datasets. Here, that study is extended and a vast
array of signal to noise conditions will be considered together with different
selection strategies to provide a comprehensive understanding of the behavior
of complex transcriptomic designs.
In this chapter, two novel approaches are proposed for variable selection in
the context of multifactorial gene expression experiments: minAS and Gamma
approximation. The ASCA-genes framework is used for treating the multi-
factorial nature of the data. However, the gene selection strategies proposed
rely on the probability distribution of PCA statistics and can be applied to-
gether with other dimension reduction techniques. Both minAS and Gamma
methods in combination with ASCA-genes have been implemented in the web
suite for Serial Gene Expression Analysis: SEA (http://sea.bioinfo.cipf.es/)
[102], which is freely available to the scientific community. Moreover, the
minAS strategy has been applied to other multivariate variable selection sce-
narios [31, 113] that will be presented and briefly discussed at the end of this
chapter.
3.2 Methods
The methods presented in this chapter were initially designed to be used
for analyzing gene expression data measured by microarrays. However, with
proper data transformations, they could be also used on data coming from
other technologies, such as RNA-seq. In this work, methods have been vali-
dated on microarray data and the simulation studies also mimic the behavior
of this kind of data.
Let X0 be the gene expression matrix, with dimensions M ×N , where N
is the number of variables (e.g. genes) and M is the number of observations
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(biological samples). If samples have been taken according to a certain ex-
perimental design, including one or more different factors such as treatment,
tissue, time, etc. with different levels and different number of replicates in
each level, we are dealing with multifactorial datasets. The experimental
setup must be taken into account when choosing the appropriate dimension
reduction technique in order to better extract the information contained in
the data. ASCA model was used because it tackles the problem of complex
experimental designs and efficiently separates signal from noise to achieve an
optimal interpretation of the results in terms of experimental factors effects
[103].
3.2.1 The ASCA-genes framework
To present the ASCA-genes methodology, let us consider the specific case
of an experiment with two factors. In the context of genomic experimental
designs, one of the factors is usually time (say, for example, factor a). The
other factor b indicates the experimental group, such as treatment or tissue.
If xijr is the expression level for a given gene measured at time point i, under
experimental condition j and for replicate r, Equation 3.1 shows the ANOVA
model definition for that gene, where µ is an offset term, αi is the model
parameter for the time factor on level i, βj measures the j-th group effect,
(αβ)ij represents the interaction effect between the i-th time and j-th group,
and the individual variation is indicated by (αβγ)ijr:
xijr = µ+ αi + βj + (αβ)ij + (αβγ)ijr (3.1)
Estimates of the ANOVA parameters of Equation 3.1 can be obtained
for all genes and collected into matrices as in Equation 3.2, where the gene
expression matrix X0 has been mean centered, resulting in matrix X.
X = Xa +Xb +Xab +Xabg (3.2)
Each one of the submatrices on the right hand side of Equation 3.2 con-
tains the estimated effects associated with a certain experimental factor, for
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example factor a, factor b, the interaction ab between them or the residuals
abg. The estimation of these effects depends on the nature of the factors (be-
tween or within subjects, random or fixed effects, etc.). In this work, we have
considered the most simple case of ANOVA-like decomposition: fixed effect
factors between subjects. Independence of measurements holds when expres-
sion values over time are independent, as frequently happens in genomics
because they correspond to different biological samples.
As the goal in time-course experiments is usually to detect gene expres-
sion profile changes between experimental groups (factor b), in this study,
the interaction effect has been joined to factor b effect and analyzed in one
submodel as it is shown in Equation 3.3:
X = Xa +Xb+ab +Xabg (3.3)
For the remainder of this work, ASCA submodels in Equation 3.3 will be
named as “submodel a” and “submodel b+ ab”, respectively.
PCA is applied to each one of the submatrices (Simultaneous Component
Analysis) to reveal major expression patterns associated to the experimental
factors and to identify relevant experimental conditions. At this point, dimen-
sionality reduction is undertaken by selecting, for each submodel, kx principal
components (for x=a, b+ ab, abg). Many criteria have been proposed to de-
cide the optimal number kx of principal components to choose. In this work,
a component was selected if the percentage of total variability it explained
was higher than C/nmax, nmax being the maximum number of components
(given by the rank of the matrix) and C a constant, set to 1.5 in our case.
The resulting ASCA-model is given in Equation 3.4:
X = TaP
t
a +Tb+abP
t
b+ab +TabgP
t
abg +E (3.4)
where, the scores of each submodel are given by the M × kx matrices
indicated by Ta, Tb+ab, Tabg, and the submodel loadings are given by the
N × kx matrices Pa, Pb+ab, Pabg, where PtxPx=I for x=a, b + ab or abg.
E is a matrix in which the residuals of all submodels of ASCA-model are
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collected: E = Ea + Eb+ab + Eabg, where Ex = Xx−TxPTx for x = a, b+ ab
or abg. The extension of this model to more than two experimental factors
is straightforward.
Once the major variability patterns have been identified, and assuming
that the model is biologically meaningful, the next step is to select genes
whose expression is affected by the experimental factors. When considering
the expression of a single gene, this might follow the general model, change
according to a different pattern, or simply present a flat profile. Two statistics
are proposed to characterize the behavior of genes within each submodel: the
leverage and the Squared Prediction Error (SPE).
The leverage measures the importance of a variable (gene) in the PCA
model. Leverage values for all the genes in the submodel x can be computed
from the loadings matrix according to Equation 3.5 (see [93]):
hx = diag[PxP
t
x]; x = a, b + ab (3.5)
The SPE associated with a particular gene is a measure of the goodness
of fit of the model for that specific gene. Genes not following the general
structure of the model will have high SPE. SPE values can be computed
from the residuals matrix in each submodel (Ex = Xx - TxP
t
x) according to
Equation 3.6:
SPEx = diag[E
t
xEx]; x = a, b + ab (3.6)
By combining the information given by the leverage and the SPE, genes
can be classified (as proposed in [103]) in the following groups:
• Genes relevant to the model (following the main trends): high leverage
and low SPE.
• Influential but poorly modeled genes: high leverage and high SPE.
• Badly modeled genes which are potential outliers: low leverage and high
SPE.
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• Non-responsive genes (not affected by the experimental factors): low
leverage and low SPE.
Therefore, we are interested in the genes which present a high leverage or
high SPE, because these genes may be affected by the experimental condi-
tions. To decide which genes should be classified as “interesting” (responsive),
a threshold must be established for both leverage and SPE in such a way that
those genes presenting an SPE or leverage higher than this threshold will be
selected. Nueda and co-workers calculated the SPE threshold by using Box’s
approximation [17] for SPE distribution. The leverage threshold was obtained
by resampling techniques [41]. However, they observed that these selection
strategies presented a good performance when the signal to noise ratio in the
dataset was high, but were not so effective for data with low signal to noise
ratio. Hence, in this chapter, other selection methods have been introduced
and compared to the ones in ASCA-genes under a much wider variety of bi-
ological scenarios. Both simulated and real datasets are used to evaluate the
performance of the proposed selection methods.
3.2.2 Variable selection strategies
Once the dimension reduction model has been established, the goal is often
finding the variables with higher contribution in the model. In our case, the
most “regulated” genes. The variable selection strategies we propose here
consist of three steps: first, choosing an appropriate statistic to measure the
importance of the variables in the model (leverage and SPE in this study);
second, estimating the probability distribution of this statistic (in a parametric
or non-parametric way) and, finally, establishing the threshold to separate
“interesting” from “uninteresting” variables (genes). As in ASCA-genes, our
proposals are focused on studying the univariate distribution of both SPE and
leverage statistics, although most of the methods we present are valid for
other statistics or even other multivariate methods, as it will be shown at the
end of this chapter.
38 3. VARIABLE SELECTION FOR MULTIFACTORIAL GENOMIC DATA
It should be noted that SPE and leverage statistics can be computed for
each gene in each of the different ASCA submodels a, b+ ab and abg. Gene
selection is therefore possible for each of these submodels independently. In
this work we have chosen to evaluate the gene selection coming from both a
and b+ab submodels as these capture the gene expression changes of interest
in the proposed scenario, namely, the time associated changes (submodel a)
and the time-experimental factor interaction (submodel b + ab). Depending
on the aim of the experiment, all or only specific submodels might be rele-
vant for the study, and selection will have to be based on the SPE and/or
leverage statistics of the corresponding submodels. Thus, interpretation of
the gene selection has always to be done on the light of the ASCA submodels
considered.
Generally and because of the nature of expression data, most genes present
a low SPE or low leverage values. Hence, it is expected that these statistics
follow a mixture distribution of, at least, two populations. The biggest pop-
ulation is that of “uninteresting” genes (with statistic values closer to zero).
The other population(s) correspond to “interesting” genes (those with higher
values for the statistic). As our aim is to separate “interesting” from “unin-
teresting” genes, the mixture model can be written as in Equation 3.7:
f(x) = p0f0(x) + p1f1(x) (3.7)
where, x is the value of either SPE or leverage for a particular gene, p0 is
the proportion of “uninteresting” genes (a priori unknown), f0(x) is the null
probability density function (i.e. probability density function for “uninterest-
ing” genes), and p1 and f1(x) are, respectively, the proportion of “interesting”
genes and their probability density function.
Two different approaches can be used to establish the threshold for SPE
or leverage values. The first one consists of estimating the “uninteresting”
genes distribution (null distribution) and using a percentile of this estimated
distribution as the threshold. The methods compared in this work that follow
this first approach are: Box’s method [17], Jackson & Mudholkar’s method
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[66], Gamma method and resampling techniques [41]. In the first three, the
null distribution is estimated in a parametric way, while resampling is consid-
ered a non-parametric technique. In the second approach, an approximation
is obtained for the mixture distribution and the threshold is taken as the value
which best separates the two components of the mixture. Many authors have
focused on the parametric estimation of the distribution of the mixture com-
ponents (see, for example, Efron’s work at [43] or [42]). But we observed
that, due to the huge difference between the sizes of both populations, it was
very difficult to parametrically estimate the probability distribution of each
component. Therefore, only a non-parametric approach is introduced here,
which is called minAS (MINimum Algorithmic Selection).
Box’s method
Assuming that errors from a PCA model approximately follow a multivariate
normal distribution and given that SPE is a quadratic form of the error asso-
ciated with a particular variable, Box [17] showed that SPE distribution could
be estimated by a weighted χ2-distribution (gχ2h). In ASCA-genes [103], this
distribution was used to calculate the (1-α)% confidence SPE threshold for
each PCA submodel. Parameters g and h are estimated by the matching
moments method and the following expression is obtained for SPE threshold
at α level of significance, where m is the sample mean and v is the sample
variance:
SPEα =
v
2m
χ22m2
v
(α) (3.8)
Jackson & Mudholkar’s method
Jackson and Mudholkar [66] found another approximation for SPE distribution
in PCA models, by using the residuals matrix E. Therefore, for PCA coming
from each ASCA submodel, the SPE threshold at α level of significance can
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be computed as follows:
SPEα = θ1[1− θ2h(1− h)
θ21
+
zα(2θ2h
2)1/2
θ1
]1/h (3.9)
where V= E’EN−1 , N being the number of variables (genes) in the model;
θi=trace(V
i), for i=1,2,3; and h=1-2θ1θ3
3θ22
.
Gamma method
Gnanadesikan and Kettenring [51] proposed the Gamma distribution for the
squared residuals from a PCA. Following this idea and because of the flexibility
of this distribution to suit many density curves, we used it to approximate both
the SPE and leverage null distributions. Given the statistic values for the N
genes in each submodel (x1, ..., xN ), shape (k) and scale (θ) parameters for
the gamma distribution can be estimated by maximum likelihood [27]:
θˆ =
x¯
kˆ
(3.10)
kˆ =
3− s+√(s− 3)3 + 24s
12s
s = ln(x¯)− 1
N
N∑
i=1
ln(xi)
The corresponding threshold for the statistic (either SPE or leverage) is
then the percentile (1-α)% of the estimated gamma distribution.
Resampling techniques
Resampling methods are non-parametric procedures to determine the statis-
tical significance of a result, sampling repeatedly within the same data. An
empirical distribution is generated for an statistic under the null hypothesis
by taking the original data, randomly shuffling them numerous times and
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computing the statistic value for each of the permuted datasets. The way of
permuting the data depends on the null hypothesis to be tested [41].
In ASCA-genes [103], a permutation method was used to define the
threshold of leverage. In the present work, we study the performance of per-
mutation techniques to obtain the confidence thresholds not only for leverage
but also for SPE. We also compare their permutation strategy with our pro-
posal. Both strategies are described below for the M ×N data matrix X and
are summarized in Figure 3.1.
Strategy 1.- As implemented in ASCA-genes, K row permutations of ma-
trix X are generated, destroying the structure of the experimental design. In
this case, the null hypothesis to be tested is that experimental conditions
do not affect gene expression, i.e. all genes have a flat profile across condi-
tions. For instance, the null hypothesis to test for submodel a (analogous for
submodel b+ ab) would be:
H0 : (α1)k = ... = (αt)k = 0,∀k = 1, ..., N (3.11)
Strategy 2.- The null hypothesis to test in this strategy is that all genes
are equally responsive. In the case of leverage, for example, it would imply
that all genes have equal leverage values.
H0 : (αi)1 = ... = (αi)N ,∀i (3.12)
If this is true, all the genes would have the same contribution in the PCA
model and the residual errors would also be similar. Hence, the novel per-
mutation strategy we propose in this work consists of performing K column
permutations. Moreover, the permutation of values in the columns is different
for each row so that the structure in the data (associations among genes, and
among genes and experimental conditions) is totally broken.
In this work, the number of permutations K was set to 1000. Once the
permuted matrices have been generated, an ASCA model is fitted to each
one of them. SPE and leverage values are then obtained for each gene in
each permutation to generate the reference distribution. The threshold can
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1
Strategy 1 Strategy 2
g1 g2 g3 g4 g5 g1 g2 g3 g4 g5
A1 A2 A3 A4 A5 A1 A2 A3 A4 A5
B1 B2 B3 B4 B5 B1 B2 B3 B4 B5
C1 C2 C3 C4 C5 C1 C2 C3 C4 C5
Permuting conditions Permuting genes
g1 g2 g3 g4 g5 g1 g2 g3 g4 g5
C1 C2 C3 C4 C5 A2 A5 A4 A1 A3
A1 A2 A3 A4 A5 B5 B3 B1 B2 B4
B1 B2 B3 B4 B5 C4 C5 C2 C3 C1
condA condA
condB condB
condC condC
condA condA
condB condB
condC condC
Figure 3.1: Resampling strategies.
Table 3.1: Methods to calculate SPE or leverage threshold by resampling tech-
niques
Method Permutation strategy Threshold computation
1 1 - Permuting conditions Option (a) - For each gene
2 2 - Permuting genes Option (a) - For each gene
3 2 - Permuting genes Option (b) - Globally
be calculated from this reference distribution in two ways:
Option (a).- First, the (1-α)% percentile of the K statistic values for each
gene is computed and the threshold is obtained as the (1-α)% percentile of
the N gene percentiles. This is the option implemented in ASCA-genes.
Option (b).- We propose using the (1-α)% percentiles of the KxN statistic
values obtained from the K permutations and N genes.
The three resampling methods to be compared in this work are combinations
of permutation strategies 1 and 2 and options (a) and (b) to compute thresh-
olds. They are described in Table 3.1.
minAS
In this work we introduce minAS, which is a very intuitive data-driven method.
This algorithmic approach consists of empirically estimating the mixture den-
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sity function for either the SPE or the leverage and then computing the first
local minimum closest to the “uninteresting” genes probability density curve.
The SPE or leverage value in which this minimum is reached is taken as
the threshold that separates both distributions. The minAS strategy assumes
that the mixture distribution in Equation 3.7 for SPE or leverage is, at least,
bimodal. The intrinsic nature of genomic data makes this assumption hold
in general. However, it is not always possible to visualize this bimodality in
histograms, due to the large difference in the sizes of both populations.
To estimate the mixture density curve, a non-parametric density estimator
was used: the kernel density estimator (KDE) [125]. A KDE is a sophisticated
version of histograms that produces smoothed density curves and it is defined
in Equation 3.13:
fˆ(x) =
1
N ·h
N∑
i=1
K
(
xi − x
h
)
(3.13)
where xi are the observed values, N is the total number of observed val-
ues (in this case, the number of genes), h is the bandwidth (the smoothing
parameter) and K(x) is the kernel function, that weights each observation
depending on the distance to the point for which the density is being esti-
mated. For instance, when choosing a Gaussian kernel to estimate f at x0,
and for a given bandwidth h, the highest weights correspond to the closest
observations to x0, and the weight diminishes as the distance to x0 increases.
However, the KDE goodness of fit relies more on bandwidth h than on the
kernel choice. There are different rules of thumb to compute the optimum
bandwidth. For instance, Silverman [129] takes into account the dispersion
in the data and the sample size to compute bandwidth for KDE with a Gaus-
sian kernel. These are the default options in the R density function from the
library stats, which we used to obtain the KDE within minAS.
In the minAS algorithm, users can choose the kernel and the method to
calculate bandwidth (as in the R density function), as well as the number
of points for which the density is fitted. The smoothing of the KDE is de-
termined by the bandwidth computed by the chosen method. To increase or
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decrease this smoothing, the value of the coefficient adjust (which defaults
to 1) can be increased or decreased, respectively. Several kernel functions
or methods to calculate the bandwidth can be chosen and then minAS se-
lects the mixture estimation that best fits the data according to one of the
two implemented options: “max” and “mean”. As the true density function
is unknown, cumulative distribution functions computed from the KDE are
compared with the empirical cumulative distribution function derived from
SPE or leverage values. In order to compare them, the difference between the
empirical distribution and the KDE cumulative distribution is computed for
each value. Then, in the case of the “max” option, the maximum of these
differences (Kolmogorov-Smirnov distance) is taken. For the “mean” option,
the mean of all these differences is obtained. The KDE with the smallest
maximum (or mean) difference is selected.
Once the best KDE has been obtained, minAS computes the minima of
this curve. By default, the first local minimum after the highest peak is
taken as the cutoff value to separate the two populations, i.e. “interesting”
from “uninteresting” genes. However, minAS users can also set the maximum
number of minima to be computed, calculate all of them or provide the interval
where the minimum has to be found. A plot is provided in which all the
computed minima are represented over the mixture distribution. Then, if
more than one minimum is found, users can decide to reduce the number of
selected genes by choosing a more restrictive threshold.
3.2.3 Data simulation
The synthetic data sets used to evaluate the variable selection methods were
generated using a simulation algorithm. This algorithm is intended to mimic
the behavior of gene expression across time and for different experimental
conditions. In order to cover a wide variety of biological scenarios, we varied
the values of the input parameters of the algorithm when generating the data.
The input parameters are listed in Table 3.2, and some of them are explained
in more detail below:
3.2 Methods 45
Experimental factors: Factors that are controlled by the experimentalist.
The algorithm was designed to work with two experimental factors: the time
factor and another one referring to the experimental group such as treatment,
tissue, illness, etc.
Signal genes (deg): Also called responsive genes or differentially expressed
genes. Genes which are activated at any time point and for any of the exper-
imental groups.
Expression pattern: Gene behavior over time for a certain experimental
group. As only short time series have been studied in this paper, expres-
sion patterns have been summarized and modeled according to the following
functions of time t:
• Continuous induction (β0+β1t; β1>0): Gene activity increases linearly
as time elapses.
• Continuous repression (β0+β1t; β1<0): The gene is initially active and
the activity decreases linearly as time elapses.
• Transitory induction (β0+β1t+β2t2; β1>0, β2<0): The gene is initially
inactive, it increases its activity and, after a certain time and until the
final time point, this activity decreases.
• Transitory repression (β0+β1t+β2t2; β1<0, β2>0): The gene is initially
active, it decreases its activity and, after a certain time and until the
final time point, this activity increases.
• Plain (for non-responsive genes): The gene remains inactive over time.
Coefficients β0, β1 and β2 have been computed in such a way that the
absolute value for gene expression level is not higher than a certain maximum
value. In microarray studies, expression levels are obtained as a log-ratio from
color intensities, so the expression values for responsive genes may vary be-
tween approximately 2 and 5. Thus, the maximum expression value computed
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by the algorithm is a random number between 2 and 5, 0.5, 0.3, 0.1 and 0.1
being the probabilities for values 2, 3, 4 and 5, respectively.
Class of genes: A class of genes is a group of genes that follow the
same temporal pattern within a certain experimental group (e.g. treatment).
The number of classes of genes will determine the variety of different gene
behaviors in the experiment.
The criterion for allocating the expression patterns to each class of genes
in each experimental group tries to imitate biological behavior as much as pos-
sible. Every pattern can be found in at least one class of genes. When genes
follow an induction pattern for a certain class, there must be another class
with the equivalent repression pattern. Inside every class containing respon-
sive genes, experimental groups for which genes are activated are randomly
selected taking into account that:
• Genes in that class must be active for at least one experimental group.
• If genes are expressed for several experimental groups, the expression
pattern must be the same for all of these experimental groups and
replicates.
• For two complementary gene classes, the genes must be active for the
same experimental groups.
When modeling gene behavior, noise must be introduced to get realistic
simulated expression data. Two types of noise have been considered: random
and structural noise. Random noise is generated by technology and affects
all the genes and samples in a similar way. For microarray data, it is common
that about 20% of the signal is random noise. Structural noise is related to
biological sample handling to obtain signal intensities. Hence, it takes the
same value for all the genes in the same microarray. It has been observed
that expressed genes are usually more affected by this kind of noise.
Let Gij be the “pure” expression value (without noise) for a certain gene
i and sample j.
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Table 3.2: Input parameters for simulation algorithm
Parameter Description
N Number of genes.
SN Percentage of differentially expressed
genes (%deg).
t Time points array.
f Number of experimental groups.
r Number of replicates for each time
point and experimental group.
d Number of classes of signal genes.
rn Maximum percentage of expression
level corresponding to random noise
in signal genes.
sd Standard deviation for structural noise
and for random noise in non-signal
genes.
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Random noise. Let rn be the parameter that determines the amount
of noise in the data, which is chosen by the user (by default, it is set to
20%). The simulation algorithm takes a random value δij from a uniform
distribution between -rn and rn to be used as random noise. Then, the
amount of random noise for an expressed gene is equal to δij times Gij ,
because it is expected that the effect of this kind of noise is proportional to
the level of expression. For non-expressed genes, with Gij=0, the amount of
random noise is a random value λij generated from a normal distribution with
mean 0 and standard deviation sd (a parameter that can also be set by users,
by default sd=0.3). If, by chance, the expression value for a signal gene is 0,
the random noise for that gene will also be computed this way.
Structural noise. The algorithm considers that structural noise only affects
signal genes. For a given sample j, structural noise is computed as a random
value εj from a normal distribution with mean m and standard deviation sd
and this value is equal for all the genes in the same sample. The parameter
sd is the same used for random noise in non-responsive genes and the mean
m is calculated as rn×msv, where rn is the random noise parameter defined
above and msv is the expected value for gene signal expression. As previously
mentioned, signal genes expression level can be 2, 3, 4 or 5 with probabilities
0.5, 0.3, 0.1, and 0.1 respectively. Therefore, msv turns out to be 2.8.
Hence, once the “pure” gene expression value Gij is generated, the “ob-
served” gene expression value G∗ij is computed by the algorithm according to
the following equations:
G∗ij = Gij + δij ×Gij + εj ; if Gij 6= 0 (3.14)
G∗ij = Gij + λij ; if Gij = 0
where δij ∼ U[−rn, rn]; λij ∼ N(0, sd); and εj ∼ N(m = rn× 2.8, sd).
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3.2.4 Performance indicators
The variable selection methods previously described are to be compared on
simulated data in order to assess their performance. Thus, we need to define
some indicators to measure this performance. A variety of indicators to assess
the classification of features into two groups (e.g. activated/non-activated,
differentially expressed/non-differentially expressed, etc.) have been described
in the literature. These two groups will be named as positives and negatives.
The confusion matrix in Table 3.3 illustrates the potential classification errors.
The performance indicators are then defined according to these successes and
failures.
Table 3.3: Confusion matrix for two-classes classification
Actual values
Positives Negatives
P N
Positives True Positives False Positives
Predicted P’ TP FP
values Negatives False Negatives True Negatives
N’ FN TN
These are the performance indicators we will use in this chapter:
• Sensitivity (SE), which is also known as the True Positive Rate (TPR):
SE =
TP
TP + FN
=
TP
P
• Specificity (SP) or True Negative Rate (TNR). The False Positive Rate
(FPR), which is the performance indicator used in Receiver Operating
Characteristic (ROC) curves, is equal to 1-SP.
SP =
TN
TN + FP
=
TN
N
• False Discovery Rate (FDR), which is the percentage of FP over the
total number of detections:
FDR =
FP
TP + FP
=
FP
P ′
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• Matthews correlation coefficient (MCC) [94]. Can take values from
-1 to 1, where 1 would indicate a perfect match and -1 an inverse pre-
diction. This coefficient takes into account every type of classification
error and is especially appropriate when the size of both groups is very
different, which usually happens in variable selection problems in tran-
scriptomics.
MCC =
TP × TN − FP × FN√
P ′ × P ×N ′ ×N
3.3 Results
The variable selection methods described in Section 3.2.2 were first evaluated
on simulated data in several comparative studies. According to the results
of these comparisons, the best strategies were determined and applied to an
experimental dataset.
3.3.1 Simulated data
Simulation studies were conducted, on the one hand, to compare the perfor-
mance of the proposed variable selection methods and, on the other hand, to
see which methods are preferred under certain biological scenarios or which
ones are less affected by the biological characteristics of the data.
To simplify the interpretation of the results, for each simulated dataset,
only two factors (e.g. time and experimental group) were considered: the
time factor consisting of three time points, and the number of experimen-
tal groups that was also three. Four replicates were generated for each ex-
perimental group at each time point. Two different simulation experiments
were conducted (see Simulation experiment 1 and Simulation experiment 2).
The first experiment was used to compare different options in each selection
method and to determine a good range for parameter values. Next, a global
comparison of the best combinations for each method was carried out on
the second simulation experiment to obtain a more precise selection approach
benchmarking.
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Simulation experiment 1
The biological scenarios to be simulated for this first experiment were defined
by the values of the following parameters:
• Number of genes in the dataset (N): 3000, 15000, or 30000.
• Percentage of differentially expressed genes (responsive or signal genes)
with regard to the total number of genes (%deg): 1%, 5% or 15%.
• Number of gene classes (class): 5, 10 or 25. Genes in the same class
have the same expression time pattern under the same experimental
group.
• Level of noise in the data (noise): 10% or 30%.
These parameters define 54 different biological scenarios, and 10 datasets
were generated for each of them. We made several comparisons on these 540
datasets whose results are described in the following sections.
Comparing resampling strategies
As already mentioned in Section 3.2.1, the variable selection strategies
implemented in ASCA-genes were Box’s method for SPE, and resampling
techniques for leverage. However, these approaches were not efficient in sep-
arating “interesting” from “uninteresting” genes in large dataset scenarios.
Therefore, a complete study was designed to determine which biological sce-
narios these selection strategies failed in, and to compare the three different
resampling options to calculate the leverage threshold (see Table 3.1) at sig-
nificance levels of 0.01 and 0.05. Box’s method was maintained to compute
the SPE threshold, as in the ASCA-genes paper.
Hence, the ASCA model was obtained for each of the 540 simulated
datasets and these variable selection strategies were applied. The Matthews
Correlation Coefficient (MCC) was obtained in each case and the results
were analyzed by means of an ANOVA model with repeated measures [10]
to evaluate the effect of the biological factors indicated above, the resam-
pling strategy (“leverage method”) and the significance level (α) on MCC
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values. An ANOVA with repeated measures was used because the variable
selection methods were applied to SPE and leverage values obtained from
the same simulated datasets, so the measurements were not independent in
this sense. The ANOVA results indicated that factors with a significant effect
on MCC (p-value<0.002) were: leverage method, significance level, number
of signal gene classes (class) and percentage of signal genes (%deg). The
noise level and the number of genes had no statistically significant influence
on MCC (p-value>0.6). Post-hoc tests showed that the best MCC results
(p-value<0.001) were obtained for leverage method 3, i.e. permuting genes
and computing threshold as a global percentile; α=0.01; low number of signal
genes classes and medium signal genes percentage (5%). See Figure 3.2. We
also observed that for α=0.01, the real False Positive Rate (FPR) obtained
with any of the resampling methods was similar to the significance level, but
when setting α to 0.05, FPR reached 80% in some cases. Classification fail-
ures were mainly due to the strategy used to calculate SPE threshold (Box’s
method).
Comparing selection methods for SPE
In the second study on these simulated datasets, Box’s method was com-
pared to the other SPE parametric methods: Jackson & Mudholkar’s and
Gamma. In this case, twelve different significance levels were evaluated, vary-
ing from 0.001 to 0.1. No leverage thresholds were calculated, so gene selec-
tion was based only on SPE values. Consequently, MCC results can be used
to compare SPE methods, but not to measure the global performance of the
methods. As shown in Figure 3.3, when the significance level is around 0.03,
all three methods perform similarly. For the rest of the significance levels,
Box’s method produces much worse results than the other two, which behave
similarly.
An ANOVA model with repeated measures showed that the SPE method,
significance level and all the biological factors had a statistically significant
effect on MCC (p-value<0.001), except the number of genes (p-value>0.7).
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Figure 2: Resampling strategies performance (measured by MCC) according to the signif-
icance level, the number of signal gene classes and the percentage of signal genes.
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i re 3.2: Resampling strategy performance (measured by MCC) according
to the significance level, the number of signal gene classes and the percentage
of signal genes.
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where TP is the number of True Positives, TN the number of True Neg-
atives, FP the number of False Positives and FN the number of False
Negatives. Unless otherwise stated, MCC is calculated from the selec-
tion made using both SPE and leverage values.
To simplify the interpretation of results, for each simulated data-
set, only two factors (e.g. time and experimental group) have been
considered: the time factor consisted of three time points and the
number of experimental groups was also three. Four replicates have
been generated for each experimental group at each time point. The
description of the simulation algorithm can be found in the Supple-
mentary Material. Two different simulation experiments were con-
ducted. The first experiment was used to compare different options
in each selection method and determine a good range for parameter
values. Next, a global comparison of the best methods combinations
was carried out on the second simulation experiment to obtain a
more precise benchmarking of the selection approaches.
3.1.1. Simulation experiment 1
The biological scenarios to be simulated for this first experiment
were defined by the values of the following parameters:
• Number of genes in the dataset (N): 3000, 15,000 or 30,000.
• Percentage of differentially expressed genes (responsive or signal
genes) with regard to the total number of genes (%deg): 1%, 5% or
15%.
• Number of gene classes (class): 5, 10 or 25. Genes in the same class
have the same expression time pattern under the same experimen-
tal group.
• Level of noise in the data (noise): 10% or 30%.
These parameters define 54 different biological scenarios and 10
datasets were generated for each one of them.
As already mentioned in Section 2.1, variable selection strategies
implemented in ASCA-genes were Box's method for SPE and resam-
pling techniques for leverage. However, these approaches were not
efficient in separating “interesting” from “uninteresting” genes in
large datasets scenarios (unpublished results). So in this work, a com-
plete study was designed to determine under which biological sce-
narios these selection strategies failed and to compare the three
different resampling options to calculate leverage threshold (see
Table 1) at significance levels 0.01 and 0.05. The Box's method was
maintained to compute SPE threshold, as in the ASCA-genes paper.
Hence, the ASCA model was obtained for each of the 540 simulat-
ed datasets and these variable selection strategies were applied. The
Matthews Correlation Coefficient (MCC) was obtained in each case
and the results were analyzed by means of an ANOVA model with re-
peated measures [29] to evaluate the effect of the biological factors
indicated above, the resampling strategy (“leverage method”) and
the significance level (α) on MCC values. An ANOVA with repeated
measures was used because the variable selection methods were ap-
plied to SPE and leverage values obtained from the same simulated
datasets, so the measurements were not independent in this sense.
The ANOVA results indicated that factors with a significant effect on
MCC (p-valueb0.002) were: leverage method, significance level,
number of signal gene classes (class) and percentage of signal genes
(%deg). The noise level and the number of genes had no statistically
significant influence on MCC (p-value>0.6). Post-hoc tests showed
that the best MCC results (p-valueb0.001) were obtained for leverage
method 3, i.e. permuting genes and computing threshold as a global
percentile; α=0.01; low number of signal gene classes and medium
signal genes percentage (5%). Further details on this analysis may
be found in Supplementary Material. We also observed that for
α=0.01, the real False Positive Rate (FPR) obtained with any of the
resampling methods was similar to the significance level, but when
setting α to 0.05, FPR reached 80% in some cases. Classification fail-
ures were mainly due to the strategy used to calculate SPE threshold
(Box's method).
In the second study on these simulated datasets, Box's method
was compared to the other SPE parametric methods: Jackson and
Mudholkar's and Gamma. In this case, twelve different significance
levels were evaluated, varying from 0.001 to 0.1. No leverage thresh-
olds were calculated, so gene selection was based only on SPE values.
Consequently, MCC results can be used to compare SPE methods, but
not as a measure of the global performance of the methods. It can be
observed in Fig. 1 that when significance level is around 0.03, all the
three methods present a similar performance. For the rest of signifi-
cance levels, Box's method produces much worse results than the
other two, which behave similarly.
An ANOVAmodel with repeated measures showed that SPE meth-
od, significance level and all the biological factors had a statistically
significant effect on MCC (p-valueb0.001), except the number of
genes (p-value>0.7). From post-hoc tests, it was deduced that SPE
methods were significantly different (p-valueb0.008), being Jackson
and Mudholkar and Gamma the ones presenting better results. For
significance levels between 1% and 3% the best MCC results were
obtained (p-valueb0.001). No statistically significant differences
were observed between 5 and 10 signal gene classes (p-value>0.3),
but significantly better results were obtained when number of classes
was 25 (p-valueb0.001), maybe because when so many different pat-
terns are present in the data, there are more genes badly explained by
the model and hence those genes have a high SPE value. The best MCC
results were obtained when responsive genes percentage was 5%, fol-
lowed by 15% and lastly 1% (p-valueb0.001). Finally, MCC was higher
when noise level was 30% (p-valueb0.001).
Joining the results of this study, we determined themost convenient
significance levels for eachmethod to obtain the bestMCC valuewhich-
ever the signal gene percentage and the number of signal gene classes
were. The recommendations were α=0.03 for Box's method,
0.005bαb0.02 for Jackson and Mudholkar's method and α=0.01 for
Gamma approximation (see Fig. 1).
Again, the significance level was compared to the False Positive Rate
(FPR) obtained for eachmethod. Fig. 2 presents these results and shows
that in Gamma and Jackson andMudholkar's methods this relation was
preserved, while this did not happen for Box's method.
Once the methods estimating the null distribution were com-
pared, we included minAS method in the study (always taking the
first local minimum after the highest peak as the threshold for both
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Fig. 1. SPE selection methods performance (measured by MCC) according to significance
level.
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Figure 3.3: SPE selection method performance (measured by MCC) according
to significance level.
From post-hoc tests, it was deduced that SPE methods were significantly dif-
ferent (p-value<0.008), and that Jackson & Mudholkar and Gamma methods
produced the best results. For significance levels between 1% and 3% the best
MCC results were obtained (p-value<0.001). No statistically significant dif-
ferences were observed between 5 or 10 signal gene classes (p-value>0.3),
but significantly better results were obtained when number of classes was 25
(p-value<0.001), maybe because when so many different patterns are present
in the data, there are more genes badly explained by the model and hence
those genes have a high SPE value. The best MCC results were obtained
when the percentage of responsive genes was 5%, followed by 15%, and lastly
1% (p-value<0.001). Finally, MCC was higher when the noise level was 30%
(p-value<0.001).
Joining the results of this study, we determined the most convenient signif-
icance levels for each method to obtain the best MCC value, despite the signal
gene percentage or the number of signal gene classes. Our recommendations
were α=0.03 for Box’s method, 0.005<α <0.02 for Jackson & Mudholkar’s
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SPE and leverage). To see if minAS selection was satisfactory enough
to continue studying the method in depth, it was compared to the
combinations of methods evaluated in the first study (Box's method
for SPE and resampling techniques for leverage). In this preliminary
comparison, default options in R “density” function (Gaussian kernel
and “nrd0” method to compute bandwidth) were used. As it can be
seen in Fig. 3, MCC obtained from minAS was, in general, higher
than MCC obtained with the other methods.
In addition, using the same simulated datasets, the default options in
minAS (Gaussian kernel and “nrd0” bandwidth computing method)
were compared to the best estimators according to minAS options
“max” and “mean” (see Section 2.2). Fig. 4 shows that minAS resulted
in betterMCC scores when using the default KDE thanwith the KDE pro-
ducing the minimummaximum or minimummean distance to the em-
pirical data distribution. The reason is that the other kernels or methods
to compute bandwidth tended to generate infra-smoothed curves with
toomany localminima. In these cases, the selection by thefirst localmin-
imum increased the number of false positives. Therefore, default “densi-
ty” options were used when applying the minAS procedure hereinafter.
The influence of biological parameters defining the scenarios on
MCC results for minAS method was also analyzed using an ANOVA
model. All the parameters had a statistically significant effect on
MCC (p-valueb0.01), especially the number of genes, the number of
classes and the signal genes percentage, as well as the interactions be-
tween them. It was observed that the greater the number of classes
and the percentage of signal genes, the better MCC results minAS pro-
duced, no matter the number of genes. As number of genes and signal
percentage increased, MCC was less dependent on the number of
classes. Boxplots describing these results can be seen in Supplemen-
tary Material. Hence, as general guidelines, we recommend using
minAS for datasets with a high number of variables because other-
wise the goodness of fit of KDE is not guaranteed and the multimod-
ality is more dependent on the value of the smoothing parameter. The
method can be applied to datasets with a thousand variables approx-
imately, but results show that the best performance is obtained for
more than 15000 variables. A Gaussian kernel and the method
“nrd0” to compute bandwidth have been proved to offer the best
minAS performance. Furthermore, increasing the parameter “adjust”
to get a more smoothed KDE produces even better results (see Sup-
plementary Material), although this parameter was not changed in
any of the simulation experiments we performed.
3.1.2. Simulation experiment 2
To conclude the evaluation of variable selection methods on sim-
ulated data, a new simulation experiment was designed in order to
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Fig. 2. FPR according to significance level for each one of the SPE methods studied.
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Fig. 3.MCC obtained by applying the three resampling methods in Table 1 for α=0.01
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Figure 3.4: The FPR according to the significance level for each one of the
SPE methods studied.
method, and α=0.01 for Gamma approximation (see Figure 3.3).
Again, the significance level was compared to the False Positive Rate
(FPR) obtained for ch method. Figure 3.4 pres nts th se results nd shows
that in Gamma and Jacks n & Mudholkar’s ethods this relation was pre-
served, while this did not happen for Box’s method.
Co paring minAS to the other methods
Once the methods estimating the null distribution were compared, we in-
cluded the minAS method in the study (always taking the first local minimum
after the highest peak as the threshold for both SPE and leverage). To see if
minAS selection was sufficiently satisfactory to continue studying the method
in depth, it was compared to the combinations of methods evaluated in the
first study (Box’s method for SPE and resampling techniques for leverage). In
this preliminary comparison, default options in R “density” function (Gaussian
kernel and “nrd0” method to compute bandwidth) were used. As shown in
Figure 3.5, the MCC obtained from minAS was, in general, higher than the
MCC obtained with the other methods.
In addition, using the same simulated datasets, the default options in mi-
nAS (Gaussian kernel and “nrd0” bandwidth computing method) were com-
pared to the best estimators according to minAS options “max” and “mean”
(see Section 3.2.2). Figure 3.6 shows that minAS resulted in better MCC
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SPE and leverage). To see if minAS selection was satisfactory enough
to continue studying the method in depth, it was compared to the
combinations of methods evaluated in the first study (Box's method
for SPE and resampling techniques for leverage). In this preliminary
comparison, default options in R “density” function (Gaussian kernel
and “nrd0” method to compute bandwidth) were used. As it can be
seen in Fig. 3, MCC obtained from minAS was, in general, higher
than MCC obtained with the other methods.
In addition, using the same simulated datasets, the default options in
minAS (Gaussian kernel and “nrd0” bandwidth computing method)
were compared to the best estimators according to minAS options
“max” and “mean” (see Section 2.2). Fig. 4 shows that minAS resulted
in betterMCC scores when using the default KDE thanwith the KDE pro-
ducing the minimummaximum or minimummean distance to the em-
pirical data distribution. The reason is that the other kernels or methods
to compute bandwidth tended to generate infra-smoothed curves with
toomany localminima. In these cases, the selection by thefirst localmin-
imum increased the number of false positives. Therefore, default “densi-
ty” options were used when applying the minAS procedure hereinafter.
The influence of biological parameters defining the scenarios on
MCC results for minAS method was also analyzed using an ANOVA
model. All the parameters had a statistically significant effect on
MCC (p-valueb0.01), especially the number of genes, the number of
classes and the signal genes percentage, as well as the interactions be-
tween them. It was observed that the greater the number of classes
and the percentage of signal genes, the better MCC results minAS pro-
duced, no matter the number of genes. As number of genes and signal
percentage increased, MCC was less dependent on the number of
classes. Boxplots describing these results can be seen in Supplemen-
tary Material. Hence, as general guidelines, we recommend using
minAS for datasets with a high number of variables because other-
wise the goodness of fit of KDE is not guaranteed and the multimod-
ality is more dependent on the value of the smoothing parameter. The
method can be applied to datasets with a thousand variables approx-
imately, but results show that the best performance is obtained for
more than 15000 variables. A Gaussian kernel and the method
“nrd0” to compute bandwidth have been proved to offer the best
minAS performance. Furthermore, increasing the parameter “adjust”
to get a more smoothed KDE produces even better results (see Sup-
plementary Material), although this parameter was not changed in
any of the simulation experiments we performed.
3.1.2. Simulation experiment 2
To conclude the evaluation of variable selection methods on sim-
ulated data, a new simulation experiment was designed in order to
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Fig. 2. FPR according to significance level for each one of the SPE methods studied.
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Fig. 3.MCC obtained by applying the three resampling methods in Table 1 for α=0.01
and α=0.05 and minAS method.
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Fig. 4. MCC obtained by applying minAS for both SPE and leverage on datasets from
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Figure 3.5: MCC obtained by applying the three resampling methods in Table
3.1 with α=0.01 and α=0.05 for leverage and Box’s method for SPE, and minAS
method for both of them.
scores when using the default KDE than with the KDE producing the mini-
mum maximum or minimum mean distance to the empirical data distribution.
The reason for this is that the other kernels or methods to compute bandwidth
tended to generate infra-smoothed curves with too many local minima. In
these cases, the selection by the first local minimum increased the number of
false positives. Therefore, default “density” options were used when applying
the minAS procedure hereinafter.
The influence of biological parameters defining the scenarios on MCC
results for minAS method was also analyzed using an ANOVA model. All
the parameters had a statistically significant effect on MCC (p-value<0.01),
especially the number of genes, the number of classes and the signal genes
percentage, as well as the interactions between them. It was observed that
the greater the number of classes and the percentage of signal genes, the
better MCC results minAS produced, no matter the number of genes. As the
number of genes and signal percentage increased, MCC was less dependent
on the number of classes. Boxplots describing these results can be seen in
Figure 3.7.
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SPE and leverage). To see if minAS selection was satisfactory enough
to continue studying the method in depth, it was compared to the
combinations of methods evaluated in the first study (Box's method
for SPE and resampling techniques for leverage). In this preliminary
comparison, default options in R “density” function (Gaussian kernel
and “nrd0” method to compute bandwidth) were used. As it can be
seen in Fig. 3, MCC obtained from minAS was, in general, higher
than MCC obtained with the other methods.
In addition, using the same simulated datasets, the default options in
minAS (Gaussian kernel and “nrd0” bandwidth computing method)
were compared to the best estimators according to minAS options
“max” and “mean” (see Section 2.2). Fig. 4 shows that minAS resulted
in betterMCC scores when using the default KDE thanwith the KDE pro-
ducing the minimummaximum or minimummean distance to the em-
pirical data distribution. The reason is that the other kernels or methods
to compute bandwidth tended to generate infra-smoothed curves with
toomany localminima. In these cases, the selection by thefirst localmin-
imum increased the number of false positives. Therefore, default “densi-
ty” options were used when applying the minAS procedure hereinafter.
The influence of biological parameters defining the scenarios on
MCC results for minAS method was also analyzed using an ANOVA
model. All the parameters had a statistically significant effect on
MCC (p-valueb0.01), especially the number of genes, the number of
classes and the signal genes percentage, as well as the interactions be-
tween them. It was observed that the greater the number of classes
and the percentage of signal genes, the better MCC results minAS pro-
duced, no matter the number of genes. As number of genes and signal
percentage increased, MCC was less dependent on the number of
classes. Boxplots describing these results can be seen in Supplemen-
tary Material. Hence, as general guidelines, we recommend using
minAS for datasets with a high number of variables because other-
wise the goodness of fit of KDE is not guaranteed and the multimod-
ality is more dependent on the value of the smoothing parameter. The
method can be applied to datasets with a thousand variables approx-
imately, but results show that the best performance is obtained for
more than 15000 variables. A Gaussian kernel and the method
“nrd0” to compute bandwidth have been proved to offer the best
minAS performance. Furthermore, increasing the parameter “adjust”
to get a more smoothed KDE produces even better results (see Sup-
plementary Material), although this parameter was not changed in
any of the simulation experiments we performed.
3.1.2. Simulation experiment 2
To conclude the evaluation of variable selection methods on sim-
ulated data, a new simulation experiment was designed in order to
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Fig. 2. FPR according to significance level for each one of the SPE methods studied.
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Figure 3.6: MCC obtained by applying minAS for both SPE and leverage
on datasets from simulation experiment 1, considering three options: “max”
criterion, “mean” criterion, and default options.
Hence, as general guidelines, we recommend using minAS for datasets
with a high number of variables because otherwise the goodness of fit of
KDE is not guaranteed and the multimodality is more dependent on the value
of the smoothing parameter. The method can be applied to datasets with
approximately a thousand variables, but results show that the best perfor-
mance is obtained for more than 15000 variables. A Gaussian kernel and the
method “nrd0” to compute bandwidth have been proven to offer the best
minAS performance. Furthermore, increasing the parameter “adjust” to get
a more smoothed KDE produces even better results (as shown in the following
section), although this parameter was not changed in any of the simulation
experiments we performed.
Simulation experiment 2
To conclude the evaluation of variable selection methods on simulated data,
a new simulation experiment was designed in order to compare simultane-
ously all of the previously described methods for computing SPE and leverage
thresholds. In this last comparison, other biological scenarios were simulated
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Figure 3: Performance of minAS (measured by MCC) according to the number of genes,
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10
i re 3.7: Performance of minAS (measured by MCC) according to the num-
ber of genes, the level of noise, the number of signal gene classes and the
percentage of signal genes.
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taking into account the results obtained in the previous studies. The level of
noise was not included as a parameter in these simulations because it had,
in general, very little influence on MCC results, so it was set to 20%. The
values for the rest of biological parameters were:
• Number of genes in the dataset: 5000 or 20000.
• Percentage of responsive genes: 3% or 10%.
• Number of gene classes: 5 or 25.
For each one of the 8 possible scenarios, 10 datasets were again generated.
The SPE selection methodologies to be compared in this analysis were Box’s
method, Jackson & Mudholkar’s (J&M), Gamma, minAS, and resampling
using permutation strategy 2 (genes permutation) and option (b) to compute
threshold by global percentile (Permut2b). Regarding leverage, we compared
the resampling method (Permut2b), Gamma approximation and the minAS
method. The resulting combinations of all these methods are shown in Table
3.4. The significance level that produced the best results in the previous
studies was chosen.
Figure 3.8 shows 95% confidence intervals for the mean MCC produced
by each of these methods. The overall good performance of the meth-
ods can be deduced from this plot, because all of them obtained a mean
MCC higher than 0.9. However, the ANOVA model with repeated measures
showed a statistically significant difference between them (p-value<0.001).
The worst results were obtained for those combinations in which resampling
techniques were used to compute the SPE threshold. Box’s method for SPE
is not recommended for its high standard deviation. The Gamma approx-
imation for leverage worked excellently. Considering both MCC mean and
standard deviation, the best combinations were number 6 (J&M+Gamma),
number 8 (Gamma+minAS) and number 9 (Gamma+Gamma). The ANOVA
model also showed that the number of genes and the number of signal genes
classes had no significant effect on mean MCC value (p-value=0.137 and
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Table 3.4: Selection methods combinations included in global comparison.
Combination SPE method Leverage method
1 Box - α=0.03 Permut2b - α=0.01
2 Box - α=0.03 minAS
3 Box - α=0.03 Gamma - α=0.01
4 J&M - α=0.01 Permut2b - α=0.01
5 J&M - α=0.01 minAS
6 J&M - α=0.01 Gamma - α=0.01
7 Gamma - α=0.01 Permut2b - α=0.01
8 Gamma - α=0.01 minAS
9 Gamma - α=0.01 Gamma - α=0.01
10 minAS Permut2b - α=0.01
11 minAS minAS
12 minAS Gamma - α=0.01
13 Permut2b - α=0.01 Permut2b - α=0.01
14 Permut2b - α=0.01 minAS
15 Permut2b - α=0.01 Gamma - α=0.01
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p-value=0.353, respectively). However, signal genes percentage significantly
affected the MCC value (p-value<0.001), as well as the interaction between
signal gene percentage, and method combination (p-value<0.02). In general,
the higher signal genes percentage, the higher the mean MCC. Combination
9 (Gamma+Gamma) did not result in big differences in mean MCC for the
different percentages of signal genes. However, some combinations including
minAS, for example numbers 10, 11, and 12, worked much better when the
percentage of signal genes was higher.
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compare simultaneously all of the previously described methods for
computing SPE and leverage thresholds. In this last comparison,
other biological scenarios were simulated taking into account the re-
sults obtained in the previous studies. The level of noise was not in-
cluded as a parameter in these simulations because it had, in
general, very little influence on MCC results, so it was set to 20%.
The values for the rest of biological parameters were:
• Number of genes in the dataset: 5000 or 20000.
• Percentage of responsive genes: 3% or 10%.
• Number of gene classes: 5 or 25.
For each one of the 8 possible scenarios, again 10 datasets were
generated. SPE selection methodologies to be compared in this analy-
sis were Box's method, Jackson and Mudholkar's (J&M), Gamma,
minAS and resampling using permutation strategy 2 (genes permuta-
tion) and option (b) to compute threshold by global percentile (Per-
mut2b). Regarding to leverage, we compared resampling method
(Permut2b), Gamma approximation and minAS method. The result-
ing combinations of all these methods are shown in Table 2. The sig-
nificance level that produced the best results in the previous studies
was chosen.
Fig. 5 shows 95% confidence intervals for mean MCC produced by
each one of the methods. It can be deduced from this plot the overall
good performance of the methods, since all of them got a mean MCC
higher than 0.9. However, the ANOVA model with repeated measures
showed a statistical significant difference among them (p-valueb0.001).
The worst results were obtained for those combinations in which
resampling techniques were used to compute SPE threshold. Box's
method for SPE is not recommended for its high standard deviation.
The Gamma approximation for leverage worked excellently. Consider-
ing both MCC mean and standard deviation, the best combinations
were number 6 (J&M+Gamma), number 8 (Gamma+minAS) and
number 9 (Gamma+Gamma). The ANOVA model also showed that
the number of genes and the number of signal genes classes had no sig-
nificant effect on mean MCC value (p-value=0.137 and p-value=
0.353, respectively). However, signal gene percentage significantly
affectedMCCvalue (p-valueb0.001), aswell as the interaction between
signal genes percentage and method combination (p-valueb0.02).
In general, the higher signal gene percentage, the higher mean MCC.
Combination 9 (Gamma+Gamma) did not result in big differences in
mean MCC for the different percentages of signal genes. However,
some combinations including minAS, for example numbers 10, 11 and
12, worked much better when the percentage of signal genes was
higher. Additionally, interaction plots illustrating the methods combi-
nations performance can be found in the Supplementary Material.
In all the simulation studies, the bandwidthwas computed following
the Silverman's rule (“nrd0” option). To check what happened if band-
width was modified with the “adjust” coefficient, minAS was applied
to the 80 simulated datasets in simulation experiment 2, using the de-
fault options in “density” and varying the coefficient “adjust” from 0.5
(i.e., half the bandwidth obtained by “nrd0” method) to 5 (i.e., 5 times
the bandwidth obtained by “nrd0”method), as it is described in Supple-
mentary Material. Interestingly, minAS performance improves for “ad-
just” values higher than one, that is, when the estimated density curve
is more smoothed (see Supplementary Material).
To summarize, minAS and Gamma approximation (with α=0.01)
behaved slightly better than the rest of the studied methods. Further-
more, Gamma method presented less differences in MCC value for
different signal genes percentages, while minAS had a better perfor-
mance when this percentage was higher.
3.2. Experimental data: hypoxia
Once the benchmarking with simulated data was completed, the
methods producing the best results were applied on an experimental
dataset and evaluated for their ability to select genes that led to out-
standing biological information. The Hypoxia gene expression data in
[30] was used for this biological validation. This dataset collects the
transcriptomic profile of human embryonic stem cells cultured
under different oxygen concentrations. The oxygen conditions were:
normoxia (21% of oxygen) and hypoxia (5% or 1% of oxygen). Gene
expression for 30826 genes was measured in several time points
using Agilent microarrays. An ASCA model was fit to the data. Factor
a is the time (0 h, 12 h, 24 h, 5 days and 10 days) and factor b was
used for the oxygen level (21%, 5% and 1%). Oxygen level and interac-
tion effects were joined together in the model (as in Eq. 2). Two prin-
cipal components were selected in each submodel (a and b+ab),
which explained 83.2% of the variability in submodel a and 71.9% in
submodel b+ab. Model analysis showed different gene behaviors
for each oxygen level, differentiating clearly normoxia from hypoxia
conditions, and time points 12–24 h from 5 to 10 days (results not
shown). In order to compute SPE and leverage thresholds, several
combinations of selection methods showing the best performance in
the previous simulation studies were used: Jackson and Mudholkar's
SPE method (α=0.01), Gamma approximation (α=0.01) and minAS
Table 2
Selection methods combinations included in global comparison.
Combination SPE method Leverage method
1 Box — α=0.03 Permut2b — α=0.01
2 Box — α=0.03 minAS
3 Box — α=0.03 Gamma — α=0.01
4 J&M — α=0.01 Permut2b — α=0.01
5 J&M — α=0.01 minAS
6 J&M — α=0.01 Gamma — α=0.01
7 Gamma — α=0.01 Permut2b — α=0.01
8 Gamma — α=0.01 minAS
9 Gamma — α=0.01 Gamma — α=0.01
10 minAS Permut2b — α=0.01
11 minAS minAS
12 minAS Gamma — α=0.01
13 Permut2b — α=0.01 Permut2b — α=0.01
14 Permut2b — α=0.01 minAS
15 Permut2b — α=0.01 Gamma — α=0.01
1.
00
0.
95
0.
90
0.
85
SPE selection method
95
%
 c
on
fid
en
ce
 in
te
rv
a
ls
 fo
r 
M
CC
R
es
am
pl
in
g
m
in
AS
G
am
m
a
R
es
am
pl
in
g
m
in
AS
G
am
m
a
R
es
am
pl
in
g
m
in
AS
G
am
m
a
R
es
am
pl
in
g
m
in
AS
G
am
m
a
R
es
am
pl
in
g
m
in
AS
G
am
m
a
Box J&M Gamma minAS Resampling
Leverage selection method
Fig. 5. 95% confidence intervals for mean MCC according to methods combination.
Horizontal dashed-line corresponds to overall average MCC.
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Figure 3.8: 95% confid nce intervals fo mean MC according the combination
of methods used. Horizontal dashed-line corresponds to overall average MCC.
In all the simulation studies, the ba dwidth was computed following Sil-
verman’s rule (“nrd0” option). To check what happened if the bandwidth was
modified with the “adjust” coefficient, minAS was applied to the 80 simulated
datasets in sim lation experiment 2, using the default options in “density”
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and varying the coefficient “adjust” from 0.5 (i.e., half the bandwidth ob-
tained by the “nrd0” method) to 5 (i.e., 5 times the bandwidth obtained by
“nrd0” method). The MCC results for each “adjust” value are displayed in
Figure 3.9. Interestingly, minAS performance improves for “adjust” values
higher than one, that is, when the estimated density curve is more smoothed.
It is expected that for a certain value of “adjust” coefficient not considered
in the study, performance gets worse, because the density curve would be
so smoothed that the distribution would become unimodal. Moreover, if the
bandwidth is decreased, the curve is not smooth enough and may yield false
local minima. As shown in the plot, for an “adjust” coefficient of 0.5, there
are MCC values close to 0, and the MCC first quartile is less than 0.8. The
important conclusion is that the default minAS options provide a good esti-
mation for SPE and leverage density curves. Increasing the bandwidth can
improve gene selection, but smaller bandwidths result in over-adjustment and
in the occurrence of false local minima, leading to an increase of the number
of false positives.
To summarize, minAS and Gamma approximation (with α=0.01) behaved
slightly better than the rest of the studied methods. Furthermore, the Gamma
method presented fewer differences in MCC values for different signal gene
percentages, while minAS had a better performance when this percentage
was higher.
3.3.2 Experimental data: Hypoxia
Once the benchmarking with simulated data was completed, the methods pro-
ducing the best results were applied on an experimental dataset and evaluated
for their ability to select genes that led to outstanding biological information.
The Hypoxia gene expression data in [114] was used for this biological vali-
dation. This dataset collects the transcriptomic profile of human embryonic
stem cells cultured under different oxygen concentrations. The oxygen con-
ditions were: normoxia (21% oxygen) and hypoxia (5% or 1% oxygen). Gene
expression for 30826 genes was measured at several time points using Agilent
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Figure 1: Matthew’s correlation coefficient obtained in simulated datasets according to
different values for the coefficient “adjust” (that multiplies the bandwidth obtained by
“nrd0” default method) when applying minAS selection strategy for SPE and leverage
values from ASCA model in datasets from simulation experiment 2.
3
Figure 3.9: Matthew’s correlation coefficient obtained in simulated datasets
according to different values for the coeffici nt “adjust” (that multiplies the
bandwidth obtained by the “nrd0” default method) when applying the minAS
selection strategy for SPE and leverage values from the ASCA model in datasets
from simulation experiment 2.
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Table 3.5: Number of genes selected by the method combinations studied in
the hypoxia dataset.
Combination SPE
method
Leverage
method
Sub-model
a
Sub-model
b+ab
Total
5 J&M minAS 1347 1827 2668
6 J&M Gamma 1182 1919 2618
8 Gamma minAS 1287 1076 2034
9 Gamma Gamma 1122 1176 1976
11 minAS minAS 1862 1309 2705
12 minAS Gamma 1706 1405 2649
microarrays. An ASCA model was fit to the data. Factor a is the time (0
hours, 12 hours, 24 hours, 5 days and 10 days) and factor b was used for
the oxygen level (21%, 5% and 1%). The oxygen level and interaction effects
were joined together in the model (as in Equation 3.3). Two principal compo-
nents were selected in each submodel (a and b+ab), which explained 83.2%
of the variability in submodel a and 71.9% in submodel b+ab. Model analysis
showed different gene behaviors for each oxygen level, clearly differentiating
normoxia from hypoxia conditions, and time points 12-24 hours from 5-10 days
(results not shown). In order to compute SPE and leverage thresholds, sev-
eral combinations of selection methods showing the best performance in the
previous simulation studies were used: Jackson & Mudholkar’s SPE method
(α=0.01), Gamma approximation (α=0.01) and the minAS method. Table
3.5 shows the number of genes selected by each one of these combinations
and Figure 3.10 shows the histograms and distributions fitted for SPE and
leverage values in each submodel, as well as the thresholds obtained by the
selection methods.
To evaluate the validity of the different variable selection methods, se-
lected gene lists were investigated to see whether the biological information
they contained was relevant to the study. Hence, for each one of the selected
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Finally, we have focused on multifactorial designs because the vari-
able selection issue has not been sufficiently developed for these complex
experimental setups. The ASCA-genes framework was chosen to model
these data, since it is considered a suitable methodology for the analysis
of genomic datasets with such experimental designs. However, as the
proposed variable selectionmethods are based onmodeling the distribu-
tion ofmultivariate statistics, they are generally applicable to different di-
mension reduction techniques and kind of data by changing the statistic
measuring the importance of the variables in the model. In fact, we have
successfully applied our methods in other contexts, as for example in
[37], where minAS was used for selecting variables from genomic and
metabolomic data in Tucker3 and N-PLS models.
The minAS and Gamma variable selection methods applied to
ASCA-genes analysis have been implemented in the web suite for Se-
rial Expression Analysis, SEA (http://sea.bioinfo.cipf.es/) [18], and are
freely available to the scientific community.
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Figure 3.10: Histograms for SPE and leverage in each submodel. Curves repre-
sent the distributions fitted by the variable selection methods applied. Vertical
lines r the thresholds c mputed from these distributions. The X-axis has b en
zo ed for better v sua ization and t refore they do not show the full range of
SPE and leverage values.
66 3. VARIABLE SELECTION FOR MULTIFACTORIAL GENOMIC DATA
gene sets, we carried out a functional enrichment (FE) analysis by means
of the FatiGO tool, included in Babelomics suite [2], using the Gene Ontol-
ogy (GO) gene function annotation to compare selected versus non-selected
genes. FE is an established methodology to interpret and evaluate transcrip-
tomic data, that assesses whether specific cellular functions (in this case, GO
terms) are overrepresented within the set of significant genes. Significant en-
riched GO terms for the selected genes sets were visualized with the Blast2GO
software [28], that allowed them to be colored, depending on the number of
selection methods by which they had been detected. This kind of graph en-
abled us to evaluate which of the selected gene sets contributed more to the
biological interpretation of the experimental results (see an example in Figure
3.11).
In general, all of the tested methodologies generated gene selections en-
riched in a number of GO terms that represent key general processes of the
hypoxia treatment. These were, among others, “developmental process”,
“metabolic process”, “response to stimulus”, “transcription factor activity”,
“chemokine receptor binding”, “lipid transport activity”, “immune system
process”, “intrinsic to plasma membrane”, “organ morphogenesis”, “angio-
genesis”, “response to wounding” and “humoral immune response”. “Organ
morphogenesis” and “angiogenesis” refer to the establishment of the circula-
tory system in mammals, one of the first events during the embryo develop-
ment [22, 75]; while the metabolism of lipids has also been postulated to play
an important role in the embryo differentiation [56]. Also “ectoderm develop-
ment” and “epidermis development” were functions identified by most of the
methods, and are directly related to the differentiation process analyzed in
this experiment. Additionally, some specific processes were only revealed by
some of the selection methods. For example, combinations 5 and 6 (both us-
ing J&M method for SPE selection) highlighted the “central nervous system
development” (associated to normoxia) and “sensory organ development”
or “chemokine receptor binding” (both related to hypoxia). Combinations
11 and 12 (SPE selection by minAS) discovered metabolic processes such
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Figure 3.11: Example of a Blast2GO graph displaying enriched GO terms
detected by the FatiGO tool (adjusted p-value < 0.05) when comparing genes
selected by each of the method combinations against the others.
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as “hormone metabolic process”, “hexose metabolic process” and “glucose
metabolic process”. Combinations 9 and 12 (leverage selection by Gamma)
found the “extracellular matrix part” GO term, which plays a fundamental
role in regulating remodeling processes in embryo development and is also
involved in repair processes, inflammation and tumor invasion [65].
In summary, most of the biological information is shared by all the com-
pared methods combinations, but not all of them contribute equally to im-
proving our biological knowledge about the gene products dynamics in this
context. Each of the combinations leads to the extraction of some particular
biological functions than the rest of the methods do not detect or, at least,
not with the same degree of specificity.
3.3.3 Other applications
Some of the variable selection strategies described here have also been applied
in other multivariate contexts different from ASCA method.
In [31], multi-way projection methods such as Tucker3 and N-PLS were
used for the integrative analysis of a functional genomics dataset where tran-
scriptomics, metabolomics and physiological data were available from an ex-
periment on rats to assess the effect of hepatotoxicant bromobenzene. The
most relevant biological features were selected by applying minAS to either the
loadings corresponding to one of the model components or the projection of
several component loadings into the line that best separated the experimental
conditions.
In [113], the PANA computational methodology is introduced. It studies
the functional interconnections among the molecular elements of a biological
system by using high-throughput genomics measurements and a functional
annotation scheme. PCA is applied to extract an activity profile from each
functional block -or pathway. Next, machine-learning methods infer the rela-
tionships between these functional profiles to obtain an interconnected net-
work of pathways that represents the functional cross-talk within the molec-
ular system. minAS is again used to identify the main gene contributors to
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pathway profiles computed from PCA models also taking the loadings as the
variable importance measurement. We showed the benefits of the PANA ap-
proach to describe the functional transcriptional connections during the yeast
cell cycle and to identify pathways that change their connectivity in a disease
condition using an Alzheimer example.
3.4 Discussion
In this chapter, we have presented and compared several strategies to se-
lect the most relevant genes in multivariate models applied to the analysis of
complex genomic data. The starting point of this contribution is the adop-
tion of a multivariate dimension reduction strategy, commonly used in data
exploration for the identification of important genes. In comparison to uni-
variate methods that carry out gene-wise analysis, the multivariate approach
exploits the coordinated nature of gene expression and avoids the applica-
tion of multiple testing corrections that seriously diminishes statistical power
in genomic research. In these scenarios, two additional factors are also im-
portant. Firstly, the high-dimensionality of the feature space, that results in
data structures where the number of variables can be two or three orders of
magnitude the number of observations. And second, the low signal to noise
ratio of the measurements. This implies that traditional multivariate feature
selection methods are generally not applicable. The basic contribution in this
paper is that the variable selection choices we propose always involve studying
the distribution of the statistics used to measure the importance of the vari-
ables. Hence, the threshold for these statistics is set according to the shape
of the distribution rather than selecting a fixed percentage of the total num-
ber of variables, which is a common and rather arbitrary practice in this kind
of analysis. Our main concern in this study was to identify methodologies
that will generally work well in different scenarios of dataset size, diversity
of gene expression signals and levels of noise, since these features are not
normally fixed by the experimentalist. We also tried to gather selection meth-
ods with an easy implementation and comprehension, as we understand that
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variable selection is only a small part of a genomic study and researchers may
need quick but consistent solutions. In this work, some methods were taken
from the literature (Box, Jackson & Mudholkar) or adapted to be used in
this context (resampling), while others are novel proposals (minAS, Gamma
approximation). These variable selection methods were first compared on
simulated datasets to evaluate which ones presented the best performance
and to quantify the influence of some biological data features on the good-
ness of the selection. In general, Gamma and minAS methods showed the
best behavior for both SPE and leverage thresholds computation, as well as
Jackson & Mudholkar’s method for SPE. It was also seen that the higher
the percentage of signal genes or the number of genes are, the better minAS
performance is, while Gamma approximation is not significantly affected by
these biological parameters, therefore making it a more robust methodology.
However, modifying minAS default options (such as increasing the smoothing
parameter) improved the performance of this method. The application of
these three approaches on a real experimental dataset verified their useful-
ness for selecting relevant genes. In all cases, relevant biological conclusions
could be obtained on the gene selection provided by the different methods,
although specific biological functions were differentially uncovered by each
approach. Interestingly, the major differences in gene selection and functional
enrichment were the result of the method choice for the SPE statistic, while
leverage seemed to be more robust for the statistical model applied. This
result is interesting as the SPE measures the deviation of each gene from
the general multivariate model. Differentially expressed genes that follow a
minority expression pattern tend to have high SPE values [103]. Our results
indicate that selection on this part of the signal is also biologically relevant.
It should be outlined that the conclusions of this chapter are based on the
simulation studies performed and might not be valid outside the biological
scenarios analyzed. However, since the simulation algorithm was carefully
designed to mimic real datasets and a vast variety of scenarios was considered
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(comprising more than 600 datasets), we believe that the results are generally
valid for most multifactorial gene expression experiments.
Finally, we focused on multifactorial designs because the variable selection
issue has not yet been sufficiently developed for these complex experimental
setups. The ASCA-genes framework was chosen to model these data, since
it is considered a suitable methodology for the analysis of genomic datasets
with such experimental designs. However, as the proposed variable selection
methods are based on modeling the distribution of multivariate statistics, they
are generally applicable to different dimension reduction techniques and kind
of data by changing the statistic measuring the importance of the variables
in the model. In fact, we have successfully applied our methods in other
contexts, as for example in [31], where minAS was used for selecting variables
from genomic and metabolomic data in Tucker3 and N-PLS models, and
in [113], where minAS is again used to identify the main gene contributors
to pathway profiles computed from PCA models taking the loadings as the
variable importance measurement.
The minAS and Gamma variable selection methods applied to the ASCA-
genes analysis have been implemented in the web suite for Serial Expression
Analysis, SEA (http://sea.bioinfo.cipf.es/) [102], which is freely available to
the scientific community.
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4.1 Introduction
RNA-seq is a recently emerged high-throughput sequencing technology which
is increasingly being applied to quantify gene expression levels. With RNA-
seq, no previous knowledge of the genome is required, and in addition to
estimating expression levels, it also allows structural analysis of the transcrip-
tome: alternative splicing, 3’ UTR regions, novel splice junctions, antisense
regulation, intragenic expression, etc. [91, 124].
At the dawn of RNA-seq applications it was claimed that this technology
would produce unbiased, ready-to-analyze gene expression data. However, the
reality has turned out to be very different. It is now generally admitted that
it collects a number of biases and that accuracy at the low expression level is
still limited [77, 99]. RNA-seq technology boasts a generally high level of data
reproducibility across lanes and flow-cells, which reduces the need for techni-
cal replication within these experiments [92, 99], but neither data processing
nor experimental design are straightforward. While microarrays provide gene
expression measurements in a format that can be directly analyzed by the
researcher, the information generated by sequencing platforms must be care-
fully processed to obtain these expression estimations. There are many steps
between biological sample collection and expression quantification, including
RNA isolation, library construction, sequencing, read alignment, etc. Un-
fortunately, the files generated at each of these processing steps frequently
contain biases that are introduced by the sequencing technology [124], during
sample preparation [60, 98] and/or by the selected mapping algorithm [45].
Therefore, when analyzing sequencing data performing quality control at each
step to get an idea of how reliable the data are, and how well they fit with the
expected outcome is a fundamental requirement. However, despite the many
procedures that have been developed to reduce the noise at each one of these
processing steps and to control the quality of the data generated [8, 49], the
technology is still far from being perfect and therefore it is absolutely nec-
essary to be able to detect potential biases once the expression levels (read
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counts) have been obtained, and crucially, before proceeding with any further
analyses such as differential expression analysis.
An important trait of sequencing technologies that must be taken into
account when designing an experiment is the amount of reads to be gener-
ated (sequencing depth). In RNA-seq, in particular, the more the target is
sequenced, the more transcripts are identified and the higher the value of the
expression level. Although most of the existing analysis methods address this
issue by including a correction factor related to library size [18, 99], higher
sequencing rates will presumably result in a more accurate estimation of the
expression level and, concomitantly, the detection of significant changes in
expression may be very much determined by the sequencing depth. Inevitably
this leads to the question of how many reads should be generated in an RNA-
seq experiment to obtain robust results. Some reports suggest that, in a
mammalian genome, ∼ 700 million reads would be required to obtain accu-
rate quantification of more than 95% of expressed transcripts [14]. Knowledge
of the relationship between sequencing depth and feature detection is needed
for experimental design purposes and for understanding the characteristics
of the analysis results. Hence, the number of replicates and the sequenc-
ing depth at which one should sample remains an important question to be
answered when designing an RNA-seq experiment [19].
Another issue that must be faced when dealing with analysis of short
reads is that the quantification of expression depends on the length of the
biological features under study (genes, transcripts, or exons), as longer fea-
tures generate more reads than shorter ones [106]. In the case of the Illumina
RNA-seq platform, which is probably the most widely used, a guanine and
cytosine nucleotide content (GC content) bias has also been reported [119].
Genomic sequences with either a high or low GC content are prone to under-
representation in the sequencing outcome, which means that the correspond-
ing estimated expression levels will be lower [12, 57]. Another drawback is the
very nature of the sequencing technology, which is basically a sampling proce-
dure from a population of transcripts, implying that differences in the relative
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distributions of transcripts between samples affect the assessment of differen-
tial expression [15, 120]. Furthermore, the ability to detect and quantify rare
transcripts is obscured by the wide dynamic range of mapped reads and the
concentration of a large portion of the sequencing output in a reduced number
of highly expressed transcripts. Hence, all these factors interfere in the linear
relationship between transcript abundance and the number of mapped reads
at a gene locus. The correction of these potential biases to make expres-
sion across samples or genes comparable is known as normalization, and it is
therefore a substantial step in RNA-seq data processing. Different methods
are available to tackle both within-sample and between-sample normalization
[18, 38, 119, 154].
In this chapter, we will focus on quality control procedures to be applied
on expression data, i.e. read count, which may be useful to explore the data
before proceeding with further analyses. This exploratory analysis helps to
gain knowledge about the biological characteristics of the detected features
and also to choose an appropriate normalization method according to the
potential biases observed in the data. We also discuss the normalization
procedures to be applied in order to correct these biases and propose some
methods to filter out the low count features since they may be inaccurate and
may introduce noise into the analysis.
All these procedures have been implemented in the NOISeq R package,
which is available in the open-source Bioconductor repository [50]. Some of
them were introduced in [141] and are also available in the Qualimap software
[49]. The functionalities of the NOISeq package are summarized in Figure 4.1
and were used to generate most of the results in this chapter and in chapter
5.
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Figure 4.1: Outline of NOISeq package functionalities. Black arrows highlight
that some quality control plots are used to take decisions on data processing.
4.2 Data
To illustrate the usefulness of the quality control tools described in this chap-
ter, three experimental RNA-seq data sets were chosen. Two of them will
also be used in the next chapter to assess the performance of the methods
introduced there.
• ENCODE data set
RNA-seq data from human monocytes (cell line Cd14) were obtained by
the Cold Spring Harbor Laboratory for the ENCODE project [32]. Two
different RNA extraction protocols were applied: PolyA+ extraction
method (Pap) and PolyA- selection procedure (Pam). The sequencing
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was done with an Illumina GAIIx platform and the reads were mapped
to the reference genome (hg19 GRCh37) downloaded from UCSC [61]
using TopHat v2.0.8 [71]. Gene expression was quantified using the
HTSeq Python package version 0.5.3p3 [6], taking multi-hits into ac-
count by using an in-house script. This dataset will be referred to as
ENCODE.
• Fusarium oxysporum data set
Fusarium oxysporum is a soil-borne fungal pathogen that may affect a
broad range of animals, from arthropods to humans, and also more than
100 plant species. It can produce localized skin or corneal infections in
immunocompetent humans and frequently lethal infections in immuno-
compromised patients. This experiment was conducted by one of our
collaborators on the “Transcriptional networks controlling virulence in
filamentous fungal pathogens” project (TRANSPAT), which co-funded
this work. The aim of TRANSPAT was to explore transcriptional net-
works which enable fungi to survive and proliferate in the mammalian
bloodstream, given the increasing incidence of invasive fungal infec-
tions in immunocompromised patients, and associated mortality rates
as high as 85-90%. Therefore, in order to study the infection mech-
anisms, the fungus was cultured in either minimal medium (MM) or
human whole blood, and RNA was extracted from these samples and
sequenced using SOLiD protocols. Two biological replicates were ob-
tained for both blood and MM conditions and these were mapped to
the reference genome from the Ensembl Fungi database (release 14)
[47] using Lifescope software. CLC Bio tools were used to quantify the
gene expression. This dataset will be referred to as FO.
• Human prostate data set
These RNA-seq data were taken from the work of Ren et al. [118] and
were publicly available at the SRA repository. In this work, samples
of tumoral and healthy prostate that came from Shanghai Changhai
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Hospital patients were sequenced. There were 11 biological replicates
for the tumoral prostate condition and 12 replicates for the healthy
prostate condition. The sequencing was done with an Illumina HiSeqTM
2000 and the reads were mapped to the Homo sapiens reference genome
downloaded from Ensembl (release 68) [47] using TopHat 1.4.1 [143].
To quantify the gene expression the HTSeq Python package version
0.5.3p3 [6] was used. This dataset will be referred to as HS.
4.3 Quality control analysis
The quality control measures for read count data proposed in this chapter
address three issues. First, biotype detection is used to obtain a global view
of the type of genes detected in relation to the composition of the reference
genome. Second, sequencing depth is analyzed to assess detection and quan-
tification of the expressed genes. Finally, analysis of potential technical biases
in the data is performed, such as the influence of gene length or GC content
on expression or the differing RNA composition of the samples.
The NOISeq package offers the possibility of easily generating a quality
control report with all these plots in PDF format (see an example in Ap-
pendix).
4.3.1 Biotype distribution
The Ensembl database [48] provides a biological classification of genes accord-
ing to the role they play in transcription or translation. For instance, some
of the biological groups include “protein-coding” genes (genes that code for
proteins), “miRNA” (for microRNAs, which are small transcripts that can
degrade messenger RNA in the cytoplasm), or “tRNA” (for transfer RNA,
which serves as the physical link between the nucleotide sequence of DNA or
RNA and the amino acid sequence of proteins), among others.
RNA-seq experiments may follow different RNA purification protocols to
select specific target RNA species (i.e., long mRNAs or microRNAs) that may
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be subjected to different levels of technical variation. Also, library preparation
choices result either in data being stranded and hence allowing the identifi-
cation of antisense expression, or ignoring the strand origin of the transcript.
A standard protocol for an mRNA library preparation includes poly-A mRNA
isolation, RNA fragmentation, and size selection from a gel. Therefore, tran-
scripts should be polyadenylated and larger than the size selection cutoff
(typically 200 bp) to be captured by the sequencing procedure. Polyadenyla-
tion signals are present in protein-coding genes but have also been identified
in long-range, noncoding transcripts [23] and some snoRNAs1 [54, 81]. The
expression of pseudogenes is controversial, but reports indicate that these
might be transcribed, giving rise to non-functional messengers in a tissue
specific manner [153]. Furthermore, poly-A stretches might be present in
retrotransposed pseudogenes2 that originate from genome insertion events
of these transcribed messengers [153]. Poly-A tails are also added to pri-
miRNAs, nascent miRNA transcripts that undergo processing to reach the
mature miRNA state [72]. Although pri-miRNAs can be long molecules, they
are of transient nature and miRNAs are typically not captured by mRNA-seq
library preparation protocols; alternatively, miRNAs embedded in the introns
of coding genes could still be sequenced from partially processed transcripts.
Other RNAs such as tRNAs, snRNAs3, snoRNAs, and rRNAs4 may undergo
cytoplasmic polyadenylation to targeting them for degradation [7, 131]. Addi-
tionally, rRNA depletion usually precedes mRNA preparation and the presence
of rRNA is considered as contamination in mRNA-seq experiments. In general,
these small RNA species can be considered as non-targeted by the mRNA-seq
procedure. Therefore, in RNA-seq experiments involving polyA selection, it is
1Small nucleolar RNAs
2Pseudogenes are dysfunctional relatives of genes that have lost their protein-coding
ability or are otherwise no longer expressed in the cell. Pseudogenes often result from the
accumulation of multiple mutations within a gene whose product is not required for the
survival of the organism. Although not protein-coding, the DNA of pseudogenes may be
functional. (Wikipedia)
3Small nuclear RNAs
4Ribosomal RNAs
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expected that most of the genes with mapped reads belong to the “protein-
coding” category. The identification of other biotypes at proportions higher
than in the reference genome might indicate inefficient mRNA purification or
reveal new discoveries.
Thus, different experimental protocols may result in RNA-seq data having
a non-uniform RNA composition that may not be directly comparable. This
may be relevant, for example, when trying to combine data from different
public sources to perform a joint meta-analysis or when technical variability
with specific protocols is high. The biotype plots (Figures 4.2 and 4.3) are
useful for determining which biotypes are present in the sample to provide an
assessment on the homogeneity of samples within the data set. The “Biotype
detection” plots (Figures 4.2a and 4.2b) show the proportion of genes within
each biotype in the genome (gray bars), the proportion of them being detected
in the biological sample with counts higher than 0 (red stripped bars) and
which proportion represents each biotype within the genes detected in the
sample (red solid bars). Bars on the left of the green vertical line correspond to
the left Y axis, while bars to the right side are associated with the right Y axis
(they are less abundant biotypes). Since the plots were generated for one of
the conditions, the mean expression values (normalized to counts per million)
across all samples for that condition were computed. The “Biotype expression
range” box-plots (Figures 4.3a and 4.3b) show the range of expression levels
in counts per million reads (CPM) within each biotype and help to decide
if the expression quantification for the genes within a given biotype is good
enough to perform further analyses on that biotype.
To illustrate the usefulness of these diagnostic plots we used them to
compare RNA-seq samples generated with two different purification proto-
cols (ENCODE data). By comparing the “Biotype detection” plots of both
experimental procedures some differences are readily evident. The Pap proto-
col identifies a higher relative proportion of protein-coding genes (more than
60%) than the Pam protocol (around 55%). As a consequence, the second
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(a) Biotype detection. Pap protocol.
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(b) Biotype detection. Pam protocol.
Figure 4.2: Biotype detection. ENCODE data. Grey bars represent the
percentage of each biotype in the reference genome. Stripped color bars illus-
trate the proportion of genes in the genome, by biotype, that are detected in
the sample. Solid color bars give the percentage of each biotype within genes
detected in the sample.
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(a) Biotype expression range. Pap protocol.
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(b) Biotype expression range. Pam protocol.
Figure 4.3: Biotype expression range. ENCODE data. Expression values (Y
axis) are given in counts per million of sequencing reads (CPM). Numbers in the
upper part of the plot are the number of genes, by biotype, that are represented
in each boxplot.
protocol had a relatively higher level of other RNA species such as pseudo-
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genes, lincRNA1 or antisense transcripts (Figures 4.2a and 4.2b). Differences
in the relative percentage of detected biotypes also impact the quantification
of the different RNA species, as revealed by the “Biotype expression range”
plots (Figures 4.3a and 4.3b). The Pap protocol results in a wider dynamic
range of expression for protein-coding genes than the Pam one. In contrast,
the two Mt rRNAs2 accumulate a huge number of reads when using the Pam
protocol (around 267, 000 and 64, 000 CPM, respectively) in comparison to
Pap protocol (around 1, 100 and 230 CPM, respectively). These differences
do not only affect the quantification of each transcript but may also have an
effect on the results of any statistical analyses performed on them such as
differential expression.
4.3.2 Sequencing depth and expression quantification
A key issue when analyzing RNA-seq data is to assess whether the avail-
able sequencing depth (total number of sequencing reads) provides sufficient
coverage of expressed transcripts and an accurate quantification of gene ex-
pression. Alternatively, one may ask which sequencing depth is required to
interrogate the transcriptome with good coverage and precision. It is generally
admitted that genes detected by only a few reads are not reliably quantified
and should be removed before further statistical analysis. The quality control
plots described in this section are targeted to answer questions and provide
solutions related to these matters.
The “Saturation” plot (Figures 4.4 and 4.5) indicates the number of de-
tected genes in a biological sample (left axis) at the given sequencing depth
(solid dot) and also at simulated higher and lower sequencing depths. The bars
(right axis) show the new detections per each additional million sequencing
reads. If more sequencing does not lead to a high number of new detections,
then the saturation point has been reached and the sequencing will improve
1Large intergenic non-coding RNAs
2Mitochondrial ribosomal RNAs
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Figure 4.4: Saturation. HS data. Two of the tumoral samples are displayed.
Genes from all biotypes are considered.
the quantification of the previously detected genes. The data for lower se-
quencing depths were simulated from a multinomial distribution taking the
counts of that sample as the reference probabilities and aggregating the sim-
ulated samples to increase the depth. For each case, 10 simulations were
performed and the number of detected genes in each simulated sample were
averaged. To simulate the higher sequencing depths, the same procedure was
applied but, in order to give genes with no counts a chance to appear, we
added 0.2 to the original data.
In HS data we observed that around 50% of the annotated genes are
found at the nominal sequencing depth of between 20 and 25 million reads
(Figure 4.4). The “Saturation” plot estimates that in this range of total reads,
around 250 additional genes are detected per additional million reads. This
implies that increasing the sequencing depth by 10 million reads will increase
transcriptome coverage by 10%. While this information alone is informative,
4.3 Quality control analysis 87
PROTEIN_CODING (21684)
Sequencing depth (million reads)
0
20
40
60
80
10
0
12
0
N
ew
 d
et
ec
tio
ns
 p
er
 m
illi
on
 re
ad
s
l
l
l
l
l
l
l
15
60
0
16
20
0
16
80
0
17
40
0
18
00
0
l
l
l
l
l
l
l
N
um
be
r o
f d
et
ec
te
d 
fe
a
tu
re
s
5 10 15 20 25 30 35 40
Left axis Right axis %detected
T_10 l
−
80.1
T_14 l 75.1
(a) Saturation plot for “protein coding” biotype.
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Sequencing depth (million reads)
0
5
10
15
20
25
30
35
40
N
ew
 d
et
ec
tio
ns
 p
er
 m
illi
on
 re
ad
s
l
l
l
l
l
l
l
90
0
11
00
14
00
17
00
20
00
l
l
l
l
l
l
l
N
um
be
r o
f d
et
ec
te
d 
fe
a
tu
re
s
5 10 15 20 25 30 35 40
Left axis Right axis %detected
T_10 l
−
27.6
T_14 l 23.1
(b) Saturation plot for “lincRNA” biotype.
Figure 4.5: Saturation. HS data. Two of the tumoral samples are displayed.
88 4. RNA-SEQ DATA QUALITY CONTROL
l
ll
l
lll
l
l
lll
l
l
ll
l
l
l
l ll
l
l
l
l
l
l
ll
l
l
ll
ll ll
l
l
ll
l
l
l
l
ll
ll
l l
ll
l
lll
l l
ll
ll
l
ll
ll
l
l
ll
lll
ll
l
l
l
l
l
ll
l
l
l
l
l
l
ll
l
l l
l
l
l
l
l
N
_1
0
T_
10
N
_1
1
T_
12
N
_1
3
T_
13
N
_1
4
T_
14
N
_1 T_
1
N
_2 T_
2
N
_3 T_
3
N
_4
N
_5 T_
6
N
_7 T_
7
N
_8 T_
8
N
_9 T_
9
GLOBAL (41365)
Ex
pr
es
sio
n 
va
lu
es
0
10
10
0
10
00
10
00
0
1e
+0
5
1e
+0
6
(a) Dynamic range of expression.
0
20
40
60
80
100
N
_1
0
T_
10
N
_1
1
T_
12
N
_1
3
T_
13
N
_1
4
T_
14
N
_1 T_
1
N
_2 T_
2
N
_3 T_
3
N
_4
N
_5 T_
6
N
_7 T_
7
N
_8 T_
8
N
_9 T_
9
GLOBAL (59573)
Se
ns
itiv
ity
 (%
)
25
.3
19
.7
26 22
.5
21
.3
21
.1
23
.4
24
.3
24
.3
16
.6
22
.2
18
.7
22
.5
22
.4
24
.7
22
.1
21
.3
27
.3
19
.6
22
.3
24
.9
23 22
CPM > 0
CPM > 1
CPM > 2
CPM > 5
CPM > 10
(b) Sensitivity plot.
Figure 4.6: Expression quantification. HS data.
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it may be more relevant to analyze it in the context of biotype break-down.
Figures 4.5a and 4.5b show the “Saturation” plots for the protein-coding and
the lncRNA1 biotypes. Between 16,200 and 17,400 protein coding genes were
found in these tumor samples in RNA-seq data sets at a new detection rate
of 40. This implies that the feature detection improvement with the addition
of 10 million additional reads is estimated to be around 2% for the gene-
coding biotype. In contrast, between 1200 and 1400 lncRNAs are found in
these samples and their new detection rate stays at 35. This translates into
an estimated 25% more lncRNAs with a 10 million read sequencing depth
increase. Depending on the goal and scientific questions of the study (i.e.
whether lncRNAs are of interest) decisions on the need for additional reads
may change.
In the “Dynamic range of expression” plot (Figure 4.6a) , the distribution
of the number of read counts per million (CPM) for all the samples in the
experiment is compared. Genes with no counts in any of the samples are not
used for this plot. Similar to the biotype boxplots, this plot is useful to identify
differences in count distributions within the data set. In HS data, we observed
that the distribution of expression levels for detected genes varies considerably
among samples, and suggests that a normalization approach that corrects for
these differences would be needed to make the samples comparable. This plot
could also be used to reject samples with odd expression level distributions.
For example, one could consider removing sample N 10 from the analysis for
having a too low median expression level.
The analysis of expression quantification is complemented by the “Sensi-
tivity” plot (Figure 4.6b), that displays the number of genes with more than
0, 1, 2, 5 or 10 CPM for each sample (bars) and in any of the samples
(horizontal lines). The sequencing depth (in million sequencing reads) is also
provided in the upper side of the plot. This plot reflects the proportion of
genes with low expression from the total number of transcripts. In the HS
example, less than 35% of the genes have more than 1 CPM in any of the
1Long non-coding RNA
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samples. This means that there are a high number of genes with 1 CPM
or less in all of them. The estimation of gene expression is less reliable for
low-count genes which represent a source of noise that negatively affects sen-
sitivity and specificity in most statistical analyses [134], and therefore their
removal is recommended [5]. Hence, the “Sensitivity” plot provides a graphi-
cal representation that helps to make decisions on the CPM threshold because
it shows the percentage of features that would be removed at different CPM
values.
4.3.3 Sequencing biases
Finally, when sequencing artifacts are present in the data, the expression
quantification could be biased and lead to misleading conclusions in posterior
analysis when comparing samples or genes (e.g. differential expression stud-
ies). Therefore a proper and timely detection of these biases is needed to
choose an appropriate normalization procedure that corrects data errors and
improves downstream statistical analyses: The diagnostic plots in Figure 4.7
are especially designed for this purpose.
For the “length” and “GC content” plots (Figures 4.7a and 4.7c), bins
containing 200 genes were created according to length or GC content. The
dots in these plots show the 5% trimmed expression value mean for the 200
genes within each bin. For instance, in the case of length, the first dot on
the left corresponds to the 200 shortest genes, the following dot to the 200
next longest genes, and so on. To assess the relationship between the length
or GC content and the trimmed gene expression mean, a cubic spline regres-
sion model was fitted (red and blue line for length and GC content plots,
respectively). When the model p-value is lower than a given significance level
(e.g. α = 0.05) and R2 is high enough (e.g. higher than 70%), the fitted
curve shows a trend for the relationship between length or GC content and
expression and helps to decide whether the bias is strong enough to be cor-
rected. Both feature length and GC content bias are manifest in the FO data
(Figures 4.7a and 4.7c). The longer the gene, the higher the expression, while
4.3 Quality control analysis 91
l
ll
llll
l
ll
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
ll
l
ll
l
l
l
ll
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
0 2000 4000 6000 8000 10000 12000 14000
0
50
10
0
15
0
Blood
Length bins
M
ea
n 
ex
pr
es
sio
n
R2 = 94.23%
p−value: 3.7e−33
(a) Length bias.
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
0 2000 4000 6000 8000 10000 12000 14000
0
20
40
60
80
Blood
Length bins
M
ea
n 
ex
pr
es
sio
n
R2 = 50.27%
p−value: 2.4e−06
(b) After RPKM normalization.
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Figure 4.7: Report III. Sequencing biases. FO data (Blood condition).
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the curve that relates GC content and expression shows that the expression
level diminishes when GC content is very low or very high.
The “RNA composition” plot (Figure 4.7e) indicates if significant differ-
ences in the composition of the RNA sample are present. In these plots, M
values are computed between each sample s and a reference sample r (which
can be arbitrarily chosen) as M = log2(xs/xr), where xs are the counts in
sample s. If no bias is present, the median of M values for each comparison
is expected to be 0 [120]. Deviations from this value indicate that expres-
sion levels of a fraction of genes in one sample tend to be higher than in the
others and mean that the data violate the assumption of a uniform global
RNA distribution which is frequently made in genome-wide gene expression
experiments. Figure 4.7e shows a deviation from 0 in the M medians for
the FO data. Confidence intervals for the M median were also computed
by resampling. The confidence level was adjusted for multiple testing using
Bonferroni’s correction. These confidence intervals showed that this deviation
was statistically significant.
Confidence Intervals for the median of M values in FO data
Warning: 4197 features with 0 counts in all samples are to be
removed for this analysis.
Reference sample is: wt_B_30_37_1
Confidence intervals for median of M:
0.83% 99.17% Diagnostic Test
wt_B_30_37_2 -0.153815574418935 -0.108393535088251 FAILED
wt_M_30_37_1 -0.370808505381945 -0.370808505381945 FAILED
wt_M_30_37_2 -0.36066807247099 -0.29410617912117 FAILED
Diagnostic test: FAILED.
Normalization is required to correct this bias.
Therefore, these diagnostic plots suggest that specific normalization pro-
cedures are required to remove these observed biases. In the next section, the
most common normalization procedures are briefly described.
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4.4 Normalization
Normalization is an important step in RNA-seq analysis since it helps to reduce
potential sequencing biases and to make the samples and features comparable.
Two different types of normalization may be considered [38, 119]:
• Within-sample normalization procedures try to adjust data for gene
specific effects such as gene length or GC content. Longer genes tend
to obtain a higher number of read counts and hence a higher estimation
of their expression level. A higher or lower GC content in a region of
interest may lead to an under-estimation of gene expression [12].
• Between-sample normalization methods aim to correct for systematic
differences among samples due to either different sequencing depths or
different RNA compositions. The sequencing depth affects expression
levels because the more reads that are sequenced for a given sample,
the higher the estimation of gene expression will be for that sample.
Regarding the RNA composition, this unwanted effect is present when
there are highly expressed genes in one of the samples but not in the
other samples. These genes have a relatively higher number of reads
in that sample while not in the others. If this is the case, genes with a
lower number of read counts would not be comparable among samples
and could contribute to artificially increasing the biological variability
among samples, possibly leading to unreal expression changes between
conditions.
Many normalization strategies have been developed to deal with these
potential biases that can be detected using the plots described in the previous
section. Some of the most widely used normalization methods are briefly
described in Table 4.1, where xsi is the number of read counts for gene i in
sample s, ysi is the normalized expression value for gene i in sample s, N
s is
the total number of counts in sample s (sequencing depth), li is the length
of gene i, and Qs75 is the upper quartile of non-zero gene counts in sample s.
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Table 4.1: Normalization methods for RNA-seq data
Type Method Description
Within-
sample
EDASeq [119] Four approaches to correct for length
or GC content: Regression (loess),
Full-quantile, Median or Upper Quar-
tile normalization.
RNASeqBias [154] Generalized Additive Model to correct
for gene length or GC content.
Between-
sample
Upper Quartile
[18], also in
EDASeq [119]
ysi = x
s
i/Q
s
75
TMM [120], also
in edgeR [123]
Trimmed Mean of M values.
Given a reference sample r,
fs0 = 2
WM(log2((xs/Ns)/(xr/Nr))),
where WM is the weighted mean
after removing the highest log-ratios
and the most expressed genes. The
scaling factor is fs = fs0/e
ln(f0).
Then: ysi = x
s
i/(f
s ×N s/N¯)
Quantile [16], also
in EDASeq [119]
The distributions of gene counts are
matched across samples.
DESeq [4] If fs = Mei(x
s
i/GM(xi)), where Me
is the median and GM the geometric
mean: ysi = x
s
i/f
s.
Both RPKM [99] Reads Per Kilobase per Million
mapped reads adjusts for length bias
and sequencing depth:
ysi = 10
9 × xsi/(N s × li)
CQN [58] Conditional Quantile Normalization
to correct for any within-lane system-
atic bias and also for between-lane
normalization.
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In the NOISeq R package, three of these popular normalization methods
were included: RPKM [99], Upper Quartile [18] and TMM [120]. However,
to perform a differential expression analysis (see Chapter 5), the package also
accepts previously normalized data, so any other normalization procedure can
be applied instead.
The diagnostic plots described in the previous section (Figure 4.7) revealed
the presence of sequencing biases in the data that required a within-sample
(length or GC content) and between-sample (RNA composition) normaliza-
tion. The choice of the type of normalization depends on the ulterior analysis
to be performed. For instance, in differential expression studies, it is essential
to assure that changes in expression between two samples are indeed due to
biological differences and not to sequencing artifacts. Therefore, at least a
between-sample normalization needs to be applied.
Different types of normalization procedures conceived to target each spe-
cific bias were applied: RPKM [99] (included in the NOISeq package) to
correct for length bias, “full” within-sample normalization in the EDASeq
package to correct for GC content bias [119] and TMM [120] (also included
in the NOISeq package) to correct RNA composition bias. The expression
dependence on gene length was reduced after applying RPKM (Figure 4.7b).
The same happened for GC content bias after using the EDASeq package
(Figure 4.7d). After TMM normalization, the distributions of M values did
not shift and the median was approximately 0, which indicated that the RNA
composition bias had been mitigated (Figure 4.7f).
4.5 Filtering out low-count features
It has been often argued that, in RNA-seq, expression estimation for low count
genes is less reliable because read counts could have been assigned by chance
[97, 137]. Thus, excluding features with low counts may improve the results
of statistical analyses because the level of noise is reduced. However, the best
procedure to filter these low count features has not yet been decided.
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To the best of our knowledge, no filtering procedures have been imple-
mented so far in statistical packages for RNA-seq data, but it is a common
practice to simply remove genes with total counts for all the samples lower
than a certain cutoff, e.g. 10 counts [4, 18, 134]. This approach does not
take into account the sequencing depth of the experiment to decide the cutoff,
so genes with a relatively high expression in one of the conditions could be
ignored. A better method is the procedure described in the edgeR R package
User’s Guide in the Bioconductor repository. The authors proposal consists of
keeping genes with counts per million reads (CPM) above a given threshold in
at least as many samples as the number of samples per condition. By setting
the cutoff for the CPM instead of the raw counts, it can be assured that no
genes with a high relative expression are eliminated. In the NOISeq pack-
age, we implemented three different filtering procedures: the CPM method,
Wilcoxon test, and Proportion test, which are described in detail in the next
section.
4.5.1 CPM method
Let xsg be the number of raw counts of gene g in sample s. As in the edgeR
proposal, counts for each sample are transformed to counts per million reads
(CPM): CPM sg = 10
6 × x
s
g∑
g
xsg
. A value for CPM under which a feature is
considered to have low counts must be previously set (cpm). By default, the
CPM method takes a cutoff of cpm = 1. If there are S samples in a given
experimental condition, the cutoff for that condition would be cpm × S. A
gene g is filtered out if the sum of CPM values across all the samples in the
same condition is below the condition cutoff (
∑
s
CPM sg < cpm× S) for all
the experimental conditions.
It is also possible to remove genes that present inconsistent expression
values in any of the experimental conditions with the CPM method. A cutoff
for the coefficient of variation per condition cv has to be set a priori. Then,
a gene g will be filtered out either if it has a total CPM value per condition
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of less than cpm × S or a coefficient of variation per condition higher than
the cv cutoff for all the conditions.
4.5.2 Wilcoxon test
Although the CPM method takes the experimental design and the variability
per condition into account , it has the drawback of having to decide the
cutoffs to use for both the CPM and the coefficient of variation. Hence, we
propose the Wilcoxon test to identify those genes with a CPM value median
per condition that is significantly higher than 0. Thus, the hypothesis to test
for each gene and condition is H0 : m = 0 versus H1 : m > 0, where m
is the median of the CPM values per condition. To be more conservative,
no multiple testing correction was applied in order to retain as many genes
as possible. Genes with a p-value higher than 0.05 in all the conditions are
filtered out.
By using the Wilcoxon method, genes with inconsistent values across repli-
cates within the same condition or with a low median expression value tend
to be removed. However, this non-parametric procedure is only recommended
when the number of replicates per condition is at least five.
4.5.3 Proportion test
The proportion test aims to be the alternative to the Wilcoxon test when
few replicates per condition are available. This method requires a cutoff to
be set for CPM (cpm), but not for the coefficient of variation. It is based
on the idea that read counts for a given gene follow a binomial distribution
where the number of trials n is the sequencing depth and the probability
p is the probability of expression for that gene under a given experimental
condition, which is unknown. Thus, in this case, H0 : p = p0 is tested
versus H1 : p > p0. Since it is not possible to use p0 = 0 in a binomial
proportion test, we define p0 = cpm/10
6. If several replicates are available
for an experimental condition, we sum across replicates (xg =
∑
s
xsg) and use
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this single value as the observed binomial variable. Then, n =
∑
g
xg. Again,
to be conservative, the raw p-values are used and genes with a p-value higher
than 0.05 in all conditions are filtered out.
4.5.4 Comparing filtering methods
We applied the three NOISeq filtering procedures and edgeR proposal to FO
(with 2 replicates per condition) and HS data (with 11 and 12 replicates per
condition) to illustrate the similarities and differences of the methods. We
set a cutoff of cpm = 1 for the CPM method, Proportion test, and edgeR
approach. Because of the number of replicates, the Proportion test was only
applied to FO and the Wilcoxon test was applied to HS. We considered a
coefficient of variation of 500 for the CPM method to cancel this filter and
make this method more comparable to edgeR approach. According to the
number of replicates per condition in each dataset, genes with a CPM higher
than 1 in at least 2 or 10 samples for each dataset respectively were retained
in the edgeR approach.
Both datasets originally contained 18066 (FO) and 59573 (HS) genes.
Out of these, 9577 and 16176 respectively, were not filtered out by any of
the methods (Figure 4.8). Most of the filtered genes (7904 and 30233)
were removed by all the methods which indicates that, in general, there were
very few differences among them. The greatest difference was found for
the Wilcoxon test (HS), since there were more than 12000 genes that were
removed by CPM and edgeR but not by Wilcoxon.
We studied the characteristics of the removed genes that were not in
common for the compared filtering methods by plotting the difference be-
tween the mean CPM per condition against the maximum variability between
replicates (Figures 4.9 and 4.10). Genes filtered only by edgeR tended to
show higher differences in expression between conditions which is obviously
not good because genes with potentially significant changes in expression be-
tween conditions could be removed from the analysis. Although these genes
generally present a high variability among replicates and will probably not be
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9577
130
175
243
0
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37
7904
CPM Proportion test
edgeR
(a) FO data
16176
1024
0
7
15
12118
0
30233
CPM Wilcoxon test
edgeR
(b) HS data
Figure 4.8: Number of genes filtered out by each method
declared as differentially expressed by statistical methods, it may be preferable
to leave the decision about these cases to the statistical method instead of
filtering them out of the ulterior analysis.
Finally, to illustrate how low-count filtering affects statistical analyses,
for instance, differential expression analysis (see next chapter), we applied
the CPM filtering method with a cpm threshold of 1 to HS data and ob-
tained differentially expressed genes with two statistical packages (described
in the next chapter): NOISeqBIO and edgeR [123]. Figure 4.11 shows the
results of the filtering approach. A total of 42366 low-count genes were
removed after applying the CPM threshold, of which 292 and 887 had been
detected as differentially expressed by NOISeqBIO and edgeR, respectively. In
turn, removing these low-count genes resulted in 683 (NOISeqBIO) and 1195
(edgeR) newly detected genes that belonged to a higher expression range.
These results highlight the impact of low-count filtering in RNA-seq differen-
tial expression analysis and how the resources of the NOISeq package can be
used to address this task easily.
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Figure 4.9: Difference between expression mean per condition versus maximum
difference between replicates for genes not removed by all methods from FO
data.
4.6 Discussion
RNA-seq technology reads the population of RNA molecules in a given sam-
ple and renders a direct quantification of the abundance of each transcript,
mapping ambiguities and sequencing errors issues separately. Although this
is fundamentally true, as shown in studies on how RNA-seq data corresponds
with microarray and RT-PCR data [18, 53, 92], there is still some work to be
done to fully understand the characteristics of RNA-seq data and to properly
process them in order to obtain accurate results in further statistical analysis.
Estimation of gene expression levels from sequencing reads seems concep-
tually simple and was initially seen by many researchers as a very straightfor-
ward task. However, it implies the execution of a series of complex compu-
tational algorithms that should be chosen and adapted to the characteristics
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Figure 4.10: Difference between expression mean per condition versus maxi-
mum difference between replicates for genes not removed by all methods from
HS data.
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Figure 4.11: Differentially expressed genes not in common when filtering or
not filtering low-count genes using CPM method in HS data.
of the sequencing platform, sample preparation protocol, organism, etc.
Thus, from the files containing the sequencing reads to the estimation of
expression given by the number of reads assigned to each biological feature
being studied, a variety of tools to assess the quality of the results at each step
of the analysis have been introduced. FastQC [8] is a popular software package
for analyzing the data quality and some other aspects such as duplication of
reads, GC or N content, etc. of the raw sequencing reads. There are indeed
other software packages such as the NGS QC Toolkit [111] that not only
generate a quality control report but also include other functionalities such
as trimming the sequencing reads to remove low quality bases or adapter
sequences before continuing with the mapping step. Once the reads are
mapped to the reference genome, tools such as RSeQC [148], RNA-SeQC
[37], Qualimap [49], or RNASeqGUI (an R package with a graphical interface)
[126] can evaluate the results of the mapping. Some of them also offer
other possibilities such as expression quantification or differential expression
analysis. If mapping results are satisfactory, the next step would be to obtain
the number of reads assigned to each biological feature, i.e. the expression
quantification. These read counts will then be used as the input for statistical
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models.
However, no matter what quality control procedures were performed dur-
ing this process, it is essential to determine if there are systematic technical
effects that are biasing the expression estimation before going on with further
analyses. One of the biases that rapidly becomes evident is the effect of the
depth of the sequencing experiment; not only because counts from samples
with different sequencing depths are not comparable. Ultra-high throughput
sequencing seems advisable to detect transcripts with low expression values
because of the large dynamic range of gene expression obtained. However, as
more sequencing output is considered, the diversity and quantity of detected
off-target RNA species, such as several types of small RNAs, also increases
[141]. The extent to which each of these biotypes and transcripts are pu-
rification artifacts or have a biological significance warrants a separate study
but it does show an important property of RNA-seq data: the effect that
sequencing depth has on the distribution of reads among transcripts and the
quantification of expression, essentially a percentage in the case of this tech-
nology. Robinson et al. [120] have already highlighted the implications that
different transcript distributions might have on RNA-seq normalization and
differential expression. A preliminary exploration of the count data may also
be helpful to know the biological and quantitative characteristics of the data,
or even to detect any potential contamination. In addition, when there are
highly expressed transcripts in some of the samples that accumulate a huge
number of reads, an unwanted decrease in the read counts of transcripts with
low or medium expression is produced that might distort their comparison
across samples.
Other important elements that may affect the expression quantification
are the transcript length and the GC content. The nature of the short read
procedure makes it inevitable that longer transcripts will be preferentially
detected over shorter ones, and this has been shown to have implications on
the biological interpretation of the data [106, 152]. Also, an effect of the
104 4. RNA-SEQ DATA QUALITY CONTROL
GC content of the transcripts has been reported for Illumina sequencing reads
[12, 119] which may also bias the data.
In this chapter, we described a whole set of useful graphical and diag-
nostic tools to assess the quality of the data prior to statistical analysis. We
illustrated which kind of information these tools provide by using experimen-
tal data. With these quality control plots we obtained a useful description of
biological and quantitative traits of the data, and also assessed the effect of
sequencing biases in expression quantification in order to choose an appropri-
ate normalization procedure. After reviewing the most popular normalization
methods and, according to the results from the exploratory analysis, we se-
lected the normalization procedure which should be applied in each case. In
addition, as it has been often claimed, features with low counts may hamper
the study of the behavior of the rest of features because they cause the sta-
tistical methods used to lose their power. Here we proposed some methods to
filter out these noisy low-count genes, compared the differences among these
methods, and showed the impact of filtering on the differential expression
analysis results.
All these functionalities are included in an open Bioconductor R package
called NOISeq, which also offers the possibility of generating a Quality Control
Report PDF to facilitate exploration of the user’s data. In this package,
we also implemented a non-parametric statistical procedure to compare two
experimental conditions and to find out which genes present a significant
change in expression between conditions (differentially expressed genes) that
will be introduced in the next chapter.
Chapter 5
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5.1 Introduction
When high-throughput technologies are used to quantify the expression of
thousands of genes in several experimental conditions, one question rapidly
arises: which genes are differentially expressed? In bioinformatics, this means
identifying the genes that present a statistically significant change in expres-
sion due to an external stimulation, experimental perturbation, or simply
changes over time. These differentially expressed genes (DEGs) are likely
involved in the biological mechanisms that give rise to different phenotypes
between conditions (e.g. diseased versus healthy individuals, treated versus
control, etc.).
Methodologies to analyze differential expression (DE) have been thor-
oughly studied for microarray data [33, 108]: these take a measurement of
luminescence to estimate the expression level of the genes. Thus, the es-
timated expression level is a continuous variable and most of the proposed
methods assume a normal distribution for this type of data [133]. RNA-seq
expression measurement is totally different to microarrays, since in RNA-seq
the number of sequencing reads falling into a gene is considered to be the
estimation of the gene expression level. Therefore in this case the expression
level is a discrete variable, which has motivated the development of novel
differential expression methods specific for the NGS technologies. Methods
traditionally used for microarrays have paved the way to other approaches
that take into account the discrete nature of the expression quantification
by using discrete probability distributions to model the data. The vast ma-
jority of the methodologies proposed so far rely on parametric assumptions
[4, 59, 92, 105, 123, 136, 140]. For technical replication, they generally use
a Poisson distribution to model feature counts, following the rationale of the
sampling procedure in RNA sequencing. While in a Poisson distribution the
mean and variance have to be equal, the Negative Binomial distribution allows
for over (or under) dispersion, as occurs in the case of biological replication,
and so the read counts are modeled with the Negative Binomial distribution.
108 5. DIFFERENTIAL EXPRESSION IN RNA-SEQ
However, the subsequent confirmation of distributional assumptions is impor-
tant as they might not always hold true [18]. Moreover, there are usually very
few replicates, if any, available, which hinders the estimation of model param-
eters. Non-parametric methods such as SAMseq [82] or NPEBseq [13] have
also been proposed and they have the advantage of not requiring such strong
assumptions to be fulfilled. However, the low replication problem remains
a drawback, because these kinds of methods tend to perform better with a
higher number of replicates. Another common alternative would be the adap-
tion of popular microarray methodologies such as Limma [133] for application
on transformed counts (e.g. log2 transformation or voom transformation), as
described in the literature [79, 116].
In this chapter, we introduce two non-parametric approaches for DE
analysis: NOISeq and NOISeqBIO, which have been implemented in the
open Bioconductor R NOISeq package (http://www.bioconductor.org/
packages/release/bioc/html/NOISeq.html). The NOISeq DE method
[141] was developed in the infancy of RNA-seq when experiments with only
technical replicates or no replicates at all were being produced by researchers
(because of the still high cost of the technology) and hence were available
from public repositories. Therefore, NOISeq is optimized for the use of tech-
nical replicates and can even process experiments without replications. It has
been successfully used in several studies [21, 26, 40, 44, 85, 127, 155] and
benchmarked against the most popular differential expression methods with
good results [13, 73, 101, 134].
Biological replicates are now more common in RNA-seq experiments, al-
though the number of them is still limited. Researchers tend to invest their
budget in increasing the sequencing depth of the experiments in order to de-
tect a wider variety of transcripts. However, they should be aware of the
fact that having more replicates per condition improves the biological vari-
ability estimation which results in a more robust DE analysis that gives more
power to the DEG capture. Therefore, the strategy of increasing replication
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instead of depth should be recommended when DE analysis is to be performed
[86, 130].
To better handle biological variability, we adapted the NOISeq method and
named it NOISeqBIO. NOISeqBIO implements an empirical Bayes approach
that improves the way of dealing with the biological variability specific to
each gene and is very successful in controlling the high false discovery rate in
experiments with biological replicates, where other methods have previously
been shown to fail [134].
We tested our NOISeq and NOISeqBIO methods on both experimental
and simulated datasets, and compared them to other widely used differential
expression methods such as Fisher’s Exact Test, edgeR [123], baySeq [59],
DESeq [4], and SAMseq [82].
5.2 Data
5.2.1 Experimental data
5.2.1.1 Experimental data with technical replicates
Two publicly available human RNA-seq datasets with different sequencing
depths were used in the studies with technical replication. In both of them,
sequencing was done with Illumina technology.
The MAQC dataset [18, 128] was generated for benchmarking purposes
on RNA-seq. It consists of two samples: Ambion’s human brain reference
RNA (Brain) and Stratagene’s human universal reference RNA (UHR). Each
sample comprises seven lanes, providing a total of 42 and 45 million reads
respectively. Each lane was considered as a technical replicate. This project
additionally has RT-PCR data for validation of RNA-seq analysis results.
Griffith’s dataset [53] contains 96 and 198 million paired-end reads re-
spectively of the transcriptome of two human colorectal cancer cell lines which
only differ in the fluorouracil (5-FU) resistance phenotype. The technical repli-
cates corresponded to 13 lanes selected from each condition to equilibrate the
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sequencing depth in both conditions to around 100 million reads. RT-PCR
data were also available in this data set for a number of genes.
Raw fastq files containing the sequencing reads were downloaded from
the SRA archive [80] and mapped against the Homo sapiens high cover-
age assembly Hg19 from Ensembl [46] using Tophat [143], allowing up to 2
mismatches and discarding reads mapping at multiple locations. Counts for
each gene were computed by means of the HTSeq Python package [6] using
Ensembl genes’ annotation (version 60) and only exonic reads.
Regarding the RT-PCR measurements from these two experiments, we
identified positive (RT-PCR differentially expressed) and negative (RT-PCR
non-differentially expressed) genes following a previously reported procedure
[18, 53] and matched them to Ensembl IDs. After discarding replicates and
eliminating unmatched genes, a total of 330 and 82 positive genes and 83
and 12 negative genes for MAQC and Griffith’s dataset, respectively, were
taken to compute the indicators for the performance plots.
5.2.1.2 Experimental data with biological replicates
We used two experiments with a very different number of biological replicates
that were described in detail in the Data section in Chapter 4. Briefly, the FO
experiment was done with the fungal pathogen F. oxysporum, and compares
fungal growth in a human blood culture against growth on a minimal medium
with the purpose of studying the mechanisms of proliferation of the fungus in
humans. It has two replicates per condition. The prostate cancer experiment
(HS) compares tumoral and healthy tissues from Chinese patients with 11
and 12 replicates per condition respectively.
For the preliminary studies on simulated data with biological replication
we also used samples from an experiment carried out within our TRANSPAT
project. In this case another opportunistic human pathogen, the fungus As-
pergillus fumigatus, was cultured in human blood and in minimal medium with
the same goal as in the FO experiment: comparing gene expression between
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these two experimental conditions to elucidate which genes were responsible
for the infection process in humans.
5.2.2 Simulated data
5.2.2.1 Simulated data with technical replication
The synthetic data included in the baySeq R package [59], which contains
counts for 1000 features evaluated in two experimental conditions with 5
replicates each, were used. The first hundred features are differentially ex-
pressed.
5.2.2.2 Simulation algorithm for biological replication
We developed an algorithm to simulate data with biological replicates in order
to better assess the performance of the DE methods being compared.
It has been reported [4, 59, 123] that the number of reads mapping to a
given gene resembles an over-dispersed Poisson distribution when considering
biological replicates and that one way of modeling this over-dispersion is by
taking the negative binomial distribution. Thus, our simulation algorithm is
based on randomly generating the counts from a negative binomial distribution
as done previously in other studies [124, 134]. Figure 5.1 shows the outline
of the algorithm.
These are the main steps of the simulation algorithm:
1. An initial number of counts per gene (µg0) is used to simulate the
replicates for each condition. This µg0 determines the proportion of
sequencing reads initially assigned to each gene g. It can be either pro-
vided by the user or randomly generated from a power-law distribution:
f(x) ∝ x−λ, where x is the gene expression level, 0 ≤ x ≤ depth/1000
and λ = 0.5. Thus, if ngenes is the number of genes in the simulated
dataset, ngenes values are randomly generated from this distribution
to be used as the initial counts µ0 when no experimental samples are
provided by the user.
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Figure 5.1: Outline of the simulation algorithm used for biological replications
2. The proportion of differentially expressed genes (propdeg) is chosen by
the user and is used to obtain the number of DEGs. The proportion
of DEGs that will be upregulated in condition 1 is generated from the
uniform distribution U(0.25, 0.75), and the rest of the DEGs are down-
regulated in this condition. Genes that are up and down regulated are
randomly taken from the total set of genes.
3. The number of replicates per condition is given by the parameter nrepl.
Each biological replicate for a given gene and condition is simulated
from a negative binomial distribution with mean µ and variance σ2. To
describe the relationship between the mean and the variance, previously
used parametrization [123] was applied: σ2 = µ(1 + φµ). This is how
µ and σ2 are estimated from the initial counts µ0:
• Estimation of µ
For each condition i (i = 1, 2), the mean expression is defined
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Figure 5.2: The fold-change is generated randomly from a Beta distribution
with shape parameters α = 1.5 and β (which can be modified, by default β = 6).
The larger the β value, the lower the probability of having high fold-changes.
as µgi = (µ
g
0 + K
g) × FCg, for g ∈ DEG, and µgi = µg0, for
g /∈ DEG. The fold-change FCg is randomly generated from a
Beta distribution:
FCg − 1.5
100
∼ Beta(α, β), where α = 1.5. By
default, β = 6, but it can be modified by the user (see Figure 5.2).
The constant Kg is included because, if µ
g
0 = 0, no change would
be applied to that specific gene. We set Kg = 5, ∀g ∈ DEG. The
mean µgi thereby obtained for each gene and condition is adjusted
so their sum is equal to the given total number of counts (depth).
Finally, in order to allow a certain level of noise in the data (noise),
the final µgi is the maximum between 0.1 and a random value from
the uniform distribution U(µi−noise×µi, µi +noise×µi). The
reason for taking the maximum is to give any gene with no initial
counts some chance to appear.
• Estimation of φ
To compute the variance σ2, we first need to estimate the value
of the dispersion parameter φ. We evaluated several experimental
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data sets with different number of replicates and biological variabil-
ity to obtain realistic scenarios of either high or low biological vari-
ability. We followed the estimation procedure described in [124].
For each dataset, only samples with a total number of counts
higher than 106 and the genes with a mean expression higher than
1 were chosen. Once this filter was applied, the remaining sam-
ples were adjusted so all of them had the same number of counts
(depth). With these normalized data, the mean expression of each
gene was computed, which is the maximum likelihood estimator
(MLE) of µg. The MLE of φg was obtained by maximizing the log-
likelihood function. This was done for each experimental dataset
and all the pairs (µg, φg) from every dataset were pooled. All µ
values were divided into bins containing approximately 1000 values
each. Figure 5.3 shows the dependence of φg on µg for the sce-
nario of high biological variability. The higher the value of µ, the
lower the median and variability of φ. The mid-point of the bin
was computed for each bin of µ values, as well as the median and
the median absolute deviation (mad) of φ values within the bin.
Thus, for each condition i, φg is randomly taken from a normal
distribution N(µgφ, σ
g
φ), where µ
g
φ = µφ(µ
g
i ) and σ
g
φ = σφ(µ
g
i ) are
obtained by linear interpolation from µ mid-points and φ medians.
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Figure 5.3: Distribution of φ values (in log-scale) from experimental datasets
within each bin of µ values (containing approximately 1000 values each).
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Figure 5.4 shows some examples of simulated datasets for different levels
of noise and DEG proportions and with high biological variability.
Figure 5.4: Example of simulated data. A sample from the Fusarium oxysporum
experimental dataset was taken as the initial counts µ0. The parameters in
common for all the simulations were: nrepl = 5 in both conditions, depth = 30
million and beta = 6. The values for parameters noise and propdeg are indicated
in each plot. The differentially expressed genes are highlighted in red.
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5.3 Methods
5.3.1 NOISeq
NOISeq is a non-parametric approach for the identification of DEGs between
two experimental conditions from count data with technical replicates or no
replicates at all. The basic idea underlying NOISeq is that a given feature
may be considered differentially expressed if its change in expression between
the two experimental conditions is greater (or has a higher probability of
being greater) than the change observed among replicates within the same
condition. Essentially, NOISeq creates a noise distribution of count changes by
contrasting fold-change differences (M) and expression differences (D) for all
the genes in samples within the same condition. This reference distribution
is then used to assess whether the (M,D) values computed between two
conditions for a given gene are likely to be part of the noise or represent true
differential expression (Figure 5.5). In practice, NOISeq creates the noise
distribution by joining (M,D) values from all possible pair-wise comparisons
between replicates of either condition.
Let xgij be the expression of gene g in condition i (i = 1, 2) and replicate j.
To measure the expression level change between two conditions, NOISeq takes
two statistics into consideration: the log fold change (M) and the difference
(D), that are calculated as in Equations 5.1 and 5.2:
Mgs = log2(x¯
g
1/x¯
g
2) (5.1)
Dgs = x¯
g
1 − x¯g2 (5.2)
The reason for using these two statistics is to get more reliable measure-
ments of the change, because the fold change for features with low read
counts can be misleading; the same occurs for the difference in expression
between two conditions in the range of high counts. To avoid indeterminate
values when computing the M statistic, values of 0 are changed to a constant
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Figure 5.5: (M, |D|) plot for signal distribution (green), noise distribution
(black) and genes declared as differentially expressed (red).
value k, where k can be chosen by the user or computed as the midpoint be-
tween 0 and the next highest value. The use of normalized data for analyzing
differential expression with NOISeq method is highly recommended. NOISeq
has the advantage of accepting already normalized expression values instead
of gene counts, so it can be used with any normalization procedure. It is also
possible to use the raw counts as input and specify which of the normalization
methods implemented in the package is to be used.
Note that when technical replicates correspond to different lanes of the
flow-cells used to sequence the biological samples, the counts of the replicates
are summed instead of averaged.
There are two variants of the method: NOISeq-real and NOISeq-sim.
When technical replicates are available, NOISeq-real uses them to compute
the noise distribution. NOISeq-sim simulates them in the absence of replica-
tion. It should be noted that the NOISeq-sim simulation procedure equates
to technical replication and does not reproduce biological variability, which
5.3 Methods 119
is necessary for population inferential analysis. However, many RNA-seq ex-
periments still have low replication, thus the ability of statistical methods to
work with technical replicates, or no replicates at all, is relevant. It is also
very common to generate pilot data before completing a whole experiment,
so NOISeq-sim can be applied in these cases to get a preliminary picture of
the genes which change between conditions.
5.3.1.1 NOISeq-real
In order to determine the probability of differential expression, the algorithm
creates a so called “noise” distribution by pooling the (Mn, Dn) values com-
puted among replicates within the same condition. Thus, these noise values
can be calculated as: Mn = log2(x
g
ij/x
g
ik) and Dn = x
g
ij − xgik, for each pair
of replicates j and k (j 6= k) and for any condition i or gene g. All these
values are pooled together to generate the bivariate noise distribution.
Next, we derive an empirical cumulative distribution function F (M,D)
from the absolute value of these “noise” measurements (Mn, Dn). Given a
certain gene with (ms, ds) values of the “signal” statistics (Ms, Ds), com-
puted from the comparison of both experimental conditions, we suggest that
the probability of differential expression be estimated as follows:
F (|ms|, |ds|) = P (|Mn| ≤ |ms|, |Dn| ≤ |ds|) (5.3)
The higher this probability, the higher the change in expression between
conditions with regard to “noise”, and the more we expect that change be-
tween conditions is due to the experimental factor effect and not to chance.
We recommended that a threshold around 0.8 is used for this probability. This
threshold would be equivalent to an odds of 4:1, which means that the gene
is four times more likely to be differentially expressed than non-differentially
expressed.
Because the NOISeq method was developed for technical replicates or no
replicates at all it was not our intention to compute statistical significance in
terms of p-values. However, many NOISeq users have requested equivalence
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between the probability of differential expression returned by NOISeq and p-
values. The statistic (M,D) used by NOISeq to assess differential expression
is a bivariate statistic. We searched in the literature for cases in which a p-
value was computed from bivariate statistics, but we found that in multivariate
hypothesis testing, the statistic is transformed to a univariate distribution
(e.g. Hotelling’s T 2 when testing equality of means in multivariate normal
populations). This is the approach we followed in NOISeqBIO, as we will see
in the next section. However, to preserve the bivariate nature of the NOISeq
statistic when testing H0 : µ1 = µ2, we suggest computing the p-value as in
Equation 5.4, taking into account that in NOISeq we consider the absolute
values of M and D to obtain the probability of differential expression and
that we intend to declare a gene as DEG when both M and D values are
higher than in noise.
p− value(ms, ds) = P (|Mn| > |ms|, |Dn| > |ds|) (5.4)
Note that the p-value is not equivalent to 1 − F (|ms|, |ds|). NOISeq
performance using this p-value definition has not yet been tested.
5.3.1.2 NOISeq-sim
When there are no technical replicates available in any of the experimental
conditions, the NOISeq algorithm can simulate them. The simulation relies
on the assumption that read counts follow a multinomial distribution, where
the probability for a given class (gene) in the multinomial distribution is the
probability of a read to map to that gene. These mapping probabilities are
approximated using counts in the only available sample of the corresponding
experimental condition. Counts equal to zero are replaced with 0.5, to give
all genes some chance to appear.
Given the sequencing depth si of the unique available sample in condition
i, sequencing depth for the simulated samples is generated randomly from a
uniform distribution in the interval [(pnr-v)*si), (pnr+v)*si]. The parameter
pnr is a percentage that determines the number of reads of each simulated
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replicate, and the v parameter allows for some variability in the sequencing
depths across simulated samples. Both parameters can be chosen by the users,
as well as the number of replicates to be simulated (nss). The recommended
values for these parameters are: nss ≥ 5, pnr=0.2 and v=0.02.
Once the replicates have been simulated, the procedure to estimate dif-
ferential expression is the same as in NOISeq-real.
5.3.2 NOISeqBIO
In RNA-seq, technical replicates have been reported to present low variability
[18, 92]. Therefore, although no real inference can be made from technical
replicates, the NOISeq method can serve to estimate differential expression
under these circumstances. When biological replication is available, it is cru-
cial to consider the biological variability inherent to each gene under each
experimental condition in order to design a method able to detect genes with
significant statistical changes in expression between conditions.
Starting from the statistical framework developed in the NOISeq method
[141], we proposed a variant named NOISeqBIO that takes into account the
biological variability and tests the hypothesis H0 : µ1 = µ2, where µi is the
average of expression in experimental condition i. NOISeqBIO incorporates
the statistical modeling proposed by Efron et al. [43] into the NOISeq formu-
lation. These authors used an empirical Bayes approach on microarray data in
which they defined a statistic Z to evaluate the change in expression between
two conditions. Their method assumes that the genes can be classified into
two different populations: genes with invariant expression between two exper-
imental conditions and genes with expression changing between conditions,
so the probability distribution of this Z statistic can be described as a mixture
of two distributions. The mixture distribution f of Z can be written as in
Equation 5.5, where p0 is the probability of a gene having the same expres-
sion in both conditions and p1 = 1 − p0 is the probability of a gene having
different expression between conditions. f0 and f1 are the densities of Z for
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genes with no change in expression between conditions and for differentially
expressed genes respectively.
f(z) = p0f0(z) + p1f1(z) (5.5)
If one of these two distributions can be estimated, the probability of a
gene belonging to one of the two groups can be calculated.
Our adaptation of this strategy to the NOISeq context consists of the
following steps:
1. Choose an appropriate differential expression statistic Z.
2. Estimate the values of the Z statistic when there is no change in ex-
pression, i.e. the null statistic Z0.
3. Estimate the probability density functions f and f0.
4. Obtain the posterior probability of differential expression p1(zi) for each
gene i.
1. Differential expression statistic Z
Let xgij be the expression of gene g in condition i and replicate j. As
previously described, we measured the expression change in signal (that
is, between both conditions) by computing Mgs = log2(x¯
g
1/x¯
g
2) and
Dgs = x¯
g
1 − x¯g2. Let Ms and Ds be the vectors containing Mgs and Dgs
values for all the genes. Ms and Ds statistics must be corrected for the
biological variability by dividing them by their standard errors. Let σˆ2M
and σˆ2D be the vectors containing the standard errors of Ms and Ds for
all genes respectively. They were estimated as follows, assuming that
x¯1 and x¯2 are independent.
σˆ2M = V ar(log2(x¯1/x¯2)) = V ar(log2(x¯1)− log2(x¯2)) =
= V ar(log2(x¯1)) + V ar(log2(x¯2)) (5.6)
5.3 Methods 123
We used a Taylor approximation (δ-method) to estimate the variance
[24]: V ar(log2(X)) =
(
1
E(X)log(2)
)2
V ar(X). For each condition
i, we estimated E(x¯i) = x¯i and V ar(x¯i) = S
2
i /ni. Hence:
σˆ2M ≈
1
x¯21log(2)
2
S21
n1
+
1
x¯22log(2)
2
S22
n2
(5.7)
σˆ2D = V ar(x¯1 − x¯2) =
S21
n1
+
S22
n2
(5.8)
Therefore, Ms and Ds statistics are corrected for biological variability
as described in Equations 5.9 and 5.10, where the constant a0 serves
to stabilize the denominator of the statistic [109]. This constant may
be computed as a given percentile of all the values in σˆM or σˆD, re-
spectively, as in [43]. The authors suggest the 90th percentile as the
best option.
M∗s =
Ms
a0 + σˆM
(5.9)
D∗s =
Ds
a0 + σˆD
(5.10)
Finally, we computed the Z statistic by combining the Ms and Ds
values. Combining both statistics instead of using the bivariate statistic
(M∗s , D∗s) allows us to derive a procedure to obtain a probability of
differential expression which can be considered equivalent to an adjusted
p-value [43]. We considered two different possibilities to combine both
statistics (Equations 5.11 and 5.12).
Z =
M∗s +D∗s
2
(5.11)
Z =
D∗s
|D∗s |
√
(M∗s )2 + (D∗s)2 (5.12)
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2. Null scores Z0
Let X be the gene expression matrix with G rows (genes) and n1 + n2
columns, where ni is the number of biological replicates for condition i.
We assume that X is normalized (e.g. by converting the raw counts to
TMM [120] or RPKM [99] values) and that genes with no expression
across all the replicates for both conditions have been removed.
In order to compute the null density f0, we first need to estimate the
values of the Z-scores for genes with no change between conditions. To
estimate these null scores, we permuted the labels of samples (columns)
in X r times and each time we computed the differential expression
statistic Z, as previously described. In this way, we obtained a matrix
Z0 with as many columns as the number of permutations r. The G× r
elements of matrix Z0 are pooled together and are considered the null
scores that will be used to later estimate the null distribution f0.
However, when there are few replicates available for each condition, the
resulting null distribution is very poor because the number of different
permutations is low. Therefore, when the number of replicates per
condition is less than 5, it is convenient to borrow information from
across genes. The procedure we followed was to cluster all the genes
according to their expression values across replicates by using the k-
means algorithm. Hence, genes with similar expression values across
all replicates were clustered together. For each cluster of genes (k),
we considered the expression values of all the genes in the cluster as
observations within the corresponding condition (i.e. as replicates).
Thus, we shuffled this submatrix r × gk times, where gk is the number
of genes within cluster k. For each permutation, we calculated (M,D)
values and their corresponding standard errors. In order to reduce the
computing time and to get a refined clustering of the greatest clusters,
if gk ≥ 1000, we re-applied the k-means algorithm to subdivide cluster
k into subclusters.
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3. Estimation of densities
Once the Z and Z0 scores have been obtained, the density functions f
and f0 can be estimated. In [43], they directly estimate the ratio f0/f
using nonparametric logistic regression. In NOISeqBIO, we propose to
estimate f and f0 separately using a kernel density estimator (KDE)
with a Gaussian kernel (see Section 3.2.2). By default, the smoothing
parameter (adj in noiseqbio() function) was set to 1.5, which means
that the bandwidth is computed as 1.5 times the optimum bandwidth
obtained by “‘nrd0” Silverman’s rule of thumb [129]. Therefore, the
density curves we estimate are smoother than the default curves gener-
ated by the R density() function. In Section 5.4 we show that using this
KDE option in NOISeqBIO improved the performance of the method.
4. Probability of differential expression
Given a gene with a score z for the Z statistic, let p1(z) be the proba-
bility of that gene being differentially expressed between the two exper-
imental conditions being compared. Therefore, p1(z) is the conditional
probability of differential expression for an observed value of z for a
given gene. Thus, this probability can be derived from Bayes Rule as
follows:
p1(z) =
p1f1(z)
f(z)
= 1− p0 f0(z)
f(z)
(5.13)
Moreover, as Efron et al. showed [43], the a posteriori probability
p0(z) = 1 − p1(z) we calculate in Equation 5.13 is closely connected
to the FDR defined by Benjamini and Hochberg [11], so p0(z) can be
considered equivalent to a multiple testing adjusted p-value.
Thus, we only need to estimate p0 in order to calculate p1(z) because
we already estimated f0 and f . We took an upper bound of p0 as
suggested in [43]. Taking into account that p1(z) must be nonnegative
leads to the restriction p0 ≤ minZ{f(Z)/f0(Z)}, which can be used
as the estimate for p0.
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According to [43], more stable upper bounds can be constructed by
integrating over an interval I near Z = 0. Then, p0 ≤
∫
I f(Z)∫
I f0(Z)
. The
choice I = [−0.5, 0.5] is recommended, particularly when the true p0 is
near 1, which usually happens in differential expression analysis. This
upper bound can be directly estimated by
γI(Z)/|Z|
γI(Z0)/|Z0| , where γI(X)
is the number of X values inside the interval I. However, when applied
to our work, this upper bound for p0 sometimes resulted in negative
probabilities, and so we discarded this option.
5.3.3 Other differential expression methods
NOISeq and NOISeqBIO were compared to other differential expression meth-
ods that are summarized in the following paragraphs.
These are the methods NOISeq was compared to. All of them are para-
metric except Fisher’s exact test (FET).
• Fisher’s exact test. This procedure is used when no biological replicates
are available to assess if the percentage of reads falling in a given gene
is significantly different for the two experimental conditions. Thus, a
FET is performed on each gene and the resulting p-values are corrected
for multiple testing using the Benjamini and Hochberg procedure [11].
• DEGseq [147] is a Bioconductor R package which integrates three ex-
isting differential expression methods and another two methods which
were developed by the authors. In this work, we chose two of them:
– DEGseq-LRT: RNA sequencing can be modeled as a random sam-
pling process, in which each read is sampled independently and
uniformly [67]. Under this assumption the number of reads coming
from a gene follows a binomial distribution (and can be approx-
imated by a Poisson distribution). A likelihood ratio test (LRT)
based on a Poisson distribution had previously been proposed to
identify differentially expressed genes [15, 92]. This test was im-
plemented inside the DEGseq package.
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– DEGseq-MARS: MA-plot is a widely used tool to detect the de-
pendence of fold-change (M) on intensity (A) for microarray data
that can also be extended to RNA-seq data. Let Ci denote the
counts of reads mapped to a specific gene in sample i, with
Ci ∼ Binomial(ni, pi), i = 1, 2, where ni is the total num-
ber of mapped reads and pi is the probability of a read coming
from that gene. M is defined as M = log2C1 − log2C2, and
A = (log2C1 + log2C2)/2. The authors proved that the condi-
tional distribution of M given that A = a follows an approximate
normal distribution. For each gene on the MA-plot, they do the
hypothesis test of H0 : p1 = p2 versus H1 : p1 6= p2.
• baySeq [59]: An empirical Bayesian approach to estimate the posterior
probabilities of models that define different patterns of differential ex-
pression across experimental groups. First, the models are defined by
indicating which samples behave similarly to each other, and for which
sets of samples there are identifiable differences. Samples behaving sim-
ilarly to each other should possess the same prior distribution on the
underlying parameters of that tuple, while samples behaving differently
should possess different prior distributions. The method is based on
either a Poisson distribution (PO) or a Negative Binomial distribution
(NB) for the tuple data, and derives an empirical distribution in the set
of underlying parameters from the whole dataset.
• edgeR [123] models count data using an over-dispersed Poisson model,
i.e. a Negative Binomial distribution, and uses parametrization to relate
the mean µ and the variance σ2: σ2 = µ+αµ2. In this way, only the α
parameter has to be estimated from the data. Gene-wise dispersions are
estimated by conditional maximum likelihood, conditioning on the total
count for that gene. An empirical Bayes procedure is used to shrink the
dispersions towards a consensus value, effectively borrowing information
from across genes [121]. Finally, differential expression is assessed for
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each gene using an exact test analogous to Fisher’s exact test, but
adapted for over-dispersed data [122]. In the technical replication study,
two variants of this method were considered:
– CD, which estimates a Common Dispersion for all tags.
– TWD, which estimates a Tag-Wise dispersion.
• DESeq [4] is a statistical procedure similar to edgeR. The authors extend
the edgeR model by allowing more general, data-driven relationships of
variance and mean, and they use a different procedure to estimate the
dispersion.
NOISeqBIO was compared to the following methods. Because the NOISe-
qBIO study was more recent, new versions of the methods were available with
improved performance.
• edgeR [123] (see description above).
• DESeq2 is a more recent and improved version of DESeq [4].
• SAMseq [82] is a non-parametric procedure that uses resampling to
account for the different sequencing depths. The method is based on the
Wilcoxon statistic to compare two samples and a permutation approach
is applied to approximate the distribution of this statistic.
5.3.4 Data processing
In NOISeq comparisons, a library size correction was applied to compute differ-
ential expression whenever the methods included this option. In some cases,
gene length correction was also applied, where gene length was computed
as the median length of transcripts of each gene. Since NOISeq-sim works
with no replicates, counts from different lanes were summed up so there was
always a unique replicate but with a different sequencing depth in each case.
In the studies related to NOISeqBIO, we applied the following normaliza-
tion and low count filtering procedures on both simulated and experimental
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data. TMM normalization was used for NOISeqBIO and edgeR differential
expression methods. For DESeq2 and SAMseq we used their own normal-
ization algorithms. Prior to normalizing the data, we filtered out genes with
an average expression per condition lower than 1 count per million in both
conditions. Filtering was done using the CPM method from the NOISeq R
package (see Chapter 4 for more details).
5.3.5 Tools for performance assessment
5.3.5.1 Performance indicators
The performance of the DE methods was assessed according to the values
of some indicators previously defined in Chapter 3: Sensitivity (SE), False
Discovery Rate (FDR) and Matthews Correlation Coefficient (MCC). These
indicators were either used for the plots described in the following text or
computed for the DE results obtained at a significance level of 5% (which is
the most frequently used by researchers).
5.3.5.2 Precision-recall curves and false discovery rate plots
Precision-recall curves (PRC) and False Discovery Rate (FDR) plots were
generated for both simulated and RT-PCR datasets. “Recall” is the sensitivity
or true positive rate (TPR) and “Precision” is defined as TP/(TP+FP ),
making it equal to 1-FDR. PRCs are good performance estimators when the
number of negatives greatly exceeds the number of positives, as is the case
of expression datasets [35].
5.3.5.3 Box plots
In some cases, to compare the performance of DE methods, we used box plots
with a notch at both sides of the box. This notch represents a sort of 95%
confidence interval for the median computed from Equation 5.14, where IQR
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is the interquartile range and n is the number of observations represented in
a given box plot.
Median∓ 1.58× IQR/√n (5.14)
This confidence interval was proposed by McGill et al. [96] and provides
a way to measure the difference between medians. If two of these confidence
intervals (for two different methods) do not overlap, it means that the medians
are, roughly, significantly different at an approximate confidence level of 95%.
The assumptions made in order to construct such confidence intervals are:
asymptotic normality for the median and equal (or very similar) sample sizes
for the two medians being compared. In principle the procedure should not
be sensitive to the underlying distributions of the samples. In this way, we
can use these intervals to test the null hypothesis that the true medians are
equal. However, when more than two samples are compared, it must be taken
into account that no multiple testing correction is applied [25].
5.4 Results
5.4.1 NOISeq performance
We compared NOISeq to a selection of RNAseq differential expression meth-
ods, namely edgeR [123], baySeq [59], DEGseq [147], DESeq [4] and FET
on data with technical replicates. In contrast to NOISeq which makes no as-
sumptions about the distribution of the M and D statistics, all these methods
follow parametric approaches (except FET).
5.4.1.1 Comparison on simulated data
To concentrate the comparison on a subset of representative and but different
approaches, we first evaluated the general performance of all of these differ-
ential expression methods and compared them to NOISeq using the synthetic
dataset included in the baySeq R package [59].
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Both PRC and FDR plots separated RNA-seq statistical methodologies
into two groups (Figure 5.6). The two options for the edgeR method (CD
and TWD), DESeq, baySeq-NB and both versions of NOISeq showed good
accuracy and consistent control of false discoveries, whereas MARS, LRT,
FET, and baySeq-PO showed poorer performances. Therefore, we selected
edgeR-CD, baySeq-NB, DESeq, and FET (the last one was included for its
extensive use by researchers), together with NOISeq-sim and NOISeq-real for
further analysis.
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Figure S10: Precision-Recall and False Discovery Rate curves for the differential expression methods com-
pared, applied to the synthetic dataset included in baySeq package.
Table S3: True and False Positive Rates for differential expression methods applied to Griffith’s dataset
and using RT-PCR as gold-standard. Genes considered as true positives are those declared differentially
expressed on RT-PCR data (82 genes). Genes considered as true negatives are those not found differentially
expressed by RT-PCR (12 genes).
Method Length correction # TP TPR # FP FPR
NOISeq-real No 47 57.3% 0 0.0%
NOISeq-real Yes (RPKM) 35 42.7% 0 0.0%
NOISeq-sim No 63 76.8% 2 16.7%
NOISeq-sim Yes (RPKM) 61 74.4% 0 0.0%
FET No 14 17.1% 0 0.0%
FET RPKM 9 11.0% 0 0.0%
edgeR No 73 89.0% 5 41.7%
DESeq No 70 85.4% 4 33.3%
baySeq No 58 70.7% 3 25.0%
baySeq Yes 61 74.4% 3 25.0%
17
Figure 5.6: Precision-Recall and False Discovery Rate curves for the differential
expression methods compared, as applied to the synthetic dataset included in
the baySeq R package.
5.4.1.2 Comparison on experimental data
The selected methodologies were applied to the MAQC and Griffith datasets.
We also included the analysis of gene length corrected data when the methods
permitted this input. Note that FET was applied on counts normalized by
the library size.
On the MAQC dataset, two performance indicators, PRC and FDR indi-
cated that NOISeq performed better compared to other methodologies (Figure
5.7). Specifically, false discoveries were higher for edgeR, DESeq and baySeq.
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FET had a low FDR regardless of the significance threshold but also showed
a poorer precision-recall figure. Interestingly, PRC and FDR were very similar
on data with and without length correction. Griffith RT-PCR data were more
limited but led to the same conclusions (Table 5.1).
different methodologies use different parameters to select signifi-
cant features, it was not always clear which cutoff values would
produce comparable analysis scenarios. In this study, we chose q =
0.8 for NOISeq, a probability of 0.999 for baySeq, and an adjusted
P-value threshold of 0.001 for the remaining methods. Less re-
strictive values for comparedmethodologies resulted in far too large
a number of selected genes. We performed our study using library
size–normalized count data, as all evaluated methods allowed this
possibility. Next, we introduced feature length normalization into
the analysis for those methodologies that permitted this option.
SD dependence in number and type of differential expression calls
We first investigated the number of differential expression calls as
a function of the SD (Fig. 4; Supplemental Table S4). A very pro-
nounced dependency between gene selection and read number
was observed for edgeR, DESeq, and baySeq. FET did not show this
dependency but did identify a reduced number of significant
genes. NOISeq had an intermediate behavior with a moderate
number of d.e.g. in theMarioni andMAQCdata sets, and increased
only slightly with SD. Results for Griffith’s data were slightly dif-
ferent. While FET and NOISeq identified a small number of sig-
nificant genes (between 150 and 200), close to the figure reported
in the original study, other methods resulted in larger selection
sets. Moreover, both FET and NOISeq-real lost significant calls as
more lanes were considered, reflecting the high variability of this
data set. We then looked at differential expression curves by tran-
script biotype and noticed that, for parametric approaches, a sig-
nificant and increasing number of off-target transcripts were se-
lected as more reads were considered (Supplemental Fig. S11),
whereas NOISeq again behaved moderately here. In fact, NOISeq
significant calls were the most enriched in protein-coding genes,
Figure 3. NOISeq method: description and performance. (A) Schematic representation of the NOISeq methodology. M-D distribution in noise (black),
signal (green), and differentially expressed genes (red). Both axis scales have been trimmed to improve visualization. (B) Precision-recall curves and false-
discovery rates for the differential expression methods compared on MAQC data set using RT-PCR results as a gold-standard.
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Figure 5.7: Precision-recall curves and false discovery rates for the differential
expression methods compared on the MAQC dataset using RT-PCR results as
a gold-standard.
In summary, our performance nalysis highlighted differences between
RNA-seq differential expression methods and pointed to NOISeq as a high
performing methodology.
We also investigated how the number of technical replicates influences
the number of differential expression calls (Figure 5.8), the gene length, the
fold-change (M) and the mean expression level of DEGs (Figure 5.9).
Figure 5.8 shows the very pronounced dependency between gene selection
and number of replicates (lanes) observed for edgeR, DESeq and baySeq.
FET did not show this dependency but did identify a reduced number of
significant genes. NOISeq had an intermediate behavior with a moderate
number of DEGs in the MAQC dataset which increased only slightly with the
number of replicates. Results for Griffith data were slightly different. While
FET and NOISeq identified a small number of significant genes (between 150
and 200), close to the figure reported in the original paper, other methods
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Method Length correction # TP TPR # FP FPR
NOISeq-real None 47 57.3% 0 0.0%
NOISeq-real RPKM 35 42.7% 0 0.0%
NOISeq-sim None 63 76.8% 2 16.7%
NOISeq-sim RPKM 61 74.4% 0 0.0%
FET None 14 17.1% 0 0.0%
FET RPKM 9 11.0% 0 0.0%
edgeR None 73 89.0% 5 41.7%
DESeq None 70 85.4% 4 33.3%
baySeq None 58 70.7% 3 25.0%
baySeq Yes 61 74.4% 3 25.0%
Table 5.1: True and false positive rates for differential expression methods
applied to the Griffith dataset and using RT-PCR as a gold-standard. Genes
considered as true positives are those declared as differentially expressed on RT-
PCR data (82 genes). Genes considered as true negatives are those not found
to be differentially expressed by RT-PCR (12 genes).
where other methods included higher proportions of non-
polyadenylated transcripts (Supplemental Fig. S12).
SD influence on length, expression, and fold-change of significant genes
To better understand how SD affects other properties of differential
expression, we plotted the transcript length, fold-change (M ), and
mean expression level of significant genes as a function of the
available number of reads (Fig. 5; Supplemental Fig. S13). The pat-
tern of differences betweenmethods was similar to that observed in
previous analyses. The edgeR, DESeq, and baySeq methods showed
SDdependency,whereasNOISeq and FET didnot. FEThad large and
constant values for these three parameters.
In the parametric approaches, the mean transcript length of
the statistically significant genes decreased as the number of lanes
grew. This length shortening effect was only very moderately
present in NOISeq, which, at the highest SDs, generally selected
larger genes than did the other methods. This difference is in agree-
ment with the observed higher selection of small, noncoding RNAs
by the parametric approaches. Furthermore, themean fold-change of
the genes detected by compared methodologies was greatly influ-
enced by the total read number. The larger the sequencing output,
the smaller the count differences between samples declared as sig-
nificant, and this was especially notable in the largeGriffith’s data set
(100million reads), wheremeanM values for d.e.g. dropped below
1. NOISeq, on the contrary, selected genes with larger count dif-
ferences and had a robust behavior with changing SD. Finally, we
also observed a strong dependency on the level of expression.
Current RNA-seq statistical methods tend to identify genes with
a lower relative abundance as the number of available reads grows.
Again here, NOISeq, and especially NOISeq-real, offered a more
constant and intermediate result, selecting genes with lower ex-
pression at smaller SDs and genes with larger count numbers at
higher depths than did parametric RNA-seq methods.
Most statistical analysis methods for RNA-seq suffer from high FDRs
All previous results indicated that d.e.g. identified by parametric
approaches strongly increase in number as more sequencing is
generated and that this results in calling significant genes with
smaller fold changes. Although this could be explained by an ap-
parent higher accuracy of gene expression estimates in large sam-
pling sizes, the prominent discrepancy with a data-driven meth-
odology such as NOISeq and the results of our initial performance
analysis led us to suspect a general failure of those methods in
controlling FDR as the sequencingoutput increase. To verify this, we
analyzed the available MAQC RT-PCR data as a function of the SD,
looking both at the false-positive (FPR) and true-positive (TPR) rates.
Figure 4. Differentially expressed genes according to sequencing depth for each data set and method. No gene length correction was applied to
the data.
Figure 5. Relationship between gene length, fold-change M, expression level of differentially expressed genes, and the number of lanes used, for each
method in MAQC data set. No length correction was applied to the data. RpMi is the number of reads in condition i per million reads, namely,
RpMi =
106 3 gene counts in condition i
total counts in condition i
.
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Figure 5.8: The number of differentially expressed genes according to the
number of technical replicates for each dataset and method. No gene length
correcti n was applied to the dat .
resulted in larger selecti n sets. Moreover, both FET and NOISeq-real lost
significant calls as more lanes were considered, reflecting the high variability
of this dataset.
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where other methods included higher proportions of non-
polyadenylated transcripts (Supplemental Fig. S12).
SD influence on length, expression, and fold-change of significant genes
To better understand how SD affects other properties of differential
expression, we plotted the transcript length, fold-change (M ), and
mean expression level of significant genes as a function of the
available number of reads (Fig. 5; Supplemental Fig. S13). The pat-
tern of differences betweenmethods was similar to that observed in
previous analyses. The edgeR, DESeq, and baySeq methods showed
SDdependency,whereasNOISeq and FET didnot. FEThad large and
constant values for these three parameters.
In the parametric approaches, the mean transcript length of
the statistically significant genes decreased as the number of lanes
grew. This length shortening effect was only very moderately
present in NOISeq, which, at the highest SDs, generally selected
larger genes than did the other methods. This difference is in agree-
ment with the observed higher selection of small, noncoding RNAs
by the parametric approaches. Furthermore, themean fold-change of
the genes detected by compared methodologies was greatly influ-
enced by the total read number. The larger the sequencing output,
the smaller the count differences between samples declared as sig-
nificant, and this was especially notable in the largeGriffith’s data set
(100million reads), wheremeanM values for d.e.g. dropped below
1. NOISeq, on the contrary, selected genes with larger count dif-
ferences and had a robust behavior with changing SD. Finally, we
also observed a strong dependency on the level of expression.
Current RNA-seq statistical methods tend to identify genes with
a lower relative abundance as the number of available reads grows.
Again here, NOISeq, and especially NOISeq-real, offered a more
constant and intermediate result, selecting genes with lower ex-
pression at smaller SDs and genes with larger count numbers at
higher depths than did parametric RNA-seq methods.
Most statistical analysis methods for RNA-seq suffer from high FDRs
All previous results indicated that d.e.g. identified by parametric
approaches strongly increase in number as more sequencing is
generated and that this results in calling significant genes with
smaller fold changes. Although this could be explained by an ap-
parent higher accuracy of gene expression estimates in large sam-
pling sizes, the prominent discrepancy with a data-driven meth-
odology such as NOISeq and the results of our initial performance
analysis led us to suspect a general failure of those methods in
controlling FDR as the sequencingoutput increase. To verify this, we
analyzed the available MAQC RT-PCR data as a function of the SD,
looking both at the false-positive (FPR) and true-positive (TPR) rates.
Figure 4. Differentially expressed genes according to sequencing depth for each data set and method. No gene length correction was applied to
the data.
Figure 5. Relationship between gene length, fold-change M, expression level of differentially expressed genes, and the number of lanes used, for each
method in MAQC data set. No length correction was applied to the data. RpMi is the number of reads in condition i per million reads, namely,
RpMi =
106 3 gene counts in condition i
total counts in condition i
.
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where other methods included higher proportions of non-
polyadenylated transcripts (Supplemental Fig. S12).
SD influence on length, expression, and fold-change of significant genes
To better understand how SD affects other properties of differential
expression, we plotted the transcript length, fold-change (M ), and
mean expression level of significant genes as a function of the
available number of reads (Fig. 5; Supplemental Fig. S13). The pat-
tern of differences betweenmethods was similar to that observed in
previous analyses. The edgeR, DESeq, and baySeq methods showed
SDdependency,whereasNOISeq and FET didnot. FEThad large and
constant values for these three parameters.
In the parametric approaches, the mean transcript length of
the statistically significant genes decreased as the number of lanes
grew. This length shortening effect was only very moderately
present in NOISeq, which, at the highest SDs, generally selected
larger genes than did the other methods. This difference is in agree-
ment with the observed higher selection of small, noncoding RNAs
by the parametric approaches. Furthermore, themean fold-change of
the genes detected by compared methodologies was greatly influ-
enced by the total read number. The larger the sequencing output,
the smaller the count differences between samples declared as sig-
nificant, and this was especially notable in the largeGriffith’s data set
(100million reads), wheremeanM values for d.e.g. dropped below
1. NOISeq, o the contrary, selecte genes with larger count dif-
ferences and had a robust behavior with changi g SD. Finally, we
also observed a str ng dependency on the level of expressi n.
Current RNA-seq statistical methods tend to identify genes with
a lower relative abundance as the number of available reads grows.
Again here, NOISeq, and especially NOISeq-r al, offer a more
constant and intermediate result, selecting genes wit lower x-
pression at smaller SDs and genes with larger count numbers at
higher depths than did parametric RNA-seq methods.
Most statistical analysis methods for RNA-seq suffer from high FDRs
All previous results indicated that d.e.g. identified by parametric
approaches strongly increase in number as more sequencing is
generated and that this results in calling significant genes with
smaller fold changes. Although this could be explained by an ap-
parent higher accuracy of gene expression estimates in large sam-
pling sizes, the prominent discrepancy with a data-driven meth-
odology such as NOISeq and the results of our initial performance
analysis led us to suspect a general failure of those methods in
controlling FDR as the sequencingoutput increase. To verify this, we
analyzed the available MAQC RT-PCR data as a function of the SD,
looking both at the false-positive (FPR) and true-positive (TPR) rates.
Figure 4. Differentially expressed genes according to sequencing depth for each data set and method. No gene length correction was applied to
the data.
Figure 5. Relationship between gene length, fold-change M, expression level of differentially expressed genes, and the number of lanes used, for each
method in MAQC data set. No length correction was applied to the data. RpMi is the number of reads in condition i per million reads, namely,
RpMi =
106 3 gene counts in condition i
total counts in condition i
.
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Figure 5.9: R lationship between gen length, fold-change M, expression level
of differentially expressed genes, and the number of lanes used, for each method
using the MAQC data set. No length correction was applied to the data. RpMi
is the number of reads per million reads in condition i.
Regarding gene length, fold-change and mean expression (Figure 5.9), the
dependence of the results on the number of replicates was once again stronger
for parametric methods. The mean gene length decreased as the number of
lanes grew. This length shortening effect was only very moderately present
in NOISeq which, at the highest sequencing depths, generally selected larger
genes than the other methods. The mean fold-change of the genes detected
by parametric methodologies was smaller for a larger number of replicates.
On the contrary, NOISeq selected genes with larger count differences and
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behaved robustly with changing sequencing depth. Finally, we also observed
a strong dependency on the level of expression. Current RNA-seq statistical
methods tend to identify genes with a lower relative abundance as the number
of available replicates grows. Again here NOISeq, and especially NOISeq-
real, gave more constant and intermediate results, selecting genes with lower
expression and genes with larger count numbers than parametric RNA-seq
methods when a lower or higher number of lanes were used respectively. FET
had large and constant values for these three parameters.
Previous results indicated that the number of DEGs identified by paramet-
ric approaches strongly increases in number as more technical replicates are
used for the analysis. Although this could be explained by an apparent higher
accuracy of gene expression estimates in large sampling sizes, the prominent
discrepancy with a data-driven methodology such as NOISeq, along with the
results from our initial performance analysis, led us to suspect a general failure
of these methods in controlling the FDR as the sequencing output increased.
To verify this, we analyzed the available MAQC RT-PCR data as a function
of the number of replicates, looking both at the false (FPR) and true (TPR)
positive rates. As suspected, current RNA-seq analysis methods progressively
incorporated more false calls as more lanes were used, reaching more than
60% false positives using the edgeR method (Fig. 5.10). In contrast, NOISeq
maintained a stable and low FPR even as the number of lanes increased. Only
FET had better FPR performance, however at a significant cost of the num-
ber of true detections. The TPR obtained from the other methods compared
was slightly higher than that of NOISeq, which is logically the consequence
of the large number of the DEGs called by these methodologies. Notably,
genes selected by both NOISeq and other approaches did contain a functional
signature, i.e., they were significantly enriched in many biological functions
while those only detected by parametric methods had no specific functional
charge (Table 5.2).
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As suspected, current RNA-seq analysis methods progressively in-
corporated false calls as more sequencing data were used, reaching
above 60% of false positives in edgeR (Fig. 6). In contrast, NOISeq
maintained a stable and low FPR throughout the increasing number
of lanes. Only FET had better FPR performance, however, at a sig-
nificant cost of the number of true detections. The TPR obtained
from the other compared methods was slightly higher than that of
NOISeq, which is logically the consequence of the large number of
the d.e.g. called by these methodologies. Furthermore, we verified
that false positives were basically genes with shorter length, de-
creasing expression level, and smaller fold-change differences at
each SD value (Supplemental Fig. S16a). Notably, genes selected in
common by NOISeq and other approaches did contain a functional
signature; that is, they were significantly enriched in many bi-
ological functions, while those only detected by parametric
methodshadno specific functional charge (SupplementalMaterial).
Effect of normalization by feature length on SD biases
Lastly, we evaluated whether normalization of count data by a fea-
ture length correctionmethod, such as RPKM, affected the observed
patterns of SD dependence. We introduced length normalization
into NOISeq-sim, NOISeq-real, FET, and baySeq and repeated our
analysis (edgeR and DESeq packages do not allow for this correc-
tion). Figures were essentially the same as in non–length-normal-
ized data regarding number (Supplemental Fig. S14), mean fold-
change, and mean expression value of d.e.g. (Supplemental Fig.
S15b,c). However, the dependence between library size and tran-
script length was significantly changed, and all methodologies
showed now a constant behavior and a shorter mean length value
than did non-normalized counterparts (Supplemental Fig. S15a).
Finally, false- and true-positive curves for MAQC data (Fig. 7A,B;
Supplemental Fig. S16b) again resembled previous results: baySeq
increasingly detected false positiveswith increasing SD, and FETand
NOISeq maintained a low level of true positive detection.
Discussion
Estimation of gene expression levels by sequencing is conceptually
simple and has been seen as a very straightforward task. Sequencing
reads the population of RNA molecules in a given sample and ren-
ders a direct quantification of the abundance of each transcript,
mapping ambiguities and sequencing errors issues apart. Although
this is fundamentally true, as shown in studies on correspondence
of RNA-seq data with microarrays and RT-PCR (Marioni et al. 2008;
Bullard et al. 2010; Griffith et al. 2010), we believe that there is still
some work to be done to fully understand the characteristics of
RNA-seq data and their processing by statisticalmethods. Oneof the
biases that rapidly became evidentwas the effect of transcript length
in the quantification and identification of differential expression.
The nature of the short read procedure makes it inevitable that
longer transcripts will be preferentially detected over shorter ones,
and this has been shown to have implications in the biological in-
terpretation of the data (Oshlack and Wakefield 2009; Young et al.
2010). Another important element is themagnitude of the depth of
the sequencing experiment, the subject of this study. Due to the
large dynamic range of gene expression, ultra-high-throughput se-
quencing seems advisable to detect transcripts with low expression
values. However, we have seen that, as more sequencing output is
considered, the diversity and quantity of detected off-target RNA
species, such as several types of small RNAs, also increase (Fig. 2B).
The extent to which each of these biotypes and transcripts are pu-
rification artifacts or have a biological significance warrants a sepa-
rate study, but it does show an important property of RNA-seq data:
the effect that SDhas on the distribution of reads among transcripts
and the quantification of expression, essentially a percentage in the
case of this technology. Robinson and Oshlack (2010) have already
highlighted the implications that different transcript distributions
might have in RNA-seq normalization and differential expression.
Our observations suggest that it is advisable to take equal SDs be-
tween samples in order to support accurate statistical analysis.
We have evaluated several RNA-seq differential expression
methods regarding their behavior throughout SDs: edgeR, DESeq,
baySeq, the traditional FET, and a novel method proposed here:
NOISeq. edgeR,DESeq, and baySequse theNBdistribution. The first
two apply an exact test, while baySeq is a Bayesianmethod. NOISeq
creates an empirical distribution of count changes adapted to the
available data, fromwhich the probability of differential expression
for each feature can be derived. In this nonparametric approach,
differential expression does not rely on individual transcript mea-
surements but in the joint distribution of M-D values for all the
features within the data set. We studied the effect of SD on the
number of d.e.g., their length, fold-change value, and expression
level. The pattern produced by NOISeq and FET was more constant
across the different variables analyzed, whereas the other three
methods showed a pronounced dependence. The parametric ap-
proaches strongly increased the number of significant calls as more
sequencing output was included, resulting in a considerable num-
ber of false positives (Fig. 6). The newly
detected genes were shorter, were of lower
relative expression, and had smaller fold-
change differences than did those obtained
with less data, and they contained many
off-target RNA species (Fig. 5; Supplemen-
tal Fig. S12). False-positive genes identified
in the analysis of the MAQC data had
similar characteristics, suggesting that
large library size data sets analyzed by these
parametric approaches incorporate many
falsely called significant genes at the low
expression range and/or with small fold-
change differences. The constant pattern
of FET was intrinsically due to a low de-
tection power that identified only highly
expressed transcripts. However, NOISeq
showed more robustness against these SD
Figure 6. Relationship between the number of true positives ( TP) and false positives (FP) and se-
quencing depth. TP and FP were obtained applying different statistical methods on the MAQC data
set and comparing the results to RT-PCR positive and negative genes.
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Figure 5.10: The relationship between the number of true positives (TP) and
false positives (FP) and the number of technical replicates (lanes). TP and FP
were obtained by applying the statistical methods to be compared to the MAQC
dataset and then comparing results to RT-PCR positive and negative genes.
5.4.2 NOISeqBIO performance
In this section, we evaluate the performance of the NOISeqBIO method.
Prior to the comparison of NOISeqBIO to other DE methodologies, we show
the results of some preliminary studies that had two main purposes. Firstly,
they served to adjust the various options and parameters of NOISeqBIO that
we described in Section 5.3.2. Secondly, and in order to simplify the huge
number of biological scenarios that could be defined when simulating data,
we identified which parameters in the simulation algorithm had a greater
influence on DE results and which were the most informative values for these
parameters. This information was then used to generate the final set of
simulated datasets to compare the DE methods.
5.4.2.1 Preliminary studies on simulated data
Determining the best options for NOISeqBIO
The purpose of the first study on simulated data with biological repli-
cations was to determine the best choice for the parameters and options
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edgeR DESeq baySeq
In common between NOISeq and the other method 9735 9693 9712
Up in BRAIN 3468 3431 3457
Up in UHR 6267 6262 6255
# GO terms (Up in BRAIN) 192 178 190
# GO terms (Up in UHR) 486 481 485
Detected by the other method and not by NOISeq 137 7230 5398
Up in BRAIN 2731 3707 1826
Up in UHR 5406 3517 3572
BRAIN = UHR 0 6 0
# GO terms (Up in BRAIN) 0 0 2
# GO terms (Up in UHR) 0 4 1
Detected by NOISeq and not by the other method 0 42 23
Table 5.2: Comparison of the genes declared as differentially expressed by
NOISeq and by the other methods, including the number of significantly enriched
GO terms for each set of genes.
considered in NOISeqBIO. These optimized options were then used in the
remaining analyses.
In this study, we simulated data from an A. fumigatus sample for 9862
genes, with 5% DEGs and 0% noise. Data were normalized using the TMM
method. A gene was declared as differentially expressed when its probability of
having differential expression was higher than 0.95 which is, as we previously
stated, equivalent to FDR = 0.05 [43].
We compared the performance of the method for datasets with 5 and 10
replicates and simulated 10 different datasets for each number of replicates,
checking the following values for the input parameters:
• Differential expression statistic:
1. Mean of M∗ and D∗ values (stat = 1).
2. Distance of (M∗, D∗) to the origin with the sign of the difference
D∗ (stat = 2).
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• Method to estimate the densities f and f0:
1. Kernel density estimators (dens = 1).
2. Logistic regression using natural splines (dens = 2).
• Value for a0:
1. P50 of the values of the standard deviation of M or D, respectively,
for all the genes (a0 = 0.5).
2. P90 of the values of the standard deviation of M or D, respectively,
for all the genes (a0 = 0.9).
• Number of sample label permutations to generate the noise distribution:
20, 50 and 70.
As shown in Figures 5.11 to 5.14, NOISeqBIO generally performed well
in terms of sensitivity (SE) and FDR for simulated data sets with 5 or 10
replicates. When using the mean of M∗ and D∗ as the differential expression
statistic (stat = 1), we found no big differences for a0 = 0.5 and a0 = 0.9,
although perhaps P90 produced slightly better results. KDE (dens = 1)
improved logistic regression (dens = 2) for density estimation, especially
in the 5-replicate case. In addition, for the KDE option, the number of
permutations does not seem to influence the results.
Therefore, in the following studies we took the mean as the differential
expression statistic, KDE to estimate the densities, and used 50 permutations;
a more thorough analysis was done to choose the most proper value for a0.
A second simulation study was undertaken to assess the performance of
NOISeqBIO in terms of SE and FDR according to the level of noise in the
data (0, 0.2 or 0.4) and the proportion of DEGs (0.01, 0.05,0.10), and also
to determine the best value for a0. We compared the following values of a0:
0, P25, P50, P70, P90 and B, which means that a0 is 100 times the standard
deviation. Again, we simulated data from an A. fumigatus sample and took
a cutoff of 0.95 for the probability of differential expression.
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Figure 5.11: Comparison of different options in NOISeqBIO used on simulated
datasets with 5 replicates. Differential expression statistic was the mean of
(M∗, D∗) values.
When considering 5 or 10 replicates per condition, the method performed
best for lower levels of noise and higher proportions of DEGs, as expected.
SE was close to 1 in most cases and was always higher than 0.8. However,
in general, the FDR drastically rose when there were high levels of noise, and
was more dependent o the value of a0. The best choice for a0 was once
again P90, except in the case of 10 replicates and noise = 0.4, where option
B clearly outperforms the rest (see Figures 5.15-5.20). Thus, we set a0 to
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Figure 5.12: Comparison of different options in NOISeqBIO used on simulated
datasets with 5 replicates. The differential expression statistic was the distance
to the origin of (M∗, D∗) values.
P90 for our subsequent studies.
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Figure 5.13: Comparison of different options in NOISeqBIO used on simulated
datasets with 10 replicates. The differential expression statistic was the mean
of (M∗, D∗) values.
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Figure 5.14: Comparison of different options in NOISeqBIO used on simulated
datasets with 10 replicates. The differential expression statistic was the distance
to the origin of (M∗, D∗) values.
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Figure 5.15: Performance of NOISeqBIO applied on simulated data with 5
replicates according to different levels of noise and a0 values. Percentage of
DEGs is 1%.
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Figure 5.16: Performance of NOISeqBIO applied on s mulated data with 5
replicates according to different levels of noise and a0 values. Percentage of
DEGs is 5%.
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Figure 5.17: Performance of NOISeqBIO applied on simulated data with 5
replicates according to different levels of noise and a0 values. Percentage of
DEGs is 10%.
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Figure 5.18: Performance of NOISeqBIO applied on simulated data with 10
replicates according to different levels of noise and a0 values. Percentage of
DEGs is 1%.
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Figure 5. 9: Performance of NOISeqBIO applied on simulated data with 10
replicates according to different levels of noise and a0 values. Percentage of
DEGs is 5%.
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Figure 5.20: Performance of NOISeqBIO applied on simulated data with 10
replicates according to different levels of noise and a0 values. Percentage of
DEGs is 10%.
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NOISeqBIO for few replicates
Results derived from the previous simulation studies showed that NOISe-
qBIO behaved very poorly when the number of replicates per condition was
less than 5, no matter which options were chosen, or what parameters were
used (results not shown). This is logical because the algorithm is based on
permuting the sample labels to generate the noise distribution and so few
replicates result in bad estimations of the noise distribution, as occurs in non-
parametric methods based on resampling. Thus, we modified the algorithm
for cases in which the number of replicates was less than 5. When this hap-
pens, genes are clustered according to their expression values and resampling
is done within each cluster, considering gene expression values in the same
cluster and condition as the replicates of that condition (see Section 5.3.2 for
more details).
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Figure 5.21: Performance of NOISeqBIO using simulated data sets with 2, 3,
or 4 replicates. The parameters for the simulations were: propdeg = 0.05 and
noise = 0 or 0.3. Three data sets were generated for each scenario, organism,
and number of replicates.
In this section, we evaluated the performance of NOISeqBIO algorithm
for the case where there are few replicates. We simulated data from real
samples with different number of genes: A. fumigatus, F. oxysporum and H.
sapiens, and studied the effect of the number of replicates on SE and FDR.
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Figure 5.21 shows the expected increase in SE and decrease in FDR when the
number of replicates was increased from 2 to 4.
We also evaluated what the optimum number of clusters (k) was when
applying the k-means algorithm (Figure 5.22). The SE and FDR values were
computed for k = 10, 15 and 20 clusters in different simulated scenarios but
the results were not significantly different for 10 or 15 clusters. SE slightly
improved for 20 clusters but at the cost of also increasing the FDR. Therefore,
we decided to set the number of clusters to k = 15 by default, although users
can vary this parameter. We also used 15 clusters for further comparisons
with NOISeqBIO in this work.
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Figure 5.22: Performance of NOISeqBIO using simulated data sets for different
numbers of clusters. The parameters for the simulations were: propdeg =
0.05, and noise = 0 or 0.3. Three data sets were generated for each scenario,
organism and number of replicates (2, 3 or 4).
Influence of simulation parameters
Whilst still in the preliminary phases of the study, we analyzed the effects
of some simulation parameters on the performance of five differential expres-
sion methods: NOISeq, NOISeqBIO, edgeR, DESeq and SAMseq. These are
the simulation parameters we studied and their values:
• The β parameter, which determines the magnitude of the change in
expression between conditions: β = 5, 6, 7.
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• The proportion of DEGs: 0.01, 0.05 and 0.1.
• Noise, which is the percentage of deviation with regard to the average
expression that is allowed: 0, 20% and 40%.
For each combination of parameter values, 10 datasets were generated
from a sample of A. fumigatus RNA-seq data with 5 replicates per condition
and a sequencing depth of about 30 million reads. We used a significance level
of 0.05 for the methods that returned p-values, and a threshold of q = 0.8 for
NOISeq and q = 0.95 for NOISeqBIO. Note that we included NOISeq in this
preliminary comparison to see if it was outperformed by NOISeqBIO. However,
differential expression probabilities returned by NOISeq are not equivalent to
p-values so in this case we used the recommended cutoff for the differen-
tial expression probability (q = 0.8). We evaluated the performance of the
methods by measuring the SE, the FDR and the MCC.
We observed no influence of the β parameter on the performance of the
methods (see Figure 5.23), so we set β = 6 for further evaluations. However,
the proportion of DEGs, the level of noise, and the method applied all had
strong effects as shown in Figure 5.24, which shows MCC values for noise
= 0.2 and noise = 0.4 (results for noise = 0 are not shown because they
were very similar to noise = 0.2). In addition, we corroborated that the
performance of NOISeqBIO (Bio4 in Figure 5.24) was better than NOISeq on
data with biological replicates.
We also observed that sequencing depth had no influence in the perfor-
mance of the methods, since data are normalized to correct this effect prior
to computing differential expression (data not shown). Therefore, we used a
default value of 30 million reads for further studies. As expected, the num-
ber of replicates had an important effect on the results so we paid special
attention to this parameter in the following comparisons.
5.4.2.2 Comparison on simulated data
For this final comparison of DE methods on data with biological replicates,
we also used the simulation algorithm described in Section 5.2.2.2 to emu-
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Figure 5.23: The effect of the β parameter on the performance of several
methods (NOISeq, NOISeqBIO, edgeR, DESeq, and SAMseq) on datasets sim-
ulated from samples in an A. fumigatus experiment. The parameters for the
simulation were: ngenes = 9862, nrepl = 5 in both conditions, depth = 30
million, noise = 0, 0.2, 0.4, and propdeg = 0.01, 0.05, 0.1.
l
l l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
noise = 0
DEG proportion
SE
0.01 0.05 0.1
l Bio4
DESeq
edgeR
NOISeq
SAMseq
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
noise = 0.2
DEG proportion
SE
0.01 0.05 0.1
l Bio4
DESeq
edgeR
NOISeq
SAMseq
l
l
ll
l
l l
ll
ll
l
l
l l l l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
noise = 0.4
DEG proportion
SE
0.01 0.05 0.1
l Bio4
DESeq
edgeR
NOISeq
SAMseq
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
ll
l l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
noise = 0
DEG proportion
FD
R
0.01 0.05 0.1
l Bio4
DESeq
edgeR
NOISeq
SAMseq
l l l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
noise = 0.2
DEG proportion
FD
R
0.01 0.05 0.1
l Bio4
DESeq
edgeR
NOISeq
SAMseq
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
noise = 0.4
DEG proportion
FD
R
0.01 0.05 0.1
l Bio4
DESeq
edgeR
NOISeq
SAMseq
l
l
l
l
l
l
l
l
l
l
l
l ll
l l l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
noise = 0
DEG proportion
M
CC
0.01 0.05 0.1
l Bio4
DESeq
edgeR
NOISeq
SAMseq
l
l
l
l
l
l
l
l
ll
l
ll
l
l l l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
noise = 0.2
DEG proportion
M
CC
0.01 0.05 0.1
l Bio4
DESeq
edgeR
NOISeq
SAMseq
ll
l
l
l
l
l l
l
l
l l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
noise = 0.4
DEG proportion
M
CC
0.01 0.05 0.1
l Bio4
DESeq
edgeR
NOISeq
SAMseq
l
l
l
l
l
l
l
l
ll
ll
Figure 5.24: Performance measured by MCC of several methods when applied
to datasets simulated from samples in an A. fumigatus experiment. The param-
eters for the simulation were: ngenes = 9862, nrepl = 5 in both conditions,
depth = 30 million. Data were normalized with the TMM method.
late different biological scenarios of high and low variability. The values of
the simulation parameters were defined according to the results from studies
described in the previous section:
• Organism: The data were simulated from either FO or HS experi-
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mental samples, giving rise to data with different numbers of genes
(ngenes) and initial count distributions (µ0).
• Noise: We considered no noise (0) and 20% noise (0.2).
• Replicates: The number of replicates per condition is decisive for the
performance of statistical methods. We considered data with few repli-
cates (2 or 3 replicates), which are still quite common in RNA-seq
experiments, and data with 5 and 10 replicates.
• DEG: The percentage of differentially expressed genes was set to either
5% or 10%.
We generated 10 datasets per each combination of these parameter values,
resulting in a total number of 320 simulated datasets for each scenario of
biological variability (high and low). To assess the performance of the methods
being compared when setting a given adjusted p-value cutoff (e.g. 0.05), we
computed the SE, FDR and MCC.
Figures 5.25 and 5.26 considered all simulated scenarios with high bio-
logical variability and showed that SE is, in general, higher than 90% for
all methods, except for SAMseq. This method fails to detect any DEGs on
low replication experiments (2-3 replicates per condition) (Figure 5.25), al-
though it tends to improve for higher numbers of replicates. Differences in
performance for the other three methods can be observed in the boxplots but
were also analyzed by an ANOVA model with repeated measures for each of
the three indicators (SE, FDR and MCC) on results excluding the SAMseq
method. Tukey post-hoc tests revealed that NOISeqBIO significantly outper-
forms the other two methods in terms of FDR, except in the 2 replicates case,
where no significant differences compared to edgeR were observed. In con-
trast, parametric methods (edgeR and DESeq2) have significantly higher SE
than NOISeqBIO (except for data with 10 replicates), and generally produced
an SE of higher than 90% for all three methods. However, this higher SE for
the low-replicate case comes at the expense of increasing the FDR, which was
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higher than 5% in all cases. The SE was close to 100% in high replication
experiments for all methods, but the FDR for parametric methods was sur-
prisingly high in many cases, especially in scenarios with a high technical noise
level (Figures 5.27 to 5.30). Thus, the MCC results lead us to conclude that
for 2 replicates, the performance of NOISeq falls between edgeR and DESeq2
and, for 3 replicates, there was no difference in MCC between NOISeqBIO
and edgeR, which both outperformed DESeq2. Finally, for highly-replicated
experiments, NOISeqBIO performed significantly better than the other two
methods in terms of MCC.
When evaluating the results from the DE methods in more depth in differ-
ent biological scenarios of high variability (Figures 5.27 to 5.30), we observed
that the performance of the methods is very similar for different organisms
(with a different number of genes) and for different proportions of DEGs.
Again, all methods except SAMseq presented good results in terms of SE,
FDR and MCC when applied to non-noisy data (Figures 5.27 and 5.29).
However, when considering the more realistic scenario of a noise level of 0.2
(Figures 5.28 and 5.30), bigger differences were found between the methods
and it is in this scenario that NOISeqBIO best controlled FDR compared to
the other methods.
When analyzing the scenarios of low biological variability (Figures 5.31
and 5.32) we observed that NOISeqBIO performance on data with 5 and 10
replicates was again better than for the other methods, especially in terms
of FDR. For the 3 replicates case, NOISeqBIO FDR increases with regard
to the high variability scenario but is still lower than for the other methods.
However, when only 2 replicates are available, NOISeqBIO FDR is higher
than for edgeR but again lower than for DESeq2. SAMseq fails to detect
any DEG in data with two replicates but performs better with three replicates
when compared to high variability scenarios. If MCC results are analyzed,
NOISeqBIO outperforms the rest of the methods in all cases except the 2
replicate case, where edgeR is the best option.
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Figure 5.25: HIGH biological variability scenario. SE, FDR, and MCC of dif-
ferential expression methods for data with a low number of replicates using an
adjusted p-value cutoff of 0.05 (equivalent to a probability of 0.95 for NOISe-
qBIO). This cutoff corresponds to the red horizontal line in FDR plots. Results
for all simulation parameter values were aggregated.
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Figure 5.26: HIGH biological variability scenario. SE, FDR, and MCC of dif-
ferential expression methods for data with a high number of replicates using an
adjusted p-value cutoff of 0.05 (equivalent to a probability of 0.95 for NOISe-
qBIO). This cutoff corresponds to the red horizontal line in FDR plots. Results
for all simulation parameter values were aggregated.
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Figure 5.27: Performance of differential expression methods on data simulated
from F. oxysporum data with noise = 0, and a FDR cutoff of 0.05 for all
methods.
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Figure 5.28: Performance of differential expression methods on data simulated
from F. oxysporum data with noise = 0.2, and a FDR cutoff of 0.05 for all
methods.
156 5. DIFFERENTIAL EXPRESSION IN RNA-SEQ
l
l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.05
#replicates
SE
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.05
#replicates
FD
R
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.05
#replicates
M
CC
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.1
#replicates
SE
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.1
#replicates
FD
R
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.1
#replicates
M
CC
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.05
#replicates
SE
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l
l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.05
#replicates
FD
R
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.05
#replicates
M
CC
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.1
#replicates
SE
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l
l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.1
#replicates
FD
R
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.1
#replicates
M
CC
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.05
#replicates
SE
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.05
#replicates
FD
R
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.05
#replicates
M
CC
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.1
#replicates
SE
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.1
#replicates
FD
R
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.1
#replicates
M
CC
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.05
#replicates
SE
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l
l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.05
#replicates
FD
R
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.05
#replicates
M
CC
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.1
#replicates
SE
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l
l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.1
#replicates
FD
R
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.1
#replicates
M
CC
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.05
#replicates
SE
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.05
#replicates
FD
R
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.05
#replicates
M
CC
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.1
#replicates
SE
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.1
#replicates
FD
R
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0 ; %deg = 0.1
#replicates
M
CC
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.05
#replicates
SE
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l
l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.05
#replicates
FD
R
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.05
#replicates
M
CC
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l l l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.1
#replicates
SE
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l
l l0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.1
#replicates
FD
R
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
HS ; noise = 0.2 ; %deg = 0.1
#replicates
M
CC
2 3 5 10
l NOISeqBIO
edgeR
DESeq2
SAMseq
Figure 5.29: Performance of differential expression methods on data simulated
from prostate cancer data with noise = 0, and a FDR cutoff of 0.05 for all
methods.
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Figure 5.30: Performance of differential expression methods on data simulated
from prostate cancer data with noise = 0.2, and a FDR cutoff of 0.05 for all
methods.
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Figure 5.31: LOW biological variability scenario. SE, FDR, and MCC of dif-
ferential expression methods for data with a low number of replicates using an
adjusted p-value cutoff of 0.05 (equivalent to a probability of 0.95 for NOISe-
qBIO). This cutoff corresponds to the red horizontal line in FDR plots. Results
for all simulation parameter values were aggregated.
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Figure 5.32: LOW biological variability scenario. SE, FDR, and MCC of dif-
ferential expression methods for data with a high number of replicates using an
adjusted p-value cutoff of 0.05 (equivalent to a probability of 0.95 for NOISe-
qBIO). This cutoff corresponds to the red horizontal line in FDR plots. Results
for all simulation parameter values were aggregated.
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5.4.2.3 Results on experimental datasets
Finally, we computed differential expression on FO and HS experimental
datasets taking a cutoff of 0.05 for adjusted p-values, or equivalently, a prob-
ability cutoff of 0.95 for NOISeqBIO. The results are summarized in Figure
5.33.
FO_HS_2
Page 8
# genes CV (%) % DE genes (over total)
Data # replicates total after filter median DESeq2
FO 2 18066 10125 21.2% 31.5% 26.5% 24.5% 39.0%
HS 12 – 11 59573 17207 39.5% 2.9% 6.7% 7.4% 9.6%
NOISeqBIO edgeR SAMseq
Figure 5.33: Characteristics of FO and HS data sets regarding number of
replicates, number of genes, coefficient of variation and %DEG.
Results for the FO dataset (Figure 5.34), which has 2 replicates per condi-
tion, indicated that the number of DEGs was very high for all methods (from
25% DEG in DESeq2 to 39% in SAMseq), especially for non-parametric ap-
proaches (NOISeqBIO and SAMseq). According to the coefficient of variation,
this data set could be considered to belong to a high variability scenario so it
seems that it is confirmed that NOISeqBIO may be returning a high number
of false positives. However, NOISeqBIO results were more similar to edgeR or
DESeq2 results than SAMseq results. When considering an experiment with
more replication such as HS data with 11 and 12 replicates per condition
(Figure 5.35), the results change considerably and the proportion of DEGs
varies from 3% (NOISeqBIO) to nearly 10% (SAMseq).
Spearman’s correlation coefficient between FDR values obtained from all
the methods (Figures 5.36 and 5.37) was generally higher than 0.95, showing
a good agreement on the gene ranking between methods. The only exception
was SAMseq that presented a correlation with the rest of the methods of
around 0.6 in FO data, and from 0.85 to 0.91 in HS data, again highlighting
the effect of the number of replicates on its performance. Figures 5.36 and
5.37 also show the number of DEGs in common between each pair of methods.
GOseq [152] functional enrichment analysis was performed on each set of
DEGs from the prostate cancer data to try to determine which DE method
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Figure 5.34: Differential expression results from methods compared applied to
F. oxysporum data. The differentially expressed genes declared by each method
are displayed in color.
resulted in a more biologically meaningful set of DEG genes, i.e. to unveil if
the DEGs that were not in common contributed to generating better func-
tional characterization of the results from any of the methods. However, this
analysis revealed no major functional differences between the DE results for
the methods compared (results not shown). In all cases, the enriched Gene
Ontology terms included functions related to cancer or to prostate.
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Figure 5.35: Differential expression results from methods compared applied
to human prostate data. The differentially expressed genes declared by each
method are displayed in color.
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Figure 5.36: Differential expression results from FO data. The diagonal con-
tains the number of DEGs for each method. Above the diagonal the number
of DEGs in common for each pair of methods is shown. Below the diagonal
Spearman’s rank correlation coefficient between FDR or 1-probability for each
pair of methods is shown.
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Figure 5.37: Differential expression results from HS data. The diagonal con-
tains the number of DEGs for each method. Above the diagonal the number
of DEGs in common for each pair of methods is shown. Below the diagonal
Spearman’s rank correlation coefficient between FDR or 1-probability for each
pair of methods is shown.
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5.5 Discussion
Differential expression analysis is widely used in transcriptomics to identify
changes in gene expression. The genes that are differentially expressed under
a given experimental condition may be responsible for the change in the
phenotype and therefore are candidates for experimental validation or as the
basis for proposing new hypotheses.
With the arrival of RNA-seq technology, researchers in bioinformatics re-
alized that the statistical methods previously used for microarrays were no
longer valid because of the different nature of the measurements: discrete
values (read counts), in contrast to continuous values from microarrays (in-
tensities). Many DE methods have been developed since then, and most
of them are based on parametric assumptions [107]. Parametric methods
are said to have more power and robustness than non-parametric methods,
however, there are some drawbacks that must be taken into account. First,
researchers should check that the parametric assumptions are fulfilled, al-
though it is neither easy nor common to find this kind of verifications in
bioinformatics because of the huge number of models derived. Thus, in some
cases parametric methods could be unsuitable and using them could generate
a false positive rate higher than expected [79]. Second, parametric methods
need raw counts to be provided since they are based on discrete distributions
such as the Poisson or Negative Binomial. However, sometimes the available
data have already been normalized by the expression quantification software
(e.g. FPKM values coming from Cufflinks [144]) and so raw read counts
are not available. Other times the application of transformations to remove
technical biases or batch effects may be necessary. In these circumstances,
the distributional assumptions may not hold. Hence, the scientific commu-
nity would benefit from having appropriate non-parametric alternatives for
differential expression.
In this chapter, we presented two non-parametric differential expression
approaches included in the NOISeq R Bioconductor package: NOISeq and
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NOISeqBIO. NOISeq [141] was optimized for experiments with technical repli-
cates or without replication at all: the characteristics of the datasets available
at the dawn of the technology. NOISeqBIO is a new non-parametric empir-
ical Bayesian method for use with biological replicates, which are now more
common in RNA-seq experiments because of the decreasing cost of the tech-
nology, and it has been developed by joining the ideas from our previous work
and from that of Efron et al. [43].
NOISeq was compared to several RNA-seq differential expression methods:
edgeR, DESeq, baySeq, DEGseq and the traditional FET on data with tech-
nical replications. All but FET are parametric approaches. NOISeq creates
an empirical distribution of count changes (which is adapted to the available
data) from which the probability of differential expression for each feature can
be derived. In this non-parametric approach, differential expression does not
rely on individual transcript measurements, but rather on the joint distribution
of (M,D) values for all the features within the dataset.
Comparison of these methods on synthetic data showed that DEGseq-
MARS, DEGseq-LRT, FET and baySeq-Poisson performed worse than the
other methods. Therefore, we discarded all these methods except FET (be-
cause of its extended use) for further study on experimental data. Although
it has been claimed that the Poisson distribution is adequate for technical
replication [18, 92, 107], these results seem to highlight that the Negative
Binomial distribution may also be more suitable with technical replicates.
The experimental data we chose for the evaluation of the selected methods
on data with technical replicates (MAQC and Griffith’s) also included RT-PCR
measurements that could be used as a gold-standard to assess if the DEGs
identified by each method were correct. On MAQC data, both the Precision-
Recall curves and especially the FDR curves showed that NOISeq performed
much better than the parametric methods. FET presented a good FDR but a
poorer PRC. Griffith’s data, although more limited, confirmed these findings.
We studied the effect of the number of technical replicates (lanes) on
the number of differentially expressed genes, their length, fold-change value,
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and expression level. The pattern produced by NOISeq and FET was more
constant across the different variables analyzed, whereas the other three meth-
ods showed a pronounced dependence. The parametric approaches strongly
increased the number of significant calls as more sequencing output was in-
cluded, resulting in a considerable number of false positives (Fig. 5.10). The
newly detected genes were shorter, had a lower relative expression, and had
smaller fold-change differences than those obtained with less data. False
positive genes identified in the analysis of the MAQC data had similar char-
acteristics, suggesting that large library-size datasets analyzed by these para-
metric approaches incorporate many falsely called significant genes and/or
with small fold-change differences at the low expression range. The constant
pattern of FET was intrinsically due to a low detection power that identified
only highly expressed transcripts. However, NOISeq showed more robustness
against these sequencing depth biases while maintaining a high true positive
detection rate. We believe that, given the number of lanes sequenced and
the specific characteristics of the data analyzed, this approach creates a more
realistic estimation of the probability that a given count difference will occur
by chance, and also results in the stable control of false positives. The para-
metric approaches compared do not have this flexibility and tend to render
significant small fold-changes as sequencing numbers grow. With regard to
the two variants of NOISeq, overall NOISeq-sim and NOISeq-real performed
similarly throughout the whole study, although a slightly higher detection
rate and dependency on the sequencing depth was observed with NOISeq-
sim, and these differences were more pronounced with Griffith’s data. These
results indicate that the simulation procedure of NOISeq-sim works well to
replace technical replicates but may tend to overestimate DEG in data with
high variability among replicates.
Regarding differential expression in data with biological replicates, we car-
ried out several studies to assess the performance of the new non-parametric
method NOISeqBIO, by comparing it to some of the most widely used differen-
tial expression methods such as edgeR [123] and DESeq2 [4] on both simulated
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and experimental data. Since NOISeqBIO is a non-parametric method, we
also included the non-parametric method SAMseq [82] in these comparisons.
Preliminary studies on simulated data helped us to determine the best
variant of NOISeqBIO; this was computation of the differential expression
statistic Z as the mean of M and D, taking the 90th percentile of gene
standard deviations for the constant a0 for the variability correction, and using
the KDE to estimate densities f and f0. Since NOISeqBIO clusters genes with
similar expression levels when the number of replicates is lower than 5, we
also evaluated the effect of the number of clusters in these preliminary studies,
finally deciding to leave it to the user’s choice, although we chose 15 clusters
as the default option. The preliminary studies also served to analyze the
influence of the parameters which define the biological scenarios to simulate:
the number of replicates per condition, the noise level, and the proportion of
DEGs had the strongest effects on the performance of the methods, so a set of
scenarios for the final comparison were defined according to this information.
The final simulation study showed the superiority of NOISeqBIO in con-
trolling the FDR while maintaining a sensitivity rate above 90% in most cases,
except for the 2-replicate case in low biological variability scenarios. We ob-
served the dependence of the comparison results on the number of available
biological replicates and, interestingly, we observed that parametric methods
tend to present a higher FDR as the number of replicates increases, especially
for noisy data. SAMseq failed to detect DEGs for low replication number data
and presented a high FDR for high replication number cases.
Results from experimental datasets indicated that for data with few repli-
cates (FO) all the methods tend to declare a high number of genes as differ-
entially expressed, including SAMseq. In contrast, the proportion of detected
DEGs was lower for data with many replicates (HS), which shows the need to
increase the number of replicates to efficiently control the FDR. Correlation
of p-values was higher than 0.95 for all the methods except SAMseq. The
functional enrichment analysis rendered biologically meaningful results for all
methods.
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As RNA-seq technology becomes more affordable, experiments with a
higher number of replicates are expected and so DE methods which efficiently
deal with FDR whilst maintaining high sensitivity rates, will be needed. Hence,
NOISeqBIO perfectly fulfills these requirements. Although it has been re-
ported that non-parametric methods tend to require a higher number of repli-
cates to perform well, as we observed for SAMseq, NOISeqBIO performed
generally well with a small number of replicates while retaining the advantage
of not being based on distributional assumptions.
Therefore, in conclusion, we have proven here that we have successfully
designed two non-parametric differential expression methods (NOISeq and
NOISeqBIO) for pairwise comparisons that are a good alternative to popular
parametric approaches.
Chapter 6
General discussion and
Conclusions
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6.1 General discussion
This thesis mainly focuses on the analysis of gene expression data. Specifically,
the aim was to propose methodologies for variable selection i.e. to identify
genes whose expression significantly changes among different experimental
conditions.
Variable selection in transcriptomics is complicated for several reasons. On
the one hand, the high dimensionality of the data (many variables versus few
observations) drastically diminishes the power of statistical methods because
of the small sample size and the multiple testing correction when using univari-
ate approaches. On the other hand, data are noisy. It is not always possible to
identify the noise source and not all variables are equally noisy (for instance,
low-expression genes tend to be more noisy). The variable selection problem is
equivalent in this context to the identification of differentially expressed genes,
or genes whose change is biologically relevant and the two considerations are
not always equivalent. For example, small expression changes may be statis-
tically significant but have little biological impact. However, the effectiveness
of methods is frequently evaluated in terms of biological meaning. Univariate
statistics can capture the specifics of the behavior of each gene, although
they are strongly penalized when applying multiple testing corrections. On
the contrary, multivariate or Bayesian approaches may be more robust against
these problems but fail to identify changing genes with particular behaviors.
The technologies for measuring gene expression are constantly evolving and
statistical methods have to evolve to fit these new data structures. Moreover,
these new transcriptomics technologies give rise to novel analysis scenarios or
novel types of biases so methods need to be revisited and adapted to broader
sets of scenarios. The fact that transcriptome analysis is mostly performed by
biologists and scientists with a limited statistical background requires that any
methods proposed should be easy to adopt and apply by these users, implying
that not only methods but also accessible tools should be developed.
In this thesis we have addressed data analysis problems that were relevant
to the state of the art technologies in transcriptomics statistical analysis at
172 6. GENERAL DISCUSSION AND CONCLUSIONS
the time. We developed variable selection methods for complex microarray
experimental designs where solutions were still limited. For this purpose, we
opted for a solution that uses multivariate dimension reduction statistics with
the assumption that this would be an efficient approach to treating data that
contains both many variables and multiple conditions (Chapter 3). Subse-
quently, and as the RNA-seq technology became a reality, we investigated
suitable differential expression methods for analyzing count data (Chapter 5).
Although these two approaches may appear to have distinct target technolo-
gies, the methods or principles they use could actually be extended to each
other or to other analysis scenarios. For example, the minAS method (Chap-
ter 3), which was initially developed for using the SPE and leverage statistics
of an ASCA analysis on multifactorial data, was also a very useful strategy
for variable selection coupled to other multivariate methods. In the case of
N-way statistics, minAS effectively selected both genes and metabolites from
multivariate datasets that were modeled as three-dimensional data structures.
In the pathway network approach, where PCA is used to reduce pathway-level
gene expression data matrices to indexed pathway activities, minAS was able
to identify the most relevant (or “driving”) genes associated with each path-
way. Arguably, these methods based on dimension reduction could also be
applied to highly transformed RNA-seq data. In fact, when RNA-seq data un-
dergo extensive normalization and data transformation pre-processing steps
(such as RPKM and TMM normalization, GC bias correction, and eventually
removal of batch effects), the resulting dataset may have lost the properties
of count data and be amenable to treatment with methods normally used for
continuous data. We have observed this situation in the analysis of RNA-
seq data from the STATegra project (not shown in this work), where ASCA
and linear models were applied after several rounds of data pre-processing
(including log-transformation). On the other hand, modeling noise in gene
expression data using the M and D statistics (Chapter 5) does not specifically
require that values are discrete and hence could be applicable to other types
of genome wide gene expression measurements.
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One of the assumptions of both the minAS and the NOISeqBIO methods is
that transcriptomic changes can be modeled as a mixture of two distributions:
one corresponding to the genes that do not change their expression between
conditions and another to the genes whose expression does change. This
implies a kind of on/off situation for gene expression which is biologically jus-
tified because of how the transcriptional machinery functions. In practice, the
detection of gene expression signals is buffered by post-transcriptional regula-
tion, the broad-magnitude range of gene expression, and the noise produced
by transcriptomics technologies, which may mask the bimodal distribution.
However, we have found that in many cases bimodal modeling does return
meaningful breakpoint thresholds (as in minAS) or results in gene selection
with high accuracy (as in NOISeqBIO) which supports the general validity of
the bimodal assumption.
Another relevant aspect of this thesis is the choice of non-parametric
statistics to analyze gene expression data. Both the minAS and the NOISeq
methods are data-driven and do not rely on theoretical distributions imposed
on the data. While parametric methods can be powerful for modeling data
when the number of observations is limited, they may introduce data analysis
inaccuracies if the model assumptions are not fulfilled. This may frequently
be the case in transcriptomics, as the technologies that generate the data do
not always follow uniform or constant error rates. Conversely, non-parametric
methods may fail to identify significant changes when data is insufficient. We
have seen that the non-parametric approaches implemented in the NOISeq
package work well in terms of sensitivity and, importantly, in controlling false
discovery rates better than its parametric counterparts. Good control of the
false positives is particularly relevant in transcriptome studies due to the large
number of variables present in the datasets and the need to reliably identify
biomarkers associated with the phenotype. Alternatively, parametric methods
might be a better choice when small changes need to be detected or false
calls are not as relevant, for example, when additional filtering or validation
steps are applied to the data.
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Finally, one of the most-important lessons learned while producing the
body of work presented in this thesis was the importance of a good under-
standing of the nature of the data, and of the potential biases of the measuring
technologies, to produce quality analysis. While data pre-processing tends to
be considered a minor or prolegomenon statistical task, the reality is that pre-
processing takes most of the data analysis time and that it greatly influences
the inferential results. One important aspect here is to first identify any po-
tential biases of the technology, second to know how to assess the magnitude
of the biases in the data, and third to have tools that can, at least partially,
correct them. In this thesis, we devoted a lot of effort to developing diagnostic
plots and quality improvement procedures for RNA-seq data. These proce-
dures are now implemented in two bioinformatics resources (Qualimap [49]
and NOISeq Bioconductor R package) to make them widely accessible to the
transcriptome research community. We believe that, as quality control pro-
tocols become more generalized and easy-to-use analysis tools become more
available, the overall quality of transcriptome research will greatly improve.
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6.2 Conclusions
The conclusions of this thesis are summarized and organized in the following
text according to the goals defined in Chapter 2.
1) To develop variable selection strategies for multivariate methods
applied to microarray data.
• We proposed new variable selection methods (minAS or Gamma)
or variations of existing ones (permutation approaches) for mul-
tifactorial gene expression data and compared them to existing
methods (Box or Jackson & Mudholkar).
• The methodologies presented are all based on studying the proba-
bility distribution of a statistic which measures the importance of
the variables in the model so the selection is data-adaptive.
• We tested the performance of variable selection strategies on sim-
ulated multi-factorial expression data and checked that they gen-
erally work well in different scenarios which were defined by the
dataset size, the diversity of gene expression signals and the levels
of noise. The best strategies were Jackson & Mudholkar, minAS
and Gamma.
• These three selection strategies were applied to experimental data
to identify the genes responsible for human stem cell differentia-
tion under different oxygen concentration conditions, and relevant
biological conclusions were obtained in all cases.
• The major differences in gene selection and functional enrichment
were because of the method chosen for the SPE statistic, while
leverage seemed to be more robust for the statistical model ap-
plied.
• These strategies have been successfully applied in cases where
other multivariate techniques and “importance” statistics were
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used. They are also implemented in SEA, which is a web tool
for analyzing time-series gene expression data.
2) To generate tools to control the quality of count data from se-
quencing experiments in order to discover potential biases and to
propose procedures to mitigate their effect.
• A whole set of useful graphical and diagnostic tools was designed
to assess the quality of the RNA-seq count data prior to statistical
analysis, and the functionality of each plot was illustrated by using
experimental data.
• We provided a statistical assessment of several typical RNA-seq
biases and offered appropriate normalization tools to correct them.
• All these tools were included in an open Bioconductor R package
called NOISeq, which also offers the possibility of generating a
Quality Control Report PDF to facilitate data exploration to the
users. Some of the plots are also available in the Qualimap web
tool.
3) To develop differential expression methodologies for RNA-seq
data.
• We presented the NOISeq differential expression method for ap-
plication on RNA-seq data with technical replicates or without
replicates. NOISeq was compared to several differential expres-
sion methods: edgeR, DESeq, baySeq, DEGseq and Fisher’s exact
test. It performed well on both simulated and experimental data
and was more robust against the number of technical replicates.
• The NOISeqBIO method was adapted from NOISeq for data with
biological replicates following an empirical Bayes approach. NOISe-
qBIO was successfully compared to edgeR, DESeq2 and SAMseq
when applied on both simulated and experimental data.
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• The non-parametric NOISeq and NOISeqBIO approaches were
able to control the False Discovery Rate well when compared to
parametric or other non-parametric methods.
• Both methods have been implemented in the NOISeq Bioconduc-
tor R package.
6.3 Reach and relevance
The relevance of this thesis is justified in the following points:
• This thesis was developed within the framework of three international
research projects (TRANSPAT, Genomics and transcriptomics of detox-
ification pathways in Drosophila and STATegra) and therefore the meth-
ods developed were used to analyze the data generated by these projects,
which has contributed to the dissemination of the results of the thesis.
• The methodologies described here have been implemented as software
tools which are freely available to the scientific community: the SEA
web tool, the Qualimap suite, and the Bioconductor R package, in order
to facilitate their use. The NOISeq method has also been implemented
as an analysis option by third party software such as RNASeqGUI [126].
• This work was developed not only to generate efficient statistical meth-
ods but also with the final users of these tools (mainly biologists) in
mind. This fact is reflected in the type of journals where we have pub-
lished our research. We intend our tools to be used by as many people
as possible and considering that the number of users is proportional to
the number of citations, we are satisfied with the impact of our work (for
instance our NOISeq paper [141] had 194 citations in Google Scholar
by October 4, 2014).
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• The usefulness of these methodologies has been demonstrated to the
end users at more than ten international courses.
6.4 Future research lines
Our current and future lines of research are defined by the STATegra European
project which we are currently working on. The goal of this project is to
develop appropriate and accurate statistical procedures to integrate multiple
omics data (which have been measured on the same biological system) in order
to gain knowledge on this system. Specifically, we are tackling the analysis
of several sequencing technologies such as RNA-seq, miRNA-seq, DNase-seq,
ChIP-seq, and Methyl-seq as well as both proteomic and metabolomic data.
Efficiently integrating this variety of omics data is still a challenge and the
solutions may lie in finding the answers to each one of the following critical
points:
• Experimental design: We will study how to determine the sequencing
depth and/or the optimal number of biological replicates for each data
type, taking into account the number of biological features (genes,
genomic regions, etc.) and the intrinsic technical noise of each data
type.
• Data pre-processing: It is essential to detect and correct unwanted ef-
fects in the data such as technical biases, contamination, batch effects,
etc. in order to obtain meaningful results from posterior analysis and to
increase the power of statistical methods by reducing noise. Therefore,
we will set up efficient pre-processing procedures. We will also identify
the best approach to impute missing values.
• Variable selection: Due to the huge number of biological features that
are measured in most of the data types mentioned above, we believe
that integration strategies will benefit from previously selecting the most
relevant variables for each data type. In this sense, we are adapting some
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approaches such as pair-wise linear models (between two data types)
or machine learning methods (e.g. decision trees) and using existing
methods such as NOISeq or maSigPro.
• Integration approaches: We will apply structural equation models to
infer the connections among the different omics features from all data
types and available biological information.
• Results validation: We aim to experimentally validate some of the re-
sults generated from the statistical analysis.
• Implementation of visualization methods and user-friendly tools: Soft-
ware will be developed that allows statistical results to be visualized so
that they can be easily understood from a biological point of view. Sta-
tistical methods will also be implemented in a Bioconductor R package
and in user-friendly commercial software.

Appendix:
Quality Control Report

Quality Control of Expression Data
Generated by NOISeq on 21 Jan 2014, 18:43:47
Content
Plot Description
Biotype detection Number of genes per biotype in the genome, and detected (counts > 0) in the sample/condition.
Biotype expression Distribution of gene counts per million per biotype in sample/condition (only genes with counts > 0).
Saturation Number of detected genes (counts > 0) per sample across different sequencing depths
Expression boxplot Distribution of gene counts per million (all biotypes) in each sample/condition
Expression barplot Percentage of genes with >0, >1, >2, >5 or >10 counts per million in each sample/condition.
Length bias Mean gene expression per each length bin. Fitted curve and diagnostic test.
GC content bias Mean gene expression per each GC content bin. Fitted curve and diagnostic test.
RNA composition bias Density plots of log fold changes (M) between pairs of samples.
Confidence intervals for the median of M values.
Biotype detection per condition
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Diagnostic plot for feature length bias
FAILED. At least one of the model p−values was lower than 0.05 and R2 > 70%.
Normalization for correcting length bias is recommended.
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Diagnostic plot for GC content bias
WARNING. At least one of the model p−values was lower than 0.05, but R2 < 70% for at least one condition.
Normalization for correcting GC content bias could be advisable.
Plese check in the plots below the strength of the relationship between GC content and expression.
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Diagnostic plot for differences in RNA composition
FAILED. There is a pair of samples with significantly different RNA composition
Normalization for correcting this bias is required.
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